ID,Excretion ID,Subject group,Population,Country,Cohort,No. of subjects,No. of cases,No. of controls,Biospecimen,Analytical method,Biomarker,Biomarker detail,Cancer,Study design,Publication
1,20999,All,Renal cell carcinoma cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",448,224,224,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",Kidney cancer,Nested case-control study,Gibson 2010
6,21004,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),3004,1502,1502,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Bakker 2016
7,21005,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),3004,1502,1502,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Bakker 2016
8,21006,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),3004,1502,1502,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Bakker 2016
9,21007,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),3004,1502,1502,"Plasma, fasting and non-fasting",HPLC,Lutein,"",Breast cancer,Nested case-control study,Bakker 2016
10,21008,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),3004,1502,1502,"Plasma, fasting and non-fasting",HPLC,Zeaxanthin,"",Breast cancer,Nested case-control study,Bakker 2016
11,21009,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),3004,1502,1502,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Bakker 2016
12,21010,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),3004,1502,1502,"Plasma, fasting and non-fasting",HPLC,Retinol,"",Breast cancer,Nested case-control study,Bakker 2016
13,21011,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),3004,1502,1502,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Breast cancer,Nested case-control study,Bakker 2016
14,21012,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),3004,1502,1502,"Plasma, fasting and non-fasting",HPLC,gamma-Tocopherol,"",Breast cancer,Nested case-control study,Bakker 2016
15,21013,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),3004,1502,1502,"Plasma, fasting and non-fasting",Colorimetry,Vitamin C,"",Breast cancer,Nested case-control study,Bakker 2016
36,21035,All,Liver cancer cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",29046,208,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Liver cancer,Prospective cohort study,Lai 2014
37,21036,All,Liver cancer cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",29046,208,,"Serum, fasting",HPLC,beta-Carotene,"",Liver cancer,Prospective cohort study,Lai 2014
38,21037,All,Liver cancer cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",29046,208,,"Serum, fasting",HPLC,Retinol,"",Liver cancer,Prospective cohort study,Lai 2014
39,21038,All,Pancreatic cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),892,446,446,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Pancreatic cancer,Nested case-control study,Jeurnink 2015
40,21039,All,Pancreatic cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),892,446,446,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Pancreatic cancer,Nested case-control study,Jeurnink 2015
41,21040,All,Pancreatic cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),892,446,446,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Pancreatic cancer,Nested case-control study,Jeurnink 2015
42,21041,All,Pancreatic cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),892,446,446,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Pancreatic cancer,Nested case-control study,Jeurnink 2015
43,21043,All,Pancreatic cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),892,446,446,"Plasma, fasting and non-fasting",HPLC,Zeaxanthin,"",Pancreatic cancer,Nested case-control study,Jeurnink 2015
44,21044,All,Pancreatic cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),892,446,446,"Plasma, fasting and non-fasting",HPLC,Lutein,"",Pancreatic cancer,Nested case-control study,Jeurnink 2015
45,21045,All,Pancreatic cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),892,446,446,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Pancreatic cancer,Nested case-control study,Jeurnink 2015
46,21046,All,Pancreatic cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),892,446,446,"Plasma, fasting and non-fasting",HPLC,gamma-Tocopherol,"",Pancreatic cancer,Nested case-control study,Jeurnink 2015
47,21048,All,Pancreatic cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),892,446,446,"Plasma, fasting and non-fasting",Colorimetry,Vitamin C,"",Pancreatic cancer,Nested case-control study,Jeurnink 2015
48,21047,All,Pancreatic cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),892,446,446,"Plasma, fasting and non-fasting",HPLC,Retinol,"",Pancreatic cancer,Nested case-control study,Jeurnink 2015
51,21050,All,Renal cell carcinoma cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",448,224,224,"Serum, fasting",Tyrosine decarboxylase apoenzyme assay,Pyridoxal 5'-phosphate,"",Kidney cancer,Nested case-control study,Gibson 2010
52,21049,All,Renal cell carcinoma cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",448,224,224,"Serum, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",Kidney cancer,Nested case-control study,Gibson 2010
53,21051,All,Renal cell carcinoma cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",448,224,224,"Serum, fasting",HPLC,Riboflavin,"",Kidney cancer,Nested case-control study,Gibson 2010
54,21052,All,Renal cell carcinoma cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",448,224,224,"Serum, fasting",HPLC,Homocysteine,"",Kidney cancer,Nested case-control study,Gibson 2010
58,21064,All,Colorectal cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),2798,1399,1399,"Plasma, fasting and non-fasting",HPLC,Canthaxanthin,"",Colon and rectal cancer,Nested case-control study,Leenders 2014
59,21065,All,Colorectal cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),2798,1399,1399,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Colon and rectal cancer,Nested case-control study,Leenders 2014
60,21066,All,Colorectal cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),2798,1399,1399,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Colon and rectal cancer,Nested case-control study,Leenders 2014
61,21067,All,Colorectal cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),2798,1399,1399,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Colon and rectal cancer,Nested case-control study,Leenders 2014
62,21068,All,Colorectal cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),2798,1399,1399,"Plasma, fasting and non-fasting",HPLC,Lutein,"",Colon and rectal cancer,Nested case-control study,Leenders 2014
63,21069,All,Colorectal cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),2798,1399,1399,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Colon and rectal cancer,Nested case-control study,Leenders 2014
64,21070,All,Colorectal cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),2798,1399,1399,"Plasma, fasting and non-fasting",HPLC,Zeaxanthin,"",Colon and rectal cancer,Nested case-control study,Leenders 2014
65,21071,All,Pancreatic cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),892,446,446,"Plasma, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,Pancreatic cancer,Nested case-control study,Jeurnink 2015
68,21075,All,Prostate cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,68,,"Serum, fasting",HPLC,beta-Carotene,"",Prostate cancer,Prospective cohort study,Karppi 2012
69,21074,All,Prostate cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,68,,"Serum, fasting",HPLC,alpha-Carotene,"",Prostate cancer,Prospective cohort study,Karppi 2012
70,21076,All,Prostate cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,68,,"Serum, fasting",HPLC,Lycopene,"",Prostate cancer,Prospective cohort study,Karppi 2012
71,21077,All,Prostate cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,68,,"Serum, fasting",HPLC,Retinol,"",Prostate cancer,Prospective cohort study,Karppi 2012
72,21078,All,Prostate cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,68,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Prostate cancer,Prospective cohort study,Karppi 2012
73,21079,All,Prostate cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",1504,680,824,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",Prostate cancer,Nested case-control study,Weinstein 2012
74,21080,All,Prostate cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",1504,680,824,"Serum, non-fasting",HPLC,gamma-Tocopherol,"",Prostate cancer,Nested case-control study,Weinstein 2012
75,21081,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),2018,959,1059,"Plasma, fasting and non-fasting",Mass spectrometry (MS),Selenium,"",Prostate cancer,Nested case-control study,Allen 2008
76,21082,All,Prostate cancer cases and their controls,United States,CLUE,350,117,233,"Plasma, unspecified",HPLC,alpha-Tocopherol,"",Prostate cancer,Nested case-control study,Helzlsouer 2000
77,21083,All,Prostate cancer cases and their controls,United States,CLUE,350,117,233,"Plasma, unspecified",HPLC,gamma-Tocopherol,"",Prostate cancer,Nested case-control study,Helzlsouer 2000
78,21084,All,Prostate cancer cases and their controls,United States,CLUE,350,117,233,Toenail,Neutron activation analysis,Selenium,"",Prostate cancer,Nested case-control study,Helzlsouer 2000
79,21085,All,Lung cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,414,144,270,"Serum, unspecified",HPLC,alpha-Tocopherol,"",Lung cancer,Nested case-control study,Knekt 1993
89,21099,All,Non-Hodgkin lymphoma cases and their controls,United States,MEC (Multiethnic Cohort Study),809,271,538,"Serum, fasting and non-fasting",HPLC,Tocopherols,alpha-Tocopherol + delta-Tocopherol + beta/gamma-Tocopherol,Lymphoid cancer,Nested case-control study,Morimoto 2013
90,21098,All,Non-Hodgkin lymphoma cases and their controls,United States,MEC (Multiethnic Cohort Study),809,271,538,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Lymphoid cancer,Nested case-control study,Morimoto 2013
91,21100,All,Non-Hodgkin lymphoma cases and their controls,United States,MEC (Multiethnic Cohort Study),809,271,538,"Serum, fasting and non-fasting",HPLC,beta/gamma-Tocopherol,"",Lymphoid cancer,Nested case-control study,Morimoto 2013
92,21101,All,Non-Hodgkin lymphoma cases and their controls,United States,MEC (Multiethnic Cohort Study),809,271,538,"Serum, fasting and non-fasting",HPLC,delta-Tocopherol,"",Lymphoid cancer,Nested case-control study,Morimoto 2013
93,21105,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1086,366,720,"Serum, fasting and non-fasting",HPLC,Lutein,"",Breast cancer,Nested case-control study,Maillard 2010
94,21106,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1086,366,720,"Serum, fasting and non-fasting",HPLC,Zeaxanthin,"",Breast cancer,Nested case-control study,Maillard 2010
95,21107,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1086,366,720,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Maillard 2010
96,21108,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1086,366,720,"Serum, fasting and non-fasting",HPLC,Canthaxanthin,"",Breast cancer,Nested case-control study,Maillard 2010
97,21109,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1086,366,720,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Maillard 2010
98,21110,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1086,366,720,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Maillard 2010
99,21111,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1086,366,720,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Maillard 2010
100,21112,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1086,366,720,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Canthaxanthin,Breast cancer,Nested case-control study,Maillard 2010
101,21102,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1086,366,720,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Breast cancer,Nested case-control study,Maillard 2010
102,21103,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1086,366,720,"Serum, fasting and non-fasting",HPLC,gamma-Tocopherol,"",Breast cancer,Nested case-control study,Maillard 2010
103,21104,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1086,366,720,"Serum, fasting and non-fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,Breast cancer,Nested case-control study,Maillard 2010
104,21113,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1086,366,720,"Serum, fasting and non-fasting",HPLC,Retinol,"",Breast cancer,Nested case-control study,Maillard 2010
105,21114,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),1403,467,936,"Serum, fasting and non-fasting",Neutron activation analysis,Selenium,"",Prostate cancer,Nested case-control study,Gill 2009
106,21116,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),1403,467,936,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Prostate cancer,Nested case-control study,Gill 2009
107,21117,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),1403,467,936,"Serum, fasting and non-fasting",HPLC,gamma-Tocopherol,"",Prostate cancer,Nested case-control study,Gill 2009
108,21115,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),1403,467,936,"Serum, fasting and non-fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,Prostate cancer,Nested case-control study,Gill 2009
109,21119,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),1403,467,936,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Prostate cancer,Nested case-control study,Gill 2009
110,21120,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),1403,467,936,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Prostate cancer,Nested case-control study,Gill 2009
111,21121,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),1403,467,936,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Prostate cancer,Nested case-control study,Gill 2009
112,21122,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),1403,467,936,"Serum, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",Prostate cancer,Nested case-control study,Gill 2009
113,21118,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),1403,467,936,"Serum, fasting and non-fasting",HPLC,Carotenoids,beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Prostate cancer,Nested case-control study,Gill 2009
114,21123,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),1403,467,936,"Serum, fasting and non-fasting",HPLC,Retinol,"",Prostate cancer,Nested case-control study,Gill 2009
115,21124,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + trans-Anhydroluteins + cis-Anhydroluteins + alpha-Cryptoxanthin + cis-beta-Cryptoxanthins + cis-beta-Carotenes,Breast cancer,Nested case-control study,Epplein 2009
116,21125,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,Carotenes,alpha-Carotene + beta-Carotene + cis-beta-Carotenes,Breast cancer,Nested case-control study,Epplein 2009
117,21126,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Epplein 2009
118,21127,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,beta-Carotene (cis + trans),beta-Carotene + cis-beta-Carotenes,Breast cancer,Nested case-control study,Epplein 2009
119,21128,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Epplein 2009
120,21129,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,Zeaxanthin + Lutein,Breast cancer,Nested case-control study,Epplein 2009
121,21130,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,alpha-Cryptoxanthin,"",Breast cancer,Nested case-control study,Epplein 2009
122,21131,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Epplein 2009
123,21132,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,Retinol,"",Breast cancer,Nested case-control study,Epplein 2009
124,21133,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,Tocopherols,alpha-Tocopherol + delta-Tocopherol + beta/gamma-Tocopherol,Breast cancer,Nested case-control study,Epplein 2009
125,21134,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Breast cancer,Nested case-control study,Epplein 2009
126,21135,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,delta-Tocopherol,"",Breast cancer,Nested case-control study,Epplein 2009
127,21148,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,Tocopherols,alpha-Tocopherol + delta-Tocopherol + beta/gamma-Tocopherol,Breast cancer,Nested case-control study,Dorjgochoo 2009
128,21155,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
129,21149,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,alpha-Tocopherol,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
130,21150,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,beta/gamma-Tocopherol,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
131,21151,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,delta-Tocopherol,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
132,21152,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,Retinol,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
133,21153,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lutein + beta-Carotene + cis-Lutein/Zeaxanthin + trans-Anhydroluteins + cis-Anhydroluteins + alpha-Cryptoxanthin + cis-beta-Cryptoxanthins + cis-beta-Carotenes + Lycopenes,Breast cancer,Nested case-control study,Dorjgochoo 2009
134,21154,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,beta-Carotene (cis + trans),beta-Carotene + cis-beta-Carotenes,Breast cancer,Nested case-control study,Dorjgochoo 2009
135,21156,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,Lycopenes,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
136,21157,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,Lutein/Zeaxanthin,Zeaxanthin + Lutein,Breast cancer,Nested case-control study,Dorjgochoo 2009
137,21158,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
138,21159,All,Gastric cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),1022,511,511,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",Gastric and oesophageal cancer,Nested case-control study,Persson 2008
139,21160,All,Gastric cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),1022,511,511,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Gastric and oesophageal cancer,Nested case-control study,Persson 2008
140,21161,All,Gastric cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),1022,511,511,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Gastric and oesophageal cancer,Nested case-control study,Persson 2008
141,21162,All,Gastric cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),1022,511,511,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Gastric and oesophageal cancer,Nested case-control study,Persson 2008
142,21163,All,Gastric cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),1022,511,511,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Gastric and oesophageal cancer,Nested case-control study,Persson 2008
143,21164,All,Gastric cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),1022,511,511,"Plasma, fasting and non-fasting",HPLC,Retinol,"",Gastric and oesophageal cancer,Nested case-control study,Persson 2008
144,21165,All,Gastric cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),1022,511,511,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Gastric and oesophageal cancer,Nested case-control study,Persson 2008
145,21166,All,Gastric cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),1022,511,511,"Plasma, fasting and non-fasting",HPLC,gamma-Tocopherol,"",Gastric and oesophageal cancer,Nested case-control study,Persson 2008
154,21176,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),2030,966,1064,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Prostate cancer,Nested case-control study,Key 2007
155,21177,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),2030,966,1064,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Prostate cancer,Nested case-control study,Key 2007
156,21178,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),2030,966,1064,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Prostate cancer,Nested case-control study,Key 2007
157,21179,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),2030,966,1064,"Plasma, fasting and non-fasting",HPLC,Lutein,"",Prostate cancer,Nested case-control study,Key 2007
158,21180,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),2030,966,1064,"Plasma, fasting and non-fasting",HPLC,Zeaxanthin,"",Prostate cancer,Nested case-control study,Key 2007
159,21181,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),2030,966,1064,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Prostate cancer,Nested case-control study,Key 2007
160,21182,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),2030,966,1064,"Plasma, fasting and non-fasting",HPLC,Canthaxanthin,"",Prostate cancer,Nested case-control study,Key 2007
161,21175,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),2030,966,1064,"Plasma, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Canthaxanthin,Prostate cancer,Nested case-control study,Key 2007
162,21183,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),2030,966,1064,"Plasma, fasting and non-fasting",HPLC,Retinol,"",Prostate cancer,Nested case-control study,Key 2007
163,21184,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),2030,966,1064,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Prostate cancer,Nested case-control study,Key 2007
164,21185,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),2030,966,1064,"Plasma, fasting and non-fasting",HPLC,gamma-Tocopherol,"",Prostate cancer,Nested case-control study,Key 2007
165,21186,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),1300,213,1087,"Serum, non-fasting",HPLC,Retinol,"",Liver cancer,Nested case-control study,Yuan 2006
166,21187,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),1300,213,1087,"Serum, non-fasting",HPLC,alpha-Carotene,"",Liver cancer,Nested case-control study,Yuan 2006
167,21188,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),1300,213,1087,"Serum, non-fasting",HPLC,beta-Carotene,"",Liver cancer,Nested case-control study,Yuan 2006
168,21189,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),1300,213,1087,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",Liver cancer,Nested case-control study,Yuan 2006
169,21190,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),1300,213,1087,"Serum, non-fasting",HPLC,Lutein,"",Liver cancer,Nested case-control study,Yuan 2006
170,21191,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),1300,213,1087,"Serum, non-fasting",HPLC,Lycopene,"",Liver cancer,Nested case-control study,Yuan 2006
171,21192,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),1300,213,1087,"Serum, non-fasting",HPLC,Zeaxanthin,"",Liver cancer,Nested case-control study,Yuan 2006
172,21193,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),1300,213,1087,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",Liver cancer,Nested case-control study,Yuan 2006
173,21194,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),1300,213,1087,"Serum, non-fasting",HPLC,gamma-Tocopherol,"",Liver cancer,Nested case-control study,Yuan 2006
174,21195,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),1300,213,1087,"Serum, non-fasting",HPLC,delta-Tocopherol,"",Liver cancer,Nested case-control study,Yuan 2006
175,21196,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),1300,213,1087,"Serum, non-fasting",Atomic absorption spectrometry (AAS),Selenium,"",Liver cancer,Nested case-control study,Yuan 2006
176,21198,All,Gastric adenocarcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),889,244,645,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Gastric and oesophageal cancer,Nested case-control study,Jenab 2006
177,21199,All,Gastric adenocarcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),889,244,645,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Gastric and oesophageal cancer,Nested case-control study,Jenab 2006
178,21200,All,Gastric adenocarcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),889,244,645,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Gastric and oesophageal cancer,Nested case-control study,Jenab 2006
179,21201,All,Gastric adenocarcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),889,244,645,"Plasma, fasting and non-fasting",HPLC,Canthaxanthin,"",Gastric and oesophageal cancer,Nested case-control study,Jenab 2006
180,21202,All,Gastric adenocarcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),889,244,645,"Plasma, fasting and non-fasting",HPLC,Lutein,"",Gastric and oesophageal cancer,Nested case-control study,Jenab 2006
181,21203,All,Gastric adenocarcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),889,244,645,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Gastric and oesophageal cancer,Nested case-control study,Jenab 2006
182,21204,All,Gastric adenocarcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),889,244,645,"Plasma, fasting and non-fasting",HPLC,Zeaxanthin,"",Gastric and oesophageal cancer,Nested case-control study,Jenab 2006
183,21197,All,Gastric adenocarcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),889,244,645,"Plasma, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lutein + beta-Carotene + Canthaxanthin,Gastric and oesophageal cancer,Nested case-control study,Jenab 2006
184,21205,All,Gastric adenocarcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),889,244,645,"Plasma, fasting and non-fasting",HPLC,Retinol,"",Gastric and oesophageal cancer,Nested case-control study,Jenab 2006
185,21206,All,Gastric adenocarcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),889,244,645,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Gastric and oesophageal cancer,Nested case-control study,Jenab 2006
186,21207,All,Gastric adenocarcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),889,244,645,"Plasma, fasting and non-fasting",HPLC,gamma-Tocopherol,"",Gastric and oesophageal cancer,Nested case-control study,Jenab 2006
187,21208,All,Prostate cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",300,100,200,"Serum, fasting",HPLC,alpha-Tocopherol,"",Prostate cancer,Nested case-control study,Weinstein 2005
188,21209,All,Prostate cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",300,100,200,"Serum, fasting",HPLC,gamma-Tocopherol,"",Prostate cancer,Nested case-control study,Weinstein 2005
189,21210,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),414,116,298,"Serum, unspecified",HPLC,Retinol,"",Colon and rectal cancer,Nested case-control study,Wakai 2005
190,21211,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),414,116,298,"Serum, unspecified",HPLC,beta/gamma-Tocopherol,"",Colon and rectal cancer,Nested case-control study,Wakai 2005
191,21212,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),414,116,298,"Serum, unspecified",HPLC,alpha-Tocopherol,"",Colon and rectal cancer,Nested case-control study,Wakai 2005
192,21215,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),414,116,298,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",Colon and rectal cancer,Nested case-control study,Wakai 2005
193,21216,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),414,116,298,"Serum, unspecified",HPLC,Lycopene,"",Colon and rectal cancer,Nested case-control study,Wakai 2005
194,21219,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,beta/gamma-Tocopherol,"",Breast cancer,Nested case-control study,Epplein 2009
195,21221,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1938,969,969,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Tamimi 2005
196,21222,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1938,969,969,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Tamimi 2005
197,21223,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1938,969,969,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Tamimi 2005
198,21224,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1938,969,969,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",Breast cancer,Nested case-control study,Tamimi 2005
199,21225,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1938,969,969,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Tamimi 2005
200,21220,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1938,969,969,"Plasma, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Breast cancer,Nested case-control study,Tamimi 2005
201,21226,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1938,969,969,"Plasma, fasting and non-fasting",HPLC,Retinol,"",Breast cancer,Nested case-control study,Tamimi 2005
202,21227,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1938,969,969,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Breast cancer,Nested case-control study,Tamimi 2005
203,21228,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1938,969,969,"Plasma, fasting and non-fasting",HPLC,gamma-Tocopherol,"",Breast cancer,Nested case-control study,Tamimi 2005
204,21230,All,Basal cell carcinoma cases and their controls,Australia,Nambour Skin Cancer Study,180,90,90,"Serum, non-fasting",HPLC,alpha-Carotene,"",Skin cancer,Nested case-control study,McNaughton 2005
205,21231,All,Basal cell carcinoma cases and their controls,Australia,Nambour Skin Cancer Study,180,90,90,"Serum, non-fasting",HPLC,beta-Carotene,"",Skin cancer,Nested case-control study,McNaughton 2005
206,21232,All,Basal cell carcinoma cases and their controls,Australia,Nambour Skin Cancer Study,180,90,90,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",Skin cancer,Nested case-control study,McNaughton 2005
207,21233,All,Basal cell carcinoma cases and their controls,Australia,Nambour Skin Cancer Study,180,90,90,"Serum, non-fasting",HPLC,Lutein,"",Skin cancer,Nested case-control study,McNaughton 2005
208,21234,All,Basal cell carcinoma cases and their controls,Australia,Nambour Skin Cancer Study,180,90,90,"Serum, non-fasting",HPLC,Lycopene,"",Skin cancer,Nested case-control study,McNaughton 2005
209,21229,All,Basal cell carcinoma cases and their controls,Australia,Nambour Skin Cancer Study,180,90,90,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + Lutein + beta-Carotene,Skin cancer,Nested case-control study,McNaughton 2005
210,21235,All,Basal cell carcinoma cases and their controls,Australia,Nambour Skin Cancer Study,180,90,90,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",Skin cancer,Nested case-control study,McNaughton 2005
211,21236,All,Basal cell carcinoma cases and their controls,Australia,Nambour Skin Cancer Study,180,90,90,"Serum, non-fasting",Atomic absorption spectrometry (AAS),Selenium,"",Skin cancer,Nested case-control study,McNaughton 2005
215,21252,All,Gastric cancer cases and their controls,China,SCS (Shanghai Cohort Study),761,191,570,"Serum, non-fasting",HPLC,alpha-Carotene,"",Gastric and oesophageal cancer,Nested case-control study,Yuan 2004
216,21253,All,Gastric cancer cases and their controls,China,SCS (Shanghai Cohort Study),761,191,570,"Serum, non-fasting",HPLC,beta-Carotene,"",Gastric and oesophageal cancer,Nested case-control study,Yuan 2004
217,21254,All,Gastric cancer cases and their controls,China,SCS (Shanghai Cohort Study),761,191,570,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",Gastric and oesophageal cancer,Nested case-control study,Yuan 2004
218,21255,All,Gastric cancer cases and their controls,China,SCS (Shanghai Cohort Study),761,191,570,"Serum, non-fasting",HPLC,Lycopene,"",Gastric and oesophageal cancer,Nested case-control study,Yuan 2004
219,21256,All,Gastric cancer cases and their controls,China,SCS (Shanghai Cohort Study),761,191,570,"Serum, non-fasting",HPLC,Lutein/Zeaxanthin,"",Gastric and oesophageal cancer,Nested case-control study,Yuan 2004
220,21260,All,Gastric cancer cases and their controls,China,SCS (Shanghai Cohort Study),761,191,570,"Serum, non-fasting",HPLC,Retinol,"",Gastric and oesophageal cancer,Nested case-control study,Yuan 2004
221,21257,All,Gastric cancer cases and their controls,China,SCS (Shanghai Cohort Study),761,191,570,"Serum, non-fasting",Colorimetry,Vitamin C,"",Gastric and oesophageal cancer,Nested case-control study,Yuan 2004
222,21258,All,Gastric cancer cases and their controls,China,SCS (Shanghai Cohort Study),761,191,570,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",Gastric and oesophageal cancer,Nested case-control study,Yuan 2004
223,21259,All,Gastric cancer cases and their controls,China,SCS (Shanghai Cohort Study),761,191,570,"Serum, non-fasting",HPLC,gamma-Tocopherol,"",Gastric and oesophageal cancer,Nested case-control study,Yuan 2004
249,21307,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),1872,578,1294,"Plasma, unspecified",HPLC,alpha-Carotene,"",Prostate cancer,Nested case-control study,Gann 1999
250,21308,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),1872,578,1294,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",Prostate cancer,Nested case-control study,Gann 1999
251,21309,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),1872,578,1294,"Plasma, unspecified",HPLC,Lutein,"",Prostate cancer,Nested case-control study,Gann 1999
252,21310,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),1872,578,1294,"Plasma, unspecified",HPLC,Lycopene,"",Prostate cancer,Nested case-control study,Gann 1999
253,21311,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),1872,578,1294,"Plasma, unspecified",HPLC,alpha-Tocopherol,"",Prostate cancer,Nested case-control study,Gann 1999
254,21312,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),1872,578,1294,"Plasma, unspecified",HPLC,gamma-Tocopherol,"",Prostate cancer,Nested case-control study,Gann 1999
255,21313,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),1872,578,1294,"Plasma, unspecified",HPLC,Retinol,"",Prostate cancer,Nested case-control study,Gann 1999
256,21314,All,Lung cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,285,95,190,"Serum, unspecified",Atomic absorption spectrometry (AAS),Selenium,"",Lung cancer,Nested case-control study,Knekt 1998
257,21315,All,Lung cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,285,95,190,"Serum, unspecified",HPLC,alpha-Tocopherol,"",Lung cancer,Nested case-control study,Knekt 1998
258,21316,All,Breast cancer cases and their controls,United States,Columbia Missouri Serum Bank,308,105,203,"Serum, unspecified",HPLC,Retinol,"",Breast cancer,Nested case-control study,Dorgan 1998
259,21317,All,Breast cancer cases and their controls,United States,Columbia Missouri Serum Bank,308,105,203,"Serum, unspecified",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Dorgan 1998
260,21318,All,Breast cancer cases and their controls,United States,Columbia Missouri Serum Bank,308,105,203,"Serum, unspecified",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Dorgan 1998
261,21319,All,Breast cancer cases and their controls,United States,Columbia Missouri Serum Bank,308,105,203,"Serum, unspecified",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Dorgan 1998
262,21320,All,Breast cancer cases and their controls,United States,Columbia Missouri Serum Bank,308,105,203,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",Breast cancer,Nested case-control study,Dorgan 1998
263,21321,All,Breast cancer cases and their controls,United States,Columbia Missouri Serum Bank,308,105,203,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Dorgan 1998
264,21322,All,Breast cancer cases and their controls,United States,Columbia Missouri Serum Bank,308,105,203,"Serum, unspecified",HPLC,alpha-Tocopherol,"",Breast cancer,Nested case-control study,Dorgan 1998
265,21323,All,Breast cancer cases and their controls,United States,Columbia Missouri Serum Bank,308,105,203,"Serum, unspecified",Atomic absorption spectrometry (AAS),Selenium,"",Breast cancer,Nested case-control study,Dorgan 1998
266,21324,All,Upper aerodigestive tract cancer cases and their controls,United States,HHP (Honolulu Heart Program),207,69,138,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,Head and neck cancer,Nested case-control study,Nomura 1997
267,21325,All,Upper aerodigestive tract cancer cases and their controls,United States,HHP (Honolulu Heart Program),207,69,138,"Serum, non-fasting",HPLC,Lutein,"",Head and neck cancer,Nested case-control study,Nomura 1997
268,21326,All,Upper aerodigestive tract cancer cases and their controls,United States,HHP (Honolulu Heart Program),207,69,138,"Serum, non-fasting",HPLC,Zeaxanthin,"",Head and neck cancer,Nested case-control study,Nomura 1997
269,21327,All,Upper aerodigestive tract cancer cases and their controls,United States,HHP (Honolulu Heart Program),207,69,138,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",Head and neck cancer,Nested case-control study,Nomura 1997
270,21328,All,Upper aerodigestive tract cancer cases and their controls,United States,HHP (Honolulu Heart Program),207,69,138,"Serum, non-fasting",HPLC,Lycopene,"",Head and neck cancer,Nested case-control study,Nomura 1997
271,21329,All,Upper aerodigestive tract cancer cases and their controls,United States,HHP (Honolulu Heart Program),207,69,138,"Serum, non-fasting",HPLC,alpha-Carotene,"",Head and neck cancer,Nested case-control study,Nomura 1997
272,21330,All,Upper aerodigestive tract cancer cases and their controls,United States,HHP (Honolulu Heart Program),207,69,138,"Serum, non-fasting",HPLC,beta-Carotene,"",Head and neck cancer,Nested case-control study,Nomura 1997
273,21331,All,Upper aerodigestive tract cancer cases and their controls,United States,HHP (Honolulu Heart Program),207,69,138,"Serum, non-fasting",HPLC,Retinoids,Retinol,Head and neck cancer,Nested case-control study,Nomura 1997
274,21332,All,Upper aerodigestive tract cancer cases and their controls,United States,HHP (Honolulu Heart Program),207,69,138,"Serum, non-fasting",HPLC,Retinol,"",Head and neck cancer,Nested case-control study,Nomura 1997
275,21333,All,Upper aerodigestive tract cancer cases and their controls,United States,HHP (Honolulu Heart Program),207,69,138,"Serum, non-fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol + delta-Tocopherol,Head and neck cancer,Nested case-control study,Nomura 1997
276,21334,All,Upper aerodigestive tract cancer cases and their controls,United States,HHP (Honolulu Heart Program),207,69,138,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",Head and neck cancer,Nested case-control study,Nomura 1997
277,21335,All,Upper aerodigestive tract cancer cases and their controls,United States,HHP (Honolulu Heart Program),207,69,138,"Serum, non-fasting",HPLC,delta-Tocopherol,"",Head and neck cancer,Nested case-control study,Nomura 1997
278,21336,All,Upper aerodigestive tract cancer cases and their controls,United States,HHP (Honolulu Heart Program),207,69,138,"Serum, non-fasting",HPLC,gamma-Tocopherol,"",Head and neck cancer,Nested case-control study,Nomura 1997
279,21337,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),284,142,142,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,Prostate cancer,Nested case-control study,Nomura 1997
280,21338,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),284,142,142,"Serum, non-fasting",HPLC,Lutein,"",Prostate cancer,Nested case-control study,Nomura 1997
281,21339,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),284,142,142,"Serum, non-fasting",HPLC,Zeaxanthin,"",Prostate cancer,Nested case-control study,Nomura 1997
282,21340,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),284,142,142,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",Prostate cancer,Nested case-control study,Nomura 1997
283,21341,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),284,142,142,"Serum, non-fasting",HPLC,Lycopene,"",Prostate cancer,Nested case-control study,Nomura 1997
284,21342,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),284,142,142,"Serum, non-fasting",HPLC,alpha-Carotene,"",Prostate cancer,Nested case-control study,Nomura 1997
285,21343,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),284,142,142,"Serum, non-fasting",HPLC,beta-Carotene,"",Prostate cancer,Nested case-control study,Nomura 1997
286,21344,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),284,142,142,"Serum, non-fasting",HPLC,Retinoids,Retinol,Prostate cancer,Nested case-control study,Nomura 1997
287,21345,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),284,142,142,"Serum, non-fasting",HPLC,Retinol,"",Prostate cancer,Nested case-control study,Nomura 1997
288,21346,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),284,142,142,"Serum, non-fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol + delta-Tocopherol,Prostate cancer,Nested case-control study,Nomura 1997
289,21347,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),284,142,142,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",Prostate cancer,Nested case-control study,Nomura 1997
290,21348,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),284,142,142,"Serum, non-fasting",HPLC,delta-Tocopherol,"",Prostate cancer,Nested case-control study,Nomura 1997
291,21349,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),284,142,142,"Serum, non-fasting",HPLC,gamma-Tocopherol,"",Prostate cancer,Nested case-control study,Nomura 1997
292,21350,All,Squamous cell carcinoma cases and their controls,United States,Skin Cancer Prevention Study,396,132,264,"Plasma, non-fasting",HPLC,beta-Carotene,"",Skin cancer,Nested case-control study,Karagas 1997
293,21351,All,Squamous cell carcinoma cases and their controls,United States,Skin Cancer Prevention Study,396,132,264,"Plasma, non-fasting",HPLC,Retinol,"",Skin cancer,Nested case-control study,Karagas 1997
294,21352,All,Squamous cell carcinoma cases and their controls,United States,Skin Cancer Prevention Study,396,132,264,"Plasma, non-fasting",HPLC,alpha-Tocopherol,"",Skin cancer,Nested case-control study,Karagas 1997
295,21353,All,Squamous cell carcinoma cases and their controls,United States,Skin Cancer Prevention Study,396,132,264,"Plasma, non-fasting",Neutron activation analysis,Selenium,"",Skin cancer,Nested case-control study,Karagas 1997
296,21358,All,Ovarian cancer cases and their controls,United States,CLUE,102,35,67,"Serum, fasting and non-fasting",HPLC,Retinol,"",Ovarian cancer,Nested case-control study,Helzlsouer 1996
297,21359,All,Ovarian cancer cases and their controls,United States,CLUE,102,35,67,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + Lutein + beta-Carotene,Ovarian cancer,Nested case-control study,Helzlsouer 1996
298,21360,All,Ovarian cancer cases and their controls,United States,CLUE,102,35,67,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",Ovarian cancer,Nested case-control study,Helzlsouer 1996
299,21361,All,Ovarian cancer cases and their controls,United States,CLUE,102,35,67,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Ovarian cancer,Nested case-control study,Helzlsouer 1996
300,21362,All,Ovarian cancer cases and their controls,United States,CLUE,102,35,67,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Ovarian cancer,Nested case-control study,Helzlsouer 1996
301,21363,All,Ovarian cancer cases and their controls,United States,CLUE,102,35,67,"Serum, fasting and non-fasting",HPLC,Lutein,"",Ovarian cancer,Nested case-control study,Helzlsouer 1996
302,21364,All,Ovarian cancer cases and their controls,United States,CLUE,102,35,67,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Ovarian cancer,Nested case-control study,Helzlsouer 1996
303,21365,All,Ovarian cancer cases and their controls,United States,CLUE,102,35,67,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Ovarian cancer,Nested case-control study,Helzlsouer 1996
304,21366,All,Ovarian cancer cases and their controls,United States,CLUE,102,35,67,"Serum, fasting and non-fasting",HPLC,gamma-Tocopherol,"",Ovarian cancer,Nested case-control study,Helzlsouer 1996
305,21367,All,Ovarian cancer cases and their controls,United States,CLUE,102,35,67,"Serum, fasting and non-fasting",Neutron activation analysis,Selenium,"",Ovarian cancer,Nested case-control study,Helzlsouer 1996
306,21368,All,Skin cancer cases and their controls,United States,CLUE,297,99,198,"Serum, fasting and non-fasting",HPLC,Retinol,"",Skin cancer,Nested case-control study,Breslow 1995
307,21369,All,Skin cancer cases and their controls,United States,CLUE,297,99,198,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Skin cancer,Nested case-control study,Breslow 1995
308,21370,All,Skin cancer cases and their controls,United States,CLUE,297,99,198,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Skin cancer,Nested case-control study,Breslow 1995
309,21371,All,Skin cancer cases and their controls,United States,CLUE,297,99,198,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Skin cancer,Nested case-control study,Breslow 1995
310,21372,All,Skin cancer cases and their controls,United States,CLUE,297,99,198,"Serum, fasting and non-fasting",Neutron activation analysis,Selenium,"",Skin cancer,Nested case-control study,Breslow 1995
321,21373,All,Oral and pharyngeal cancer cases and their controls,United States,CLUE,140,28,112,"Serum, fasting and non-fasting",HPLC,Retinol,"",Head and neck cancer,Nested case-control study,Zheng 1993
322,21374,All,Oral and pharyngeal cancer cases and their controls,United States,CLUE,140,28,112,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + Lutein + beta-Carotene,Head and neck cancer,Nested case-control study,Zheng 1993
323,21375,All,Oral and pharyngeal cancer cases and their controls,United States,CLUE,140,28,112,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Head and neck cancer,Nested case-control study,Zheng 1993
324,21376,All,Oral and pharyngeal cancer cases and their controls,United States,CLUE,140,28,112,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",Head and neck cancer,Nested case-control study,Zheng 1993
325,21377,All,Oral and pharyngeal cancer cases and their controls,United States,CLUE,140,28,112,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Head and neck cancer,Nested case-control study,Zheng 1993
326,21378,All,Oral and pharyngeal cancer cases and their controls,United States,CLUE,140,28,112,"Serum, fasting and non-fasting",HPLC,Lutein,"",Head and neck cancer,Nested case-control study,Zheng 1993
327,21379,All,Oral and pharyngeal cancer cases and their controls,United States,CLUE,140,28,112,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Head and neck cancer,Nested case-control study,Zheng 1993
328,21380,All,Oral and pharyngeal cancer cases and their controls,United States,CLUE,140,28,112,"Serum, fasting and non-fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,Head and neck cancer,Nested case-control study,Zheng 1993
329,21381,All,Oral and pharyngeal cancer cases and their controls,United States,CLUE,140,28,112,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Head and neck cancer,Nested case-control study,Zheng 1993
330,21382,All,Oral and pharyngeal cancer cases and their controls,United States,CLUE,140,28,112,"Serum, fasting and non-fasting",HPLC,gamma-Tocopherol,"",Head and neck cancer,Nested case-control study,Zheng 1993
331,21383,All,Oral and pharyngeal cancer cases and their controls,United States,CLUE,140,28,112,"Serum, fasting and non-fasting",Neutron activation analysis,Selenium,"",Head and neck cancer,Nested case-control study,Zheng 1993
332,21384,All,Cervical cancer cases and their controls,United States,CLUE,149,50,99,"Serum, fasting and non-fasting",HPLC,Retinol,"",Cervical cancer,Nested case-control study,Batieha 1993
333,21385,All,Cervical cancer cases and their controls,United States,CLUE,149,50,99,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + Lutein + beta-Carotene,Cervical cancer,Nested case-control study,Batieha 1993
334,21386,All,Cervical cancer cases and their controls,United States,CLUE,149,50,99,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",Cervical cancer,Nested case-control study,Batieha 1993
335,21387,All,Cervical cancer cases and their controls,United States,CLUE,149,50,99,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Cervical cancer,Nested case-control study,Batieha 1993
336,21388,All,Cervical cancer cases and their controls,United States,CLUE,149,50,99,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Cervical cancer,Nested case-control study,Batieha 1993
337,21389,All,Cervical cancer cases and their controls,United States,CLUE,149,50,99,"Serum, fasting and non-fasting",HPLC,Lutein,"",Cervical cancer,Nested case-control study,Batieha 1993
338,21390,All,Cervical cancer cases and their controls,United States,CLUE,149,50,99,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Cervical cancer,Nested case-control study,Batieha 1993
339,21391,All,Cervical cancer cases and their controls,United States,CLUE,149,50,99,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Cervical cancer,Nested case-control study,Batieha 1993
340,21392,All,Cervical cancer cases and their controls,United States,CLUE,149,50,99,"Serum, fasting and non-fasting",HPLC,gamma-Tocopherol,"",Cervical cancer,Nested case-control study,Batieha 1993
341,21393,All,Cervical cancer cases and their controls,United States,CLUE,149,50,99,"Serum, fasting and non-fasting",Neutron activation analysis,Selenium,"",Cervical cancer,Nested case-control study,Batieha 1993
343,21394,All,Oesophageal and gastric cancer cases,China,General Population Trial in Linxian,2125,1072,1053,"Serum, unspecified",HPLC,alpha-Tocopherol,"",Gastric and oesophageal cancer,Case-cohort study,Taylor 2003
347,21395,All,Oesophageal and gastric cancer cases,China,General Population Trial in Linxian,2125,1072,1053,"Serum, unspecified",HPLC,gamma-Tocopherol,"",Gastric and oesophageal cancer,Case-cohort study,Taylor 2003
350,21396,All,Colorectal cancer cases,United States,WHI (Women's Health Initiative),5477,88,,"Serum, fasting",HPLC,Retinol,"",Colon and rectal cancer,Prospective cohort study,Kabat 2012
351,21397,All,Colorectal cancer cases,United States,WHI (Women's Health Initiative),5477,88,,"Serum, fasting",HPLC,alpha-Carotene,"",Colon and rectal cancer,Prospective cohort study,Kabat 2012
352,21398,All,Colorectal cancer cases,United States,WHI (Women's Health Initiative),5477,88,,"Serum, fasting",HPLC,beta-Carotene,"",Colon and rectal cancer,Prospective cohort study,Kabat 2012
353,21399,All,Colorectal cancer cases,United States,WHI (Women's Health Initiative),5477,88,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",Colon and rectal cancer,Prospective cohort study,Kabat 2012
354,21400,All,Colorectal cancer cases,United States,WHI (Women's Health Initiative),5477,88,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",Colon and rectal cancer,Prospective cohort study,Kabat 2012
355,21401,All,Colorectal cancer cases,United States,WHI (Women's Health Initiative),5477,88,,"Serum, fasting",HPLC,Lycopene,"",Colon and rectal cancer,Prospective cohort study,Kabat 2012
356,21402,All,Colorectal cancer cases,United States,WHI (Women's Health Initiative),5477,88,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Colon and rectal cancer,Prospective cohort study,Kabat 2012
357,21403,All,Colorectal cancer cases,United States,WHI (Women's Health Initiative),5477,88,,"Serum, fasting",HPLC,gamma-Tocopherol,"",Colon and rectal cancer,Prospective cohort study,Kabat 2012
366,21404,All,Basal cell carcinoma and squamous cell carcinoma cases,Australia,Nambour Skin Cancer Study,485,136,,"Serum, non-fasting",HPLC,alpha-Carotene,"",Skin cancer,Prospective cohort study,van der Pols 2009
367,21405,All,Basal cell carcinoma and squamous cell carcinoma cases,Australia,Nambour Skin Cancer Study,485,136,,"Serum, non-fasting",HPLC,beta-Carotene,"",Skin cancer,Prospective cohort study,van der Pols 2009
368,21406,All,Basal cell carcinoma and squamous cell carcinoma cases,Australia,Nambour Skin Cancer Study,485,136,,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",Skin cancer,Prospective cohort study,van der Pols 2009
369,21407,All,Basal cell carcinoma and squamous cell carcinoma cases,Australia,Nambour Skin Cancer Study,485,136,,"Serum, non-fasting",HPLC,Lutein/Zeaxanthin,"",Skin cancer,Prospective cohort study,van der Pols 2009
370,21408,All,Basal cell carcinoma and squamous cell carcinoma cases,Australia,Nambour Skin Cancer Study,485,136,,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",Skin cancer,Prospective cohort study,van der Pols 2009
376,21409,All,Basal cell carcinoma and squamous cell carcinoma cases,Australia,Nambour Skin Cancer Study,485,136,,"Serum, non-fasting",Atomic absorption spectrometry (AAS),Selenium,"",Skin cancer,Prospective cohort study,van der Pols 2009
378,21410,All,Pancreatic cancer cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",29092,318,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Pancreatic cancer,Prospective cohort study,Stolzenberg-Solomon 2009
379,21411,All,Breast cancer cases,United States,WHI (Women's Health Initiative),5450,190,,"Serum, fasting",HPLC,Retinol,"",Breast cancer,Prospective cohort study,Kabat 2009
380,21412,All,Breast cancer cases,United States,WHI (Women's Health Initiative),5450,190,,"Serum, fasting",HPLC,alpha-Carotene,"",Breast cancer,Prospective cohort study,Kabat 2009
381,21413,All,Breast cancer cases,United States,WHI (Women's Health Initiative),5450,190,,"Serum, fasting",HPLC,beta-Carotene,"",Breast cancer,Prospective cohort study,Kabat 2009
382,21414,All,Breast cancer cases,United States,WHI (Women's Health Initiative),5450,190,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",Breast cancer,Prospective cohort study,Kabat 2009
383,21415,All,Breast cancer cases,United States,WHI (Women's Health Initiative),5450,190,,"Serum, fasting",HPLC,Lycopene,"",Breast cancer,Prospective cohort study,Kabat 2009
384,21416,All,Breast cancer cases,United States,WHI (Women's Health Initiative),5450,190,,"Serum, fasting",HPLC,Lutein/Zeaxanthin,"",Breast cancer,Prospective cohort study,Kabat 2009
385,21417,All,Breast cancer cases,United States,WHI (Women's Health Initiative),5450,190,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Breast cancer,Prospective cohort study,Kabat 2009
386,21418,All,Breast cancer cases,United States,WHI (Women's Health Initiative),5450,190,,"Serum, fasting",HPLC,gamma-Tocopherol,"",Breast cancer,Prospective cohort study,Kabat 2009
390,21422,All,Prostate cancer cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",29133,1732,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Prostate cancer,Prospective cohort study,Weinstein 2007
391,21423,All,Gastric adenocarcinomas cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",27110,220,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Gastric and oesophageal cancer,Prospective cohort study,Nouraie 2005
393,21424,All,Gastric adenocarcinomas cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",27110,220,,"Serum, fasting",HPLC,Retinol,"",Gastric and oesophageal cancer,Prospective cohort study,Nouraie 2005
395,21425,All,Gastric adenocarcinomas cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",27110,220,,"Serum, fasting",HPLC,beta-Carotene,"",Gastric and oesophageal cancer,Prospective cohort study,Nouraie 2005
397,21426,All,Basal cell carcinoma and squamous cell carcinoma cases,United States,ISO-BCC (Isotretinoin-Basal Cell Carcinoma Prevention Trial),302,232,,"Serum, fasting",HPLC,alpha-Carotene,"",Skin cancer,Prospective cohort study,Dorgan 2004
398,21427,All,Basal cell carcinoma and squamous cell carcinoma cases,United States,ISO-BCC (Isotretinoin-Basal Cell Carcinoma Prevention Trial),302,232,,"Serum, fasting",HPLC,beta-Carotene,"",Skin cancer,Prospective cohort study,Dorgan 2004
399,21428,All,Basal cell carcinoma and squamous cell carcinoma cases,United States,ISO-BCC (Isotretinoin-Basal Cell Carcinoma Prevention Trial),302,232,,"Serum, fasting",HPLC,Lycopene,"",Skin cancer,Prospective cohort study,Dorgan 2004
400,21429,All,Basal cell carcinoma and squamous cell carcinoma cases,United States,ISO-BCC (Isotretinoin-Basal Cell Carcinoma Prevention Trial),302,232,,"Serum, fasting",HPLC,Lutein,"",Skin cancer,Prospective cohort study,Dorgan 2004
401,21430,All,Basal cell carcinoma and squamous cell carcinoma cases,United States,ISO-BCC (Isotretinoin-Basal Cell Carcinoma Prevention Trial),302,232,,"Serum, fasting",HPLC,Zeaxanthin,"",Skin cancer,Prospective cohort study,Dorgan 2004
402,21431,All,Basal cell carcinoma and squamous cell carcinoma cases,United States,ISO-BCC (Isotretinoin-Basal Cell Carcinoma Prevention Trial),302,232,,"Serum, fasting",HPLC,beta-Cryptoxanthin,"",Skin cancer,Prospective cohort study,Dorgan 2004
403,21432,All,Basal cell carcinoma and squamous cell carcinoma cases,United States,ISO-BCC (Isotretinoin-Basal Cell Carcinoma Prevention Trial),302,232,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Skin cancer,Prospective cohort study,Dorgan 2004
411,21433,All,Colorectal cancer cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",26951,184,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Colon and rectal cancer,Prospective cohort study,Malila 2002
412,21434,All,Colorectal cancer cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",26951,184,,"Serum, fasting",HPLC,beta-Carotene,"",Colon and rectal cancer,Prospective cohort study,Malila 2002
413,21435,All,Colorectal cancer cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",26951,184,,"Serum, fasting",HPLC,Retinol,"",Colon and rectal cancer,Prospective cohort study,Malila 2002
414,21436,All,Lung cancer cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",29102,1144,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Lung cancer,Prospective cohort study,Woodson 1999
415,21437,All,Prostate cancer cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",29133,317,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Prostate cancer,Prospective cohort study,Hartman 1998
418,21438,All,Oesophageal and gastric cancer cases,China,General Population Trial in Linxian,2125,1072,1053,"Serum, unspecified",HPLC,beta-Carotene,"",Gastric and oesophageal cancer,Case-cohort study,Abnet 2003
421,21439,All,Oesophageal and gastric cancer cases,China,General Population Trial in Linxian,2125,1072,1053,"Serum, unspecified",HPLC,beta-Cryptoxanthin,"",Gastric and oesophageal cancer,Case-cohort study,Abnet 2003
424,21440,All,Oesophageal and gastric cancer cases,China,General Population Trial in Linxian,2125,1072,1053,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",Gastric and oesophageal cancer,Case-cohort study,Abnet 2003
427,21441,All,Oesophageal and gastric cancer cases,China,General Population Trial in Linxian,2125,1072,1053,"Serum, unspecified",HPLC,Retinol,"",Gastric and oesophageal cancer,Case-cohort study,Abnet 2003
428,21442,All,Prostate cancer cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",29104,2041,,"Serum, fasting",HPLC,Retinol,"",Prostate cancer,Prospective cohort study,Mondul 2011
429,21443,All,Lung cancer cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",27084,1644,,"Serum, fasting",HPLC,beta-Carotene,"",Lung cancer,Prospective cohort study,Holick 2002
430,21444,All,Lung cancer cases,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",27084,1644,,"Serum, fasting",HPLC,Retinol,"",Lung cancer,Prospective cohort study,Holick 2002
431,21445,All,Prostate cancer cases,United States,NHANES (National Health and Nutrition Examination Survey),2440,84,,"Serum, unspecified",Colorimetry,Vitamin A,"",Prostate cancer,Prospective cohort study,Reichman 1990
432,21446,All,Lung cancer cases and their controls,United States,WHI (Women's Health Initiative),596,298,298,"Serum, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Lung cancer,Nested case-control study,Cheng 2017
433,21448,All,Breast cancer cases and their controls,United States,CPS (Cancer Prevention Study),992,496,496,"Plasma, non-fasting",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Wang 2015
434,21449,All,Breast cancer cases and their controls,United States,CPS (Cancer Prevention Study),992,496,496,"Plasma, non-fasting",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Wang 2015
435,21450,All,Breast cancer cases and their controls,United States,CPS (Cancer Prevention Study),992,496,496,"Plasma, non-fasting",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Wang 2015
436,21451,All,Breast cancer cases and their controls,United States,CPS (Cancer Prevention Study),992,496,496,"Plasma, non-fasting",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Wang 2015
437,21452,All,Breast cancer cases and their controls,United States,CPS (Cancer Prevention Study),992,496,496,"Plasma, non-fasting",HPLC,Lutein/Zeaxanthin,"",Breast cancer,Nested case-control study,Wang 2015
438,21447,All,Breast cancer cases and their controls,United States,CPS (Cancer Prevention Study),992,496,496,"Plasma, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Breast cancer,Nested case-control study,Wang 2015
439,21454,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),2358,1179,1179,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Sisti 2015
440,21455,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),2358,1179,1179,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Sisti 2015
441,21456,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),2358,1179,1179,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Sisti 2015
442,21457,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),2358,1179,1179,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",Breast cancer,Nested case-control study,Sisti 2015
443,21458,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),2358,1179,1179,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Sisti 2015
444,21453,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),2358,1179,1179,"Plasma, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Breast cancer,Nested case-control study,Sisti 2015
445,21459,All,Prostate cancer cases and their controls,United States,PCPT (Prostate Cancer Prevention Trial),1984,975,1009,"Serum, non-fasting",HPLC,Retinol,"",Prostate cancer,Nested case-control study,Nash 2015
446,21460,All,Prostate cancer cases and their controls,United States,PCPT (Prostate Cancer Prevention Trial),1984,975,1009,"Serum, non-fasting",HPLC,alpha-Carotene,"",Prostate cancer,Nested case-control study,Nash 2015
447,21461,All,Prostate cancer cases and their controls,United States,PCPT (Prostate Cancer Prevention Trial),1984,975,1009,"Serum, non-fasting",HPLC,beta-Carotene,"",Prostate cancer,Nested case-control study,Nash 2015
448,21462,All,Prostate cancer cases and their controls,United States,PCPT (Prostate Cancer Prevention Trial),1984,975,1009,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",Prostate cancer,Nested case-control study,Nash 2015
459,21473,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),4376,2188,2188,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Eliassen 2015
460,21474,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),4376,2188,2188,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Eliassen 2015
461,21475,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),4376,2188,2188,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Eliassen 2015
462,21476,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),4376,2188,2188,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",Breast cancer,Nested case-control study,Eliassen 2015
463,21477,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),4376,2188,2188,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Eliassen 2015
464,21478,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),4376,2188,2188,"Plasma, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Breast cancer,Nested case-control study,Eliassen 2015
465,21479,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),200,100,100,"Plasma, fasting",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Pouchieu 2014
466,21480,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),200,100,100,"Plasma, fasting",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Pouchieu 2014
467,21481,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),200,100,100,"Plasma, fasting",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Pouchieu 2014
468,21482,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),200,100,100,"Plasma, fasting",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Pouchieu 2014
469,21483,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),200,100,100,"Plasma, fasting",HPLC,Lutein,"",Breast cancer,Nested case-control study,Pouchieu 2014
470,21484,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),200,100,100,"Plasma, fasting",HPLC,Retinol,"",Breast cancer,Nested case-control study,Pouchieu 2014
471,21485,All,Urothelial cell carcinoma cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),1712,856,856,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Bladder cancer,Nested case-control study,Ros 2012
472,21486,All,Urothelial cell carcinoma cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),1712,856,856,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Bladder cancer,Nested case-control study,Ros 2012
473,21487,All,Urothelial cell carcinoma cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),1712,856,856,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Bladder cancer,Nested case-control study,Ros 2012
474,21488,All,Urothelial cell carcinoma cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),1712,856,856,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Bladder cancer,Nested case-control study,Ros 2012
475,21489,All,Urothelial cell carcinoma cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),1712,856,856,"Plasma, fasting and non-fasting",HPLC,Zeaxanthin,"",Bladder cancer,Nested case-control study,Ros 2012
476,21490,All,Urothelial cell carcinoma cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),1712,856,856,"Plasma, fasting and non-fasting",HPLC,Lutein,"",Bladder cancer,Nested case-control study,Ros 2012
477,21491,All,Urothelial cell carcinoma cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),1712,856,856,"Plasma, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,Bladder cancer,Nested case-control study,Ros 2012
478,21492,All,Urothelial cell carcinoma cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),1712,856,856,"Plasma, fasting and non-fasting",Colorimetry,Vitamin C,"",Bladder cancer,Nested case-control study,Ros 2012
479,21493,All,Non-Hodgkin lymphoma cases and their controls,United States,MEC (Multiethnic Cohort Study),809,271,538,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + alpha-Cryptoxanthin,Lymphoid cancer,Nested case-control study,Ollberding 2012
480,21494,All,Non-Hodgkin lymphoma cases and their controls,United States,MEC (Multiethnic Cohort Study),809,271,538,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",Lymphoid cancer,Nested case-control study,Ollberding 2012
481,21495,All,Non-Hodgkin lymphoma cases and their controls,United States,MEC (Multiethnic Cohort Study),809,271,538,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Lymphoid cancer,Nested case-control study,Ollberding 2012
482,21496,All,Non-Hodgkin lymphoma cases and their controls,United States,MEC (Multiethnic Cohort Study),809,271,538,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Lymphoid cancer,Nested case-control study,Ollberding 2012
483,21497,All,Non-Hodgkin lymphoma cases and their controls,United States,MEC (Multiethnic Cohort Study),809,271,538,"Serum, fasting and non-fasting",HPLC,Lutein,"",Lymphoid cancer,Nested case-control study,Ollberding 2012
484,21498,All,Non-Hodgkin lymphoma cases and their controls,United States,MEC (Multiethnic Cohort Study),809,271,538,"Serum, fasting and non-fasting",HPLC,alpha-Cryptoxanthin,"",Lymphoid cancer,Nested case-control study,Ollberding 2012
485,21499,All,Non-Hodgkin lymphoma cases and their controls,United States,MEC (Multiethnic Cohort Study),809,271,538,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Lymphoid cancer,Nested case-control study,Ollberding 2012
486,21500,All,Non-Hodgkin lymphoma cases and their controls,United States,MEC (Multiethnic Cohort Study),809,271,538,"Serum, fasting and non-fasting",HPLC,Zeaxanthin,"",Lymphoid cancer,Nested case-control study,Ollberding 2012
487,21501,All,Non-Hodgkin lymphoma cases and their controls,United States,MEC (Multiethnic Cohort Study),809,271,538,"Serum, fasting and non-fasting",HPLC,Retinol,"",Lymphoid cancer,Nested case-control study,Ollberding 2012
488,21502,All,Prostate cancer cases and their controls,United States,PCPT (Prostate Cancer Prevention Trial),3434,1683,1751,"Serum, non-fasting",HPLC,Lycopene,"",Prostate cancer,Nested case-control study,Kristal 2011
489,21504,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1230,604,626,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Tamimi 2009
490,21505,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1230,604,626,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Tamimi 2009
491,21506,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1230,604,626,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Tamimi 2009
492,21507,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1230,604,626,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Tamimi 2009
493,21508,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1230,604,626,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",Breast cancer,Nested case-control study,Tamimi 2009
494,21503,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1230,604,626,"Plasma, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Breast cancer,Nested case-control study,Tamimi 2009
497,21509,All,Prostate cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",1536,692,844,"Serum, non-fasting",HPLC,Retinol,"",Prostate cancer,Nested case-control study,Schenk 2009
498,21137,All,Lung cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),621,207,414,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Lung cancer,Nested case-control study,Epplein 2009
499,21138,All,Lung cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),621,207,414,"Plasma, fasting and non-fasting",HPLC,beta/gamma-Tocopherol,"",Lung cancer,Nested case-control study,Epplein 2009
500,21136,All,Lung cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),621,207,414,"Plasma, fasting and non-fasting",HPLC,Tocopherols,alpha-Tocopherol + beta/gamma-Tocopherol,Lung cancer,Nested case-control study,Epplein 2009
501,21140,All,Lung cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),621,207,414,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Lung cancer,Nested case-control study,Epplein 2009
502,21141,All,Lung cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),621,207,414,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Lung cancer,Nested case-control study,Epplein 2009
503,21142,All,Lung cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),621,207,414,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Lung cancer,Nested case-control study,Epplein 2009
504,21143,All,Lung cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),621,207,414,"Plasma, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",Lung cancer,Nested case-control study,Epplein 2009
505,21144,All,Lung cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),621,207,414,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Lung cancer,Nested case-control study,Epplein 2009
506,21139,All,Lung cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),621,207,414,"Plasma, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Lung cancer,Nested case-control study,Epplein 2009
507,21145,All,Lung cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),621,207,414,"Plasma, fasting and non-fasting",HPLC,Retinol,"",Lung cancer,Nested case-control study,Epplein 2009
508,21146,All,Lung cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),621,207,414,"Serum, fasting and non-fasting",Neutron activation analysis,Selenium,"",Lung cancer,Nested case-control study,Epplein 2009
510,21510,All,Colorectal cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),2798,1399,1399,"Plasma, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene + Canthaxanthin,Colon and rectal cancer,Nested case-control study,Leenders 2014
511,21511,All,Colorectal cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),2798,1399,1399,"Plasma, fasting and non-fasting",HPLC,Retinol,"",Colon and rectal cancer,Nested case-control study,Leenders 2014
512,21512,All,Colorectal cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),2798,1399,1399,"Plasma, fasting and non-fasting",HPLC,Vitamin C,"",Colon and rectal cancer,Nested case-control study,Leenders 2014
513,21513,All,Colorectal cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),2798,1399,1399,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Colon and rectal cancer,Nested case-control study,Leenders 2014
514,21514,All,Colorectal cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),2798,1399,1399,"Plasma, fasting and non-fasting",HPLC,beta/gamma-Tocopherol,"",Colon and rectal cancer,Nested case-control study,Leenders 2014
515,21515,All,Colorectal cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),2798,1399,1399,"Plasma, fasting and non-fasting",HPLC,delta-Tocopherol,"",Colon and rectal cancer,Nested case-control study,Leenders 2014
529,21086,All,Lung cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,414,144,270,"Serum, unspecified",HPLC,beta-Carotene,"",Lung cancer,Nested case-control study,Knekt 1993
530,21087,All,Lung cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,414,144,270,"Serum, unspecified",HPLC,Retinol,"",Lung cancer,Nested case-control study,Knekt 1993
531,21088,All,Lung cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,414,144,270,"Serum, unspecified",Atomic absorption spectrometry (AAS),Selenium,"",Lung cancer,Nested case-control study,Knekt 1993
532,21213,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),414,116,298,"Serum, unspecified",HPLC,Lutein/Zeaxanthin,"",Colon and rectal cancer,Nested case-control study,Wakai 2005
533,21214,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),414,116,298,"Serum, unspecified",HPLC,Canthaxanthin,"",Colon and rectal cancer,Nested case-control study,Wakai 2005
534,21217,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),414,116,298,"Serum, unspecified",HPLC,alpha-Carotene,"",Colon and rectal cancer,Nested case-control study,Wakai 2005
535,21218,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),414,116,298,"Serum, unspecified",HPLC,beta-Carotene,"",Colon and rectal cancer,Nested case-control study,Wakai 2005
536,21529,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),414,116,298,"Serum, unspecified",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Canthaxanthin + Lutein/Zeaxanthin,Colon and rectal cancer,Nested case-control study,Wakai 2005
537,21530,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Epplein 2009
538,21531,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,cis-beta-Carotenes,"",Breast cancer,Nested case-control study,Epplein 2009
539,21532,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,Lutein,"",Breast cancer,Nested case-control study,Epplein 2009
540,21533,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,Zeaxanthin,"",Breast cancer,Nested case-control study,Epplein 2009
541,21534,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,trans-Anhydroluteins,"",Breast cancer,Nested case-control study,Epplein 2009
542,21535,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,cis-Anhydroluteins,"",Breast cancer,Nested case-control study,Epplein 2009
543,21536,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),821,286,535,"Plasma, fasting and non-fasting",HPLC,cis-beta-Cryptoxanthins,"",Breast cancer,Nested case-control study,Epplein 2009
544,21537,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,cis-beta-Cryptoxanthins,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
545,21538,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
546,21539,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,cis-beta-Carotenes,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
549,21542,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,Lutein,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
550,21543,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,cis-Lutein/Zeaxanthin,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
551,21544,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,trans-Anhydroluteins,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
552,21545,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,cis-Anhydroluteins,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
553,21546,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,Zeaxanthin,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
554,21547,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1091,365,726,"Plasma, unspecified",HPLC,alpha-Cryptoxanthin,"",Breast cancer,Nested case-control study,Dorjgochoo 2009
555,21548,All,Lung cancer cases and their controls,China,SCS (Shanghai Cohort Study),596,152,444,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",Lung cancer,Nested case-control study,Stram 2007
556,21549,All,Prostate cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",1536,692,844,"Serum, non-fasting",HPLC,Lycopene,"",Prostate cancer,Nested case-control study,Peters 2007
557,21550,All,Prostate cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",1536,692,844,"Serum, non-fasting",HPLC,alpha-Carotene,"",Prostate cancer,Nested case-control study,Peters 2007
558,21551,All,Prostate cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",1536,692,844,"Serum, non-fasting",HPLC,beta-Carotene,"",Prostate cancer,Nested case-control study,Peters 2007
559,21552,All,Prostate cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",1536,692,844,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",Prostate cancer,Nested case-control study,Peters 2007
560,21553,All,Prostate cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",1536,692,844,"Serum, non-fasting",HPLC,Lutein,"",Prostate cancer,Nested case-control study,Peters 2007
561,21554,All,Prostate cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",1536,692,844,"Serum, non-fasting",HPLC,Zeaxanthin,"",Prostate cancer,Nested case-control study,Peters 2007
562,21555,All,Breast cancer cases and their controls,United States,WHS (Women’s Health Study),1016,508,508,"Plasma, unspecified",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Sesso 2005
563,21556,All,Breast cancer cases and their controls,United States,WHS (Women’s Health Study),1016,508,508,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Sesso 2005
564,21557,All,Breast cancer cases and their controls,United States,WHS (Women’s Health Study),1016,508,508,"Plasma, unspecified",HPLC,Lutein/Zeaxanthin,"",Breast cancer,Nested case-control study,Sesso 2005
565,21558,All,Breast cancer cases and their controls,United States,WHS (Women’s Health Study),1016,508,508,"Plasma, unspecified",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Sesso 2005
566,21559,All,Breast cancer cases and their controls,United States,WHS (Women’s Health Study),1016,508,508,"Plasma, unspecified",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Sesso 2005
567,21560,All,Prostate cancer cases and their controls,United States,HPFS (Health Professionals Follow-Up Study),900,450,450,"Plasma, unspecified",HPLC,Lutein/Zeaxanthin,"",Prostate cancer,Nested case-control study,Wu 2004
568,21561,All,Prostate cancer cases and their controls,United States,HPFS (Health Professionals Follow-Up Study),900,450,450,"Plasma, unspecified",HPLC,beta-Cryptoxanthin,"",Prostate cancer,Nested case-control study,Wu 2004
569,21562,All,Prostate cancer cases and their controls,United States,HPFS (Health Professionals Follow-Up Study),900,450,450,"Plasma, unspecified",HPLC,alpha-Carotene,"",Prostate cancer,Nested case-control study,Wu 2004
570,21563,All,Prostate cancer cases and their controls,United States,HPFS (Health Professionals Follow-Up Study),900,450,450,"Plasma, unspecified",HPLC,beta-Carotene,"",Prostate cancer,Nested case-control study,Wu 2004
571,21564,All,Prostate cancer cases and their controls,United States,HPFS (Health Professionals Follow-Up Study),900,450,450,"Plasma, unspecified",HPLC,Lycopene,"",Prostate cancer,Nested case-control study,Wu 2004
572,21565,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),540,270,270,"Serum, non-fasting",HPLC,Lutein,"",Breast cancer,Nested case-control study,Toniolo 2001
573,21566,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),540,270,270,"Serum, non-fasting",HPLC,Zeaxanthin,"",Breast cancer,Nested case-control study,Toniolo 2001
574,21568,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),540,270,270,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Toniolo 2001
575,21569,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),540,270,270,"Serum, non-fasting",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Toniolo 2001
576,21570,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),540,270,270,"Serum, non-fasting",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Toniolo 2001
577,21571,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),540,270,270,"Serum, non-fasting",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Toniolo 2001
578,21567,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),540,270,270,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Zeaxanthin + Lycopene + Lutein + beta-Carotene,Breast cancer,Nested case-control study,Toniolo 2001
579,21572,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),540,270,270,"Serum, non-fasting",HPLC,Retinol,"",Breast cancer,Nested case-control study,Toniolo 2001
580,21573,All,Hepatocellular carcinoma cases and their controls,Taiwan,Male adults in Taiwan,175,35,140,"Serum, unspecified",HPLC,Retinol,"",Liver cancer,Nested case-control study,Yu 1995
581,21574,All,Breast cancer cases,United States,Sister Study,3386,1611,1775,"Serum, unspecified",LC-MS,25-Hydroxycholecalciferol,"",Breast cancer,Case-cohort study,O'Brien 2017
582,21575,All,Prostate cancer cases,United States,SELECT (Selenium and Vitamin E Cancer Prevention Trial),4733,1731,3002,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Prostate cancer,Case-cohort study,Kristal 2014
583,21576,All,Prostate cancer cases,United States,MrOS (Osteoporotic Fractures in Men),1648,297,1351,"Serum, unspecified",LC-MS,25-Hydroxycholecalciferol,"",Prostate cancer,Case-cohort study,Barnett 2010
584,21577,All,Oesophageal and gastric cancer cases,China,General Population Trial in Linxian,2018,979,1039,"Serum, unspecified",Enzyme immunoassay (EIA),25-Hydroxycholecalciferol,"",Gastric and oesophageal cancer,Case-cohort study,Chen 2007
590,21581,All,"Basal cell carcinoma, squamous cell carcinoma, and melanoma cases",Australia,Nambour Skin Cancer Study,1191,493,,"Serum, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Skin cancer,Prospective cohort study,van der Pols 2013
593,21582,All,Prostate cancer cases,Germany,ESTHER,4124,171,,"Serum, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Prostate cancer,Prospective cohort study,Ordonez-Mena 2013
594,21739,All,Breast cancer cases,Germany,ESTHER,5261,137,,"Serum, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Breast cancer,Prospective cohort study,Ordonez-Mena 2013
595,21740,All,Lung cancer cases,Germany,ESTHER,9561,136,,"Serum, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Lung cancer,Prospective cohort study,Ordonez-Mena 2013
596,21741,All,Colorectal cancer cases,Germany,ESTHER,9482,136,,"Serum, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Prospective cohort study,Ordonez-Mena 2013
597,21583,All,Non-melanoma and melanoma skin cancer cases,Denmark,Copenhagen City Heart Study,10060,668,,"Plasma, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Skin cancer,Prospective cohort study,Afzal 2013
606,21585,All,Lung cancer cases,Finland,Finnish Mobile Clinic Surveys,6937,122,,"Serum, unspecified",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Lung cancer,Prospective cohort study,Kilkkinen 2008
607,21586,All,Prostate cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),603,201,402,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Sawada 2017
608,21587,All,Prostate cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",678,226,452,"Serum, non-fasting",LC-MS,25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Layne 2017
609,21588,All,Colorectal cancer cases and their controls,United States,SCCS (Southern Community Cohort Study),664,224,440,"Serum, non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Andersen 2017
610,21589,All,Colorectal cancer cases and their controls,United States,NHS (Nurses' Health Study),1067,378,689,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Song 2016
611,21590,All,Breast cancer cases and their controls,Sweden,MDCS (Malmö Diet and Cancer Study),1528,764,764,"Serum, non-fasting",HPLC,25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Shirazi 2016
612,21591,All,Head and neck cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),700,350,350,"Plasma, fasting and non-fasting",LC-MS,25-Hydroxycholecalciferol,"",Head and neck cancer,Nested case-control study,Fanidi 2016
614,21592,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),3012,1506,1506,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Eliassen 2016
615,21593,All,Prostate cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),296,129,167,"Plasma, fasting",Competitive protein-binding assay (CPBA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Deschasaux 2016
616,21594,All,Colorectal cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",952,476,476,"Serum, non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Weinstein 2015
617,21595,All,Pancreatic cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",882,295,587,"Serum, non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Pancreatic cancer,Nested case-control study,Piper 2015
618,21596,All,Colorectal cancer cases and their controls,United States,WHS (Women’s Health Study),548,274,274,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Chandler 2015
621,21597,All,Prostate cancer cases and their controls,United States,PCPT (Prostate Cancer Prevention Trial),3377,1695,1682,"Serum, non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Schenk 2014
622,21598,All,Renal cell carcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),1670,560,1110,"Plasma, fasting and non-fasting",LC-MS,25-Hydroxycholecalciferol,"",Kidney cancer,Nested case-control study,Muller 2014
623,21599,All,Renal cell carcinoma cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",524,262,262,"Serum, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Kidney cancer,Nested case-control study,Mondul 2014
624,21600,All,Breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),1414,707,707,"Plasma, fasting and non-fasting",LC-ID-MS/MS,25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Kim 2014
625,21601,All,Hepatocellular carcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),276,138,138,"Serum, fasting and non-fasting",LC-MS,25-Hydroxycholecalciferol,"",Liver cancer,Nested case-control study,Fedirko 2014
626,21602,All,Colorectal cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",832,416,416,"Serum, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Anic 2014
627,21603,All,Prostate cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",1914,950,964,"Serum, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Weinstein 2013
628,21604,All,Liver cancer cases and their controls,China,Linxian NITs (Linxian Nutrition Intervention Trials),1289,226,1063,"Serum, unspecified",Enzyme immunoassay (EIA),25-Hydroxycholecalciferol,"",Liver cancer,Nested case-control study,Wang 2013
629,21605,All,Prostate cancer cases and their controls,Norway,Janus Serum Bank,4212,2106,2106,"Serum, non-fasting",HPLC,Retinol,"",Prostate cancer,Nested case-control study,Meyer 2013
630,21606,All,Prostate cancer cases and their controls,Norway,Janus Serum Bank,4212,2106,2106,"Serum, non-fasting",LC-MS,25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Meyer 2013
631,21607,All,Lymphoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),2254,1127,1127,"Plasma, fasting and non-fasting",Enzyme immunoassay (EIA),25-Hydroxycholecalciferol,"",Lymphoid cancer,Nested case-control study,Luczynska 2013
632,21608,All,Breast cancer cases and their controls,Germany,EPIC (European Prospective Investigation into Cancer and Nutrition),2782,1391,1391,"Plasma, fasting and non-fasting",Enzyme immunoassay (EIA),25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Kuhn 2013
635,21611,All,Colorectal cancer cases and their controls,United States,WHI-CT (Women's Health Initiative Clinical Trial),620,310,310,"Serum, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Neuhouser 2012
636,21612,All,Breast cancer cases and their controls,United States,WHI-CT (Women's Health Initiative Clinical Trial),2160,1080,1080,"Serum, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Neuhouser 2012
637,21613,All,Bladder cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",500,250,250,"Serum, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Bladder cancer,Nested case-control study,Mondul 2012
638,21614,All,Bladder cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",733,369,364,"Serum, non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Bladder cancer,Nested case-control study,Mondul 2012
639,21615,All,Melanoma cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",368,92,276,"Serum, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Skin cancer,Nested case-control study,Major 2012
640,21616,All,Prostate cancer cases and their controls,Sweden,MDCS (Malmö Diet and Cancer Study),1886,943,943,"Serum, non-fasting",HPLC,25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Brandstedt 2012
641,21619,All,Lung cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",1000,500,500,"Serum, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Lung cancer,Nested case-control study,Weinstein 2011
642,21620,All,Colorectal cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",856,428,428,"Serum, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Weinstein 2011
644,21622,All,Colorectal cancer cases and their controls,United States,PHS (Physicians' Health Study),618,229,389,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Lee 2011
645,21623,All,Colorectal cancer cases and their controls,United States,PHS (Physicians' Health Study),618,229,389,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),"1,25-Dihydroxycholecalciferol","",Colon and rectal cancer,Nested case-control study,Lee 2011
650,21624,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1831,613,1218,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Eliassen 2011
651,21625,All,Head and neck cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",680,340,340,"Serum, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Head and neck cancer,Nested case-control study,Arem 2011
655,21629,All,Colorectal cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),663,229,434,"Plasma, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Woolcott 2010
658,21632,All,Ovarian cancer cases and their controls,Finland,FMC (Finnish Maternity Cohort),344,172,172,"Serum, unspecified",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Ovarian cancer,Nested case-control study,Toriola 2010
659,21633,All,Ovarian cancer cases and their controls,Finland,FMC (Finnish Maternity Cohort),798,201,597,"Serum, unspecified",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Ovarian cancer,Nested case-control study,Toriola 2010
660,21634,All,Non-melanoma skin cancer cases and their controls,United States,MrOS (Osteoporotic Fractures in Men),1108,178,930,"Serum, fasting",LC-MS,25-Hydroxycholecalciferol,"",Skin cancer,Nested case-control study,Tang 2010
661,21635,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),985,329,656,"Plasma, fasting",Enzyme immunoassay (EIA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Park 2010
662,21636,All,Bladder cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",500,250,250,"Serum, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Bladder cancer,Nested case-control study,Mondul 2010
663,21637,All,Colorectal cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),2496,1248,1248,Serum or Plasma,Enzyme immunoassay (EIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Jenab 2010
667,21640,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1908,636,1272,"Serum, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Engel 2010
668,21641,All,Basal cell carcinoma cases and their controls,United States,Kaiser Permanente Northern California (KPNC),440,220,220,"Serum, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Skin cancer,Nested case-control study,Asgari 2010
669,21642,All,Breast cancer cases and their controls,Sweden,MDCS (Malmö Diet and Cancer Study),1528,764,764,"Serum, non-fasting",HPLC,25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Almquist 2010
670,21643,All,Breast cancer cases and their controls,Finland,FMC (Finnish Maternity Cohort),200,100,100,"Serum, unspecified",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Agborsangaya 2010
671,21644,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1404,652,752,"Serum, fasting and non-fasting",Enzyme immunoassay (EIA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Travis 2009
672,21645,All,Pancreatic cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",552,184,368,"Serum, non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Pancreatic cancer,Nested case-control study,Stolzenberg-Solomon 2009
673,21646,All,Breast cancer cases and their controls,Denmark,Women referred to a diagnostic mammography examination,562,142,420,"Plasma, unspecified",LC-ID-MS/MS,25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Rejnmark 2009
674,21647,All,Breast cancer cases and their controls,United States,CPS (Cancer Prevention Study),1032,516,516,"Serum, non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,McCullough 2009
675,21648,All,Lymphoid cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",808,270,538,"Serum, fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Lymphoid cancer,Nested case-control study,Lim 2009
676,21649,All,Breast cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",2010,1005,1005,"Serum, non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Freedman 2008
677,21650,All,Breast cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",2010,1005,1005,"Serum, non-fasting",Radioimmunoassay (RIA),"1,25-Dihydroxycholecalciferol","",Breast cancer,Nested case-control study,Freedman 2008
678,21651,All,Prostate cancer cases and their controls,United States,"PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial)",1530,749,781,"Serum, non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Ahn 2008
679,21652,All,Colorectal cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),1125,375,750,"Plasma, fasting and non-fasting",Competitive protein-binding assay (CPBA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Otani 2007
682,21655,All,Prostate cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",592,296,296,"Serum, fasting",Enzyme-linked immunosorbent assay (ELISA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Faupel-Badger 2007
684,21657,All,Pancreatic cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",600,200,400,"Serum, fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Pancreatic cancer,Nested case-control study,Stolzenberg-Solomon 2006
685,21658,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1425,701,724,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Bertone-Johnson 2005
686,21659,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1425,701,724,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),"1,25-Dihydroxycholecalciferol","",Breast cancer,Nested case-control study,Bertone-Johnson 2005
687,21660,All,Prostate cancer cases and their controls,United States,HPFS (Health Professionals Follow-Up Study),920,460,460,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Platz 2004
688,21661,All,Prostate cancer cases and their controls,United States,HPFS (Health Professionals Follow-Up Study),920,460,460,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),"1,25-Dihydroxycholecalciferol","",Prostate cancer,Nested case-control study,Platz 2004
689,21662,All,Prostate cancer cases and their controls,United States,NPC (Nutritional Prevention of Cancer) trial,249,83,166,"Plasma, unspecified",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Jacobs 2004
690,21663,All,Prostate cancer cases and their controls,United States,NPC (Nutritional Prevention of Cancer) trial,249,83,166,"Plasma, unspecified",Radioimmunoassay (RIA),"1,25-Dihydroxycholecalciferol","",Prostate cancer,Nested case-control study,Jacobs 2004
691,21664,All,Colorectal cancer cases and their controls,United States,NHS (Nurses' Health Study),576,193,383,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Feskanich 2004
692,21665,All,Colorectal cancer cases and their controls,United States,NHS (Nurses' Health Study),576,193,383,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),"1,25-Dihydroxycholecalciferol","",Colon and rectal cancer,Nested case-control study,Feskanich 2004
693,21666,All,Prostate cancer cases and their controls,Finland,Helsinki Heart Study,715,149,566,"Serum, unspecified",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Ahonen 2000
694,21667,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),272,136,136,"Serum, unspecified",Competitive protein-binding assay (CPBA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Nomura 1998
695,21668,All,Prostate cancer cases and their controls,United States,HHP (Honolulu Heart Program),272,136,136,"Serum, unspecified",Competitive protein-binding assay (CPBA),"1,25-Dihydroxycholecalciferol","",Prostate cancer,Nested case-control study,Nomura 1998
696,21669,All,Breast cancer cases and their controls,United States,Kaiser Permanente Northern California (KPNC),192,96,96,"Serum, fasting",Competitive protein-binding assay (CPBA),"1,25-Dihydroxycholecalciferol","",Breast cancer,Nested case-control study,Hiatt 1998
697,21670,All,Colorectal cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",438,146,292,"Serum, fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Tangrea 1997
698,21671,All,Colorectal cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",438,146,292,"Serum, fasting",Competitive protein-binding assay (CPBA),"1,25-Dihydroxycholecalciferol","",Colon and rectal cancer,Nested case-control study,Tangrea 1997
699,21672,All,Colon cancer cases and their controls,United States,CLUE,171,57,114,"Serum, unspecified",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Braun 1995
700,21673,All,Colon cancer cases and their controls,United States,CLUE,171,57,114,"Serum, unspecified",Competitive protein-binding assay (CPBA),"1,25-Dihydroxycholecalciferol","",Colon and rectal cancer,Nested case-control study,Braun 1995
701,21674,All,Pancreatic cancer cases,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),22472,42,,"Serum, non-fasting",Fluorometry,Vitamin C,"",Pancreatic cancer,Prospective cohort study,Banim 2013
702,21675,All,Prostate cancer cases,United States,BLSA (Baltimore Longitudinal Study of Aging),515,62,,"Plasma, fasting",Colorimetry,Vitamin C,"",Prostate cancer,Prospective cohort study,Berndt 2005
703,21676,All,Gastric cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),631,215,416,"Plasma, fasting and non-fasting",Fluorometry,Vitamin C,"",Gastric and oesophageal cancer,Nested case-control study,Jenab 2006
704,21677,All,Breast cancer cases and their controls,United States,CLUE,230,115,115,"Plasma, non-fasting",Colorimetry,Vitamin C,"",Breast cancer,Nested case-control study,Wu 2000
706,21682,All,Oesophageal and gastric cancer cases,China,Linxian NITs (Linxian Nutrition Intervention Trials),947,753,194,"Serum, unspecified",HPLC,Riboflavin,"",Gastric and oesophageal cancer,Case-cohort study,Ren 2016
708,21683,All,Oesophageal and gastric cancer cases,China,Linxian NITs (Linxian Nutrition Intervention Trials),947,753,194,"Serum, unspecified",HPLC,Pyridoxal 5'-phosphate,"",Gastric and oesophageal cancer,Case-cohort study,Ren 2016
710,21684,All,Oesophageal and gastric cancer cases,China,Linxian NITs (Linxian Nutrition Intervention Trials),947,753,194,"Serum, unspecified",HPLC,Folates,"",Gastric and oesophageal cancer,Case-cohort study,Ren 2016
712,21685,All,Oesophageal and gastric cancer cases,China,Linxian NITs (Linxian Nutrition Intervention Trials),947,753,194,"Serum, unspecified",HPLC,Vitamin B12,"",Gastric and oesophageal cancer,Case-cohort study,Ren 2016
713,21686,All,"Basal cell carcinoma, squamous cell carcinoma, and melanoma cases",France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),1760,144,,"Red blood cell, fasting",Microbioassay (Lactobacillus casei),Folates,"",Skin cancer,Prospective cohort study,Donnenfeld 2015
717,21689,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5012,2491,2521,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus casei),Folates,"",Breast cancer,Nested case-control study,Matejcic 2017
718,21690,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5012,2491,2521,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",Breast cancer,Nested case-control study,Matejcic 2017
719,21691,All,Breast cancer cases and their controls,Italy,EPIC (European Prospective Investigation into Cancer and Nutrition),552,276,276,"Plasma, fasting",Chemiluminescence immunoassay (CLIA),Folates,"",Breast cancer,Nested case-control study,Agnoli 2016
720,21692,All,Breast cancer cases and their controls,Italy,EPIC (European Prospective Investigation into Cancer and Nutrition),552,276,276,"Plasma, fasting",Chemiluminescence immunoassay (CLIA),Vitamin B12,"",Breast cancer,Nested case-control study,Agnoli 2016
721,21693,All,Breast cancer cases and their controls,Italy,EPIC (European Prospective Investigation into Cancer and Nutrition),552,276,276,"Plasma, fasting",LC-MS,Riboflavin,"",Breast cancer,Nested case-control study,Agnoli 2016
722,21694,All,Breast cancer cases and their controls,Italy,EPIC (European Prospective Investigation into Cancer and Nutrition),552,276,276,"Plasma, fasting",LC-MS,Pyridoxal 5'-phosphate,"",Breast cancer,Nested case-control study,Agnoli 2016
723,21695,All,Colorectal cancer cases and their controls,United States,WHI-OS (Women's Health Initiative Observational Study),1976,988,988,"Red blood cell, fasting",Competitive protein-binding assay (CPBA),Folates,"",Colon and rectal cancer,Nested case-control study,Neuhouser 2015
724,21696,All,Colorectal cancer cases and their controls,United States,WHI-OS (Women's Health Initiative Observational Study),1976,988,988,"Plasma, fasting",Competitive protein-binding assay (CPBA),Folates,"",Colon and rectal cancer,Nested case-control study,Neuhouser 2015
725,21697,All,Colorectal cancer cases and their controls,China,SMHS (Shanghai Men’s Health Study),863,288,575,"Plasma, unspecified",Microbioassay (Lactobacillus casei),Folates,"",Colon and rectal cancer,Nested case-control study,Takata 2014
726,21698,All,Liver cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",198,95,103,"Serum, fasting",Radioimmunoassay (RIA),Folates,"",Liver cancer,Nested case-control study,Schwartz 2013
727,21699,All,Liver cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",198,95,103,"Serum, fasting",Radioimmunoassay (RIA),Vitamin B12,"",Liver cancer,Nested case-control study,Schwartz 2013
728,21700,All,Liver cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",198,95,103,"Serum, fasting",Tyrosine decarboxylase apoenzyme assay,Pyridoxal 5'-phosphate,"",Liver cancer,Nested case-control study,Schwartz 2013
729,21701,All,Liver cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",198,95,103,"Serum, fasting",HPLC,Riboflavin,"",Liver cancer,Nested case-control study,Schwartz 2013
730,21702,All,Prostate cancer cases and their controls,Norway,Janus Serum Bank,6000,3000,3000,"Serum, unspecified",HPLC after acid hydrolysis,Folates,"",Prostate cancer,Nested case-control study,de Vogel 2013
731,21703,All,Prostate cancer cases and their controls,Norway,Janus Serum Bank,6000,3000,3000,"Serum, unspecified",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",Prostate cancer,Nested case-control study,de Vogel 2013
732,21706,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),928,297,631,"Serum, non-fasting",LC-MS/MS,Pyridoxal 5'-phosphate,"",Liver cancer,Nested case-control study,Butler 2013
733,21707,All,Breast carcinoma cases and their controls,United States,MEC (Multiethnic Cohort Study),1412,706,706,"Plasma, fasting and non-fasting",LC-MS/MS,Pyridoxal 5'-phosphate,"",Breast cancer,Nested case-control study,Lurie 2012
734,21708,All,Pancreatic cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),927,463,464,"Plasma, fasting and non-fasting",LC-MS/MS,Riboflavin,"",Pancreatic cancer,Nested case-control study,Chuang 2011
735,21709,All,Pancreatic cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),927,463,464,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus casei),Folates,"",Pancreatic cancer,Nested case-control study,Chuang 2011
736,21710,All,Pancreatic cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),927,463,464,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",Pancreatic cancer,Nested case-control study,Chuang 2011
737,21711,All,Lung cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),2669,899,1770,"Serum, fasting and non-fasting",LC-MS/MS,Riboflavin,"",Lung cancer,Nested case-control study,Johansson 2010
738,21712,All,Lung cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),2669,899,1770,"Serum, fasting and non-fasting",LC-MS/MS,Pyridoxal 5'-phosphate,"",Lung cancer,Nested case-control study,Johansson 2010
739,21713,All,Lung cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),2669,899,1770,"Serum, fasting and non-fasting",Microbioassay (Lactobacillus casei),Folates,"",Lung cancer,Nested case-control study,Johansson 2010
740,21714,All,Lung cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),2669,899,1770,"Serum, fasting and non-fasting",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",Lung cancer,Nested case-control study,Johansson 2010
741,21715,All,Colorectal cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),3692,1367,2325,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus casei),Folates,"",Colon and rectal cancer,Nested case-control study,Eussen 2010
742,21716,All,Gastric cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),836,235,601,"Plasma, fasting and non-fasting",LC-MS/MS,Riboflavin,"",Gastric and oesophageal cancer,Nested case-control study,Eussen 2010
743,21717,All,Gastric cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),836,235,601,"Plasma, fasting and non-fasting",LC-MS/MS,Vitamin B6,4-Pyridoxic acid + Pyridoxal 5'-phosphate + Pyridoxal,Gastric and oesophageal cancer,Nested case-control study,Eussen 2010
744,21718,All,Gastric cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),836,235,601,"Plasma, fasting and non-fasting",LC-MS/MS,Pyridoxal 5'-phosphate,"",Gastric and oesophageal cancer,Nested case-control study,Eussen 2010
745,21719,All,Breast cancer cases and their controls,Sweden,MDCS (Malmö Diet and Cancer Study),612,204,408,"Plasma, non-fasting",Enzyme immunoassay (EIA),Folates,"",Breast cancer,Nested case-control study,Ericson 2010
746,21720,All,Colorectal cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1491,303,1188,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus casei),Folates,"",Colon and rectal cancer,Nested case-control study,Shrubsole 2009
747,21721,All,Colorectal cancer cases and their controls,United States,PHS (Physicians' Health Study),568,197,371,"Plasma, fasting and non-fasting",Tyrosine decarboxylase apoenzyme assay,Pyridoxal 5'-phosphate,"",Colon and rectal cancer,Nested case-control study,Lee 2009
748,21722,All,Colorectal cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),635,224,411,"Plasma, fasting",Radioimmunoassay (RIA),Folates,"",Colon and rectal cancer,Nested case-control study,Le Marchand 2009
749,21724,All,Colorectal cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),635,224,411,"Plasma, fasting",Tyrosine decarboxylase apoenzyme assay,Pyridoxal 5'-phosphate,"",Colon and rectal cancer,Nested case-control study,Le Marchand 2009
750,21723,All,Colorectal cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),635,224,411,"Plasma, fasting",Radioimmunoassay (RIA),Vitamin B12,"",Colon and rectal cancer,Nested case-control study,Le Marchand 2009
751,21725,All,Colorectal cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",550,275,275,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",Colon and rectal cancer,Nested case-control study,Weinstein 2008
752,21726,All,Colorectal cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",550,275,275,"Serum, fasting",Tyrosine decarboxylase apoenzyme assay,Pyridoxal 5'-phosphate,"",Colon and rectal cancer,Nested case-control study,Weinstein 2008
753,21727,All,Colorectal cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",550,275,275,"Serum, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",Colon and rectal cancer,Nested case-control study,Weinstein 2008
754,21728,All,Colorectal cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",550,275,275,"Serum, fasting",HPLC,Riboflavin,"",Colon and rectal cancer,Nested case-control study,Weinstein 2008
763,21742,All,Oesophageal cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),294,147,147,"Plasma, fasting and non-fasting",LC-MS,25-Hydroxycholecalciferol,"",Gastric and oesophageal cancer,Nested case-control study,Fanidi 2016
764,21744,All,Colorectal cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),1125,375,750,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),Folates,"",Colon and rectal cancer,Nested case-control study,Otani 2008
765,21747,All,Breast cancer cases and their controls,United States,WHS (Women’s Health Study),1696,848,848,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),Folates,"",Breast cancer,Nested case-control study,Lin 2008
766,21749,All,Breast cancer cases and their controls,United States,WHS (Women’s Health Study),1696,848,848,"Plasma, fasting and non-fasting",Tyrosine decarboxylase apoenzyme assay,Pyridoxal 5'-phosphate,"",Breast cancer,Nested case-control study,Lin 2008
767,21748,All,Breast cancer cases and their controls,United States,WHS (Women’s Health Study),1696,848,848,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),Vitamin B12,"",Breast cancer,Nested case-control study,Lin 2008
768,21750,All,Prostate cancer cases and their controls,Sweden,EPIC (European Prospective Investigation into Cancer and Nutrition),2043,869,1174,Serum or Plasma,Microbioassay (Lactobacillus casei),Folates,"",Prostate cancer,Nested case-control study,Johansson 2008
769,21751,All,Prostate cancer cases and their controls,Sweden,EPIC (European Prospective Investigation into Cancer and Nutrition),2043,869,1174,Serum or Plasma,Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",Prostate cancer,Nested case-control study,Johansson 2008
770,21752,All,Gastric cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),878,247,631,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus casei),Folates,"",Gastric and oesophageal cancer,Nested case-control study,Vollset 2007
771,21753,All,Gastric cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),878,247,631,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",Gastric and oesophageal cancer,Nested case-control study,Vollset 2007
772,21754,All,Colorectal cancer cases and their controls,United States,NHS (Nurses' Health Study),544,194,350,"Plasma, fasting and non-fasting",Tyrosine decarboxylase apoenzyme assay,Pyridoxal 5'-phosphate,"",Colon and rectal cancer,Nested case-control study,Wei 2005
773,21755,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1424,712,712,"Plasma, fasting and non-fasting",Competitive protein-binding assay (CPBA),Folates,"",Breast cancer,Nested case-control study,Zhang 2003
774,21757,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1424,712,712,"Plasma, fasting and non-fasting",Tyrosine decarboxylase apoenzyme assay,Pyridoxal 5'-phosphate,"",Breast cancer,Nested case-control study,Zhang 2003
775,21756,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1424,712,712,"Plasma, fasting and non-fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",Breast cancer,Nested case-control study,Zhang 2003
776,21758,All,Prostate cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",696,232,464,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",Prostate cancer,Nested case-control study,Weinstein 2003
777,21759,All,Prostate cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",696,232,464,"Serum, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",Prostate cancer,Nested case-control study,Weinstein 2003
778,21760,All,Prostate cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",696,232,464,"Serum, fasting",Tyrosine decarboxylase apoenzyme assay,Pyridoxal 5'-phosphate,"",Prostate cancer,Nested case-control study,Weinstein 2003
779,21761,All,Lung cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",600,300,300,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",Lung cancer,Nested case-control study,Hartman 2001
780,21762,All,Lung cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",600,300,300,"Serum, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",Lung cancer,Nested case-control study,Hartman 2001
781,21763,All,Lung cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",600,300,300,"Serum, fasting",Tyrosine decarboxylase apoenzyme assay,Pyridoxal 5'-phosphate,"",Lung cancer,Nested case-control study,Hartman 2001
782,21764,All,Cervical cancer cases and their controls,United States,CLUE,117,39,78,"Serum, fasting and non-fasting",Microbioassay (Lactobacillus casei),Folates,"",Cervical cancer,Nested case-control study,Alberg 2000
783,21765,All,Cervical cancer cases and their controls,United States,CLUE,117,39,78,"Serum, fasting and non-fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",Cervical cancer,Nested case-control study,Alberg 2000
784,21766,All,Pancreatic cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",373,126,247,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",Pancreatic cancer,Nested case-control study,Stolzenberg-Solomon 1999
785,21767,All,Pancreatic cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",373,126,247,"Serum, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",Pancreatic cancer,Nested case-control study,Stolzenberg-Solomon 1999
786,21768,All,Pancreatic cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",373,126,247,"Serum, fasting",Tyrosine decarboxylase apoenzyme assay,Pyridoxal 5'-phosphate,"",Pancreatic cancer,Nested case-control study,Stolzenberg-Solomon 1999
787,21769,All,Colorectal cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),628,105,523,"Serum, non-fasting",Enzyme immunoassay (EIA),Folates,"",Colon and rectal cancer,Nested case-control study,Kato 1999
788,21770,All,Colorectal cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",420,144,276,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",Colon and rectal cancer,Nested case-control study,Glynn 1996
789,21771,All,Breast cancer cases and their controls,Italy,EPIC (European Prospective Investigation into Cancer and Nutrition),552,276,276,"Plasma, fasting",Enzyme immunoassay (EIA),Homocysteine,"",Breast cancer,Nested case-control study,Agnoli 2016
790,21772,All,Prostate cancer cases and their controls,Norway,Janus Serum Bank,6000,3000,3000,"Serum, unspecified",GC-MS,Homocysteine,"",Prostate cancer,Nested case-control study,de Vogel 2013
791,21773,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),928,297,631,"Serum, non-fasting",LC-MS/MS,Homocysteine,"",Liver cancer,Nested case-control study,Butler 2013
792,21774,All,Pancreatic cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),927,463,464,"Plasma, fasting and non-fasting",GC-MS,Homocysteine,"",Pancreatic cancer,Nested case-control study,Chuang 2011
793,21775,All,Lung cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),2669,899,1770,"Serum, fasting and non-fasting",GC-MS,Homocysteine,"",Lung cancer,Nested case-control study,Johansson 2010
794,21776,All,Colorectal cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),635,224,411,"Plasma, fasting",HPLC,Homocysteine,"",Colon and rectal cancer,Nested case-control study,Le Marchand 2009
795,21777,All,Gastric cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),878,247,631,"Plasma, fasting and non-fasting",GC-MS,Homocysteine,"",Gastric and oesophageal cancer,Nested case-control study,Vollset 2007
796,21778,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1424,712,712,"Plasma, fasting and non-fasting",HPLC,Homocysteine,"",Breast cancer,Nested case-control study,Zhang 2003
797,21780,All,Prostate cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",696,232,464,"Serum, fasting",HPLC,Homocysteine,"",Prostate cancer,Nested case-control study,Weinstein 2003
798,21781,All,Pancreatic cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",373,126,247,"Serum, fasting",HPLC,Homocysteine,"",Pancreatic cancer,Nested case-control study,Stolzenberg-Solomon 1999
799,21782,All,Lung cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",600,300,300,"Serum, fasting",HPLC,Homocysteine,"",Lung cancer,Nested case-control study,Hartman 2001
800,21783,All,Cervical cancer cases and their controls,United States,CLUE,117,39,78,"Serum, fasting and non-fasting",HPLC,Homocysteine,"",Cervical cancer,Nested case-control study,Alberg 2000
801,21784,All,Colorectal cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),628,105,523,"Serum, non-fasting",HPLC,Homocysteine,"",Colon and rectal cancer,Nested case-control study,Kato 1999
802,21785,All,Prostate cancer cases and their controls,Sweden,VIP (Vasterbotten Intervention Project),1595,561,1034,"Plasma, unspecified",LC-MS,Pyridoxal 5'-phosphate,"",Prostate cancer,Nested case-control study,Johansson 2009
803,21786,All,Prostate cancer cases and their controls,Sweden,VIP (Vasterbotten Intervention Project),1595,561,1034,"Plasma, unspecified",LC-MS,Riboflavin,"",Prostate cancer,Nested case-control study,Johansson 2009
804,21787,All,Prostate cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),768,254,514,"Plasma, fasting and non-fasting",Competitive protein-binding assay (CPBA),Folates,"",Prostate cancer,Nested case-control study,Hultdin 2005
805,21788,All,Prostate cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),768,254,514,"Plasma, fasting and non-fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",Prostate cancer,Nested case-control study,Hultdin 2005
806,21789,All,Prostate cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),768,254,514,"Plasma, fasting and non-fasting",Fluorescence polarization immunoassay (FPIA),Homocysteine,"",Prostate cancer,Nested case-control study,Hultdin 2005
807,21790,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),1803,613,1190,"Plasma, fasting and non-fasting",LC-MS/MS,Riboflavin,"",Colon and rectal cancer,Nested case-control study,Myte 2017
808,21793,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),1803,613,1190,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus casei),Folates,"",Colon and rectal cancer,Nested case-control study,Myte 2017
809,21791,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),1803,613,1190,"Plasma, fasting and non-fasting",LC-MS/MS,Pyridoxal 5'-phosphate,"",Colon and rectal cancer,Nested case-control study,Myte 2017
810,21792,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),1803,613,1190,"Plasma, fasting and non-fasting",GC-MS,Homocysteine,"",Colon and rectal cancer,Nested case-control study,Myte 2017
811,21794,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),1803,613,1190,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",Colon and rectal cancer,Nested case-control study,Myte 2017
812,21795,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),1803,613,1190,"Plasma, fasting and non-fasting",GC-MS,Pyridoxal 5'-phosphate,"",Colon and rectal cancer,Nested case-control study,Gylling 2017
813,21796,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),993,331,662,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus casei),Folates,"",Colon and rectal cancer,Nested case-control study,Gylling 2014
814,21797,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),993,331,662,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",Colon and rectal cancer,Nested case-control study,Gylling 2014
815,21798,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),993,331,662,"Plasma, fasting and non-fasting",GC-ID-MS,Homocysteine,"",Colon and rectal cancer,Nested case-control study,Gylling 2014
816,21799,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),678,226,452,"Plasma, fasting and non-fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",Colon and rectal cancer,Nested case-control study,Dahlin 2008
817,21800,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),678,226,452,"Plasma, fasting and non-fasting",Competitive protein-binding assay (CPBA),Folates,"",Colon and rectal cancer,Nested case-control study,Dahlin 2008
818,21801,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),678,226,452,"Plasma, fasting and non-fasting",Fluorescence polarization immunoassay (FPIA),Homocysteine,"",Colon and rectal cancer,Nested case-control study,Dahlin 2008
819,21802,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),663,226,437,"Plasma, fasting and non-fasting",Competitive protein-binding assay (CPBA),Folates,"",Colon and rectal cancer,Nested case-control study,Van Guelpen 2006
820,21803,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),663,226,437,"Plasma, fasting and non-fasting",Fluorescence polarization immunoassay (FPIA),Homocysteine,"",Colon and rectal cancer,Nested case-control study,Van Guelpen 2006
821,21807,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),491,201,290,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Hulten 2001
822,21804,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),491,201,290,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Hulten 2001
823,21805,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),491,201,290,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Hulten 2001
824,21806,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),491,201,290,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Hulten 2001
825,21808,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),491,201,290,"Plasma, fasting and non-fasting",HPLC,Lutein,"",Breast cancer,Nested case-control study,Hulten 2001
826,21809,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),491,201,290,"Plasma, fasting and non-fasting",HPLC,Zeaxanthin,"",Breast cancer,Nested case-control study,Hulten 2001
827,21810,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),491,201,290,"Plasma, fasting and non-fasting",HPLC,Retinol,"",Breast cancer,Nested case-control study,Hulten 2001
828,21811,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),491,201,290,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Breast cancer,Nested case-control study,Hulten 2001
829,21812,All,Epithelial ovarian cancer cases and their controls,United States,VDPP (Cohort Consortium Vitamin D Pooling Project of Rarer Cancers),1286,516,770,Serum or Plasma,Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Ovarian cancer,Nested case-control study,Zheng 2010
830,21813,All,Endometrial cancer cases and their controls,United States,VDPP (Cohort Consortium Vitamin D Pooling Project of Rarer Cancers),1822,830,992,Serum or Plasma,Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Endometrial cancer,Nested case-control study,Zeleniuch-Jacquotte 2010
831,21814,All,Pancreatic cancer cases and their controls,United States,VDPP (Cohort Consortium Vitamin D Pooling Project of Rarer Cancers),1985,652,1333,Serum or Plasma,Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Pancreatic cancer,Nested case-control study,Stolzenberg-Solomon 2010
832,21815,All,Non-Hodgkin lymphoma cases and their controls,United States,VDPP (Cohort Consortium Vitamin D Pooling Project of Rarer Cancers),3131,1353,1778,Serum or Plasma,Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Lymphoid cancer,Nested case-control study,Purdue 2010
833,21816,All,Kidney cancer cases and their controls,United States,VDPP (Cohort Consortium Vitamin D Pooling Project of Rarer Cancers),1550,775,775,Serum or Plasma,Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Kidney cancer,Nested case-control study,Gallicchio 2010
834,21817,All,Oesophageal and gastric cancer cases and their controls,United States,VDPP (Cohort Consortium Vitamin D Pooling Project of Rarer Cancers),2131,1065,1066,Serum or Plasma,Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Gastric and oesophageal cancer,Nested case-control study,Abnet 2010
835,21819,All,Lung cancer cases and their controls,France,LC3 (Lung Cancer Cohort Consortium),10728,5364,5364,Serum or Plasma,LC-MS/MS,Pyridoxal 5'-phosphate,"",Lung cancer,Nested case-control study,Fanidi 2018
836,21818,All,Lung cancer cases and their controls,France,LC3 (Lung Cancer Cohort Consortium),10728,5364,5364,Serum or Plasma,Microbioassay (Lactobacillus casei),Folates,"",Lung cancer,Nested case-control study,Fanidi 2018
837,21825,All,Breast cancer cases and their controls,United States,CLUE,590,295,295,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Sato 2002
838,21827,All,Breast cancer cases and their controls,United States,CLUE,590,295,295,"Serum, fasting and non-fasting",HPLC,Lutein,"",Breast cancer,Nested case-control study,Sato 2002
839,21824,All,Breast cancer cases and their controls,United States,CLUE,590,295,295,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + Lutein + beta-Carotene,Breast cancer,Nested case-control study,Sato 2002
840,21821,All,Breast cancer cases and their controls,United States,CLUE,590,295,295,"Serum, fasting and non-fasting",HPLC,Retinol,"",Breast cancer,Nested case-control study,Sato 2002
841,21822,All,Breast cancer cases and their controls,United States,CLUE,590,295,295,"Serum, fasting and non-fasting",HPLC,Retinyl palmitate,"",Breast cancer,Nested case-control study,Sato 2002
842,21823,All,Breast cancer cases and their controls,United States,CLUE,590,295,295,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Sato 2002
843,21826,All,Breast cancer cases and their controls,United States,CLUE,590,295,295,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Sato 2002
844,21828,All,Breast cancer cases and their controls,United States,CLUE,590,295,295,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Sato 2002
845,21829,All,Breast cancer cases and their controls,United States,CLUE,590,295,295,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Breast cancer,Nested case-control study,Sato 2002
846,21830,All,Breast cancer cases and their controls,United States,CLUE,590,295,295,"Serum, fasting and non-fasting",HPLC,gamma-Tocopherol,"",Breast cancer,Nested case-control study,Sato 2002
847,21833,All,Breast cancer cases and their controls,United States,CLUE,390,195,195,Serum or Plasma,Competitive protein-binding assay (CPBA),Vitamin B12,"",Breast cancer,Nested case-control study,Wu 1999
848,21832,All,Breast cancer cases and their controls,United States,CLUE,390,195,195,Serum or Plasma,Competitive protein-binding assay (CPBA),Folates,"",Breast cancer,Nested case-control study,Wu 1999
849,21831,All,Breast cancer cases and their controls,United States,CLUE,390,195,195,Serum or Plasma,Tyrosine decarboxylase apoenzyme assay,Pyridoxal 5'-phosphate,"",Breast cancer,Nested case-control study,Wu 1999
850,21834,All,Breast cancer cases and their controls,United States,CLUE,390,195,195,Serum or Plasma,HPLC,Homocysteine,"",Breast cancer,Nested case-control study,Wu 1999
851,21835,All,Lung cancer cases and their controls,United States,CLUE,773,258,515,Serum or Plasma,Colorimetry,Ascorbic acid,"",Lung cancer,Nested case-control study,Comstock 1997
852,21836,All,Lung cancer cases and their controls,United States,CLUE,773,258,515,Serum or Plasma,Neutron activation analysis,Selenium,"",Lung cancer,Nested case-control study,Comstock 1997
853,21837,All,Lung cancer cases and their controls,United States,CLUE,773,258,515,Serum or Plasma,HPLC,alpha-Carotene,"",Lung cancer,Nested case-control study,Comstock 1997
854,21838,All,Lung cancer cases and their controls,United States,CLUE,773,258,515,Serum or Plasma,HPLC,beta-Carotene,"",Lung cancer,Nested case-control study,Comstock 1997
855,21839,All,Lung cancer cases and their controls,United States,CLUE,773,258,515,Serum or Plasma,HPLC,beta-Cryptoxanthin,"",Lung cancer,Nested case-control study,Comstock 1997
856,21840,All,Lung cancer cases and their controls,United States,CLUE,773,258,515,Serum or Plasma,HPLC,Lutein/Zeaxanthin,"",Lung cancer,Nested case-control study,Comstock 1997
857,21842,All,Lung cancer cases and their controls,United States,CLUE,773,258,515,Serum or Plasma,HPLC,alpha-Tocopherol,"",Lung cancer,Nested case-control study,Comstock 1997
858,21841,All,Lung cancer cases and their controls,United States,CLUE,773,258,515,Serum or Plasma,HPLC,Lycopene,"",Lung cancer,Nested case-control study,Comstock 1997
859,21843,All,Prostate cancer cases and their controls,United States,CLUE,972,324,648,Serum or Plasma,HPLC,alpha-Carotene,"",Prostate cancer,Nested case-control study,Huang 2003
860,21844,All,Prostate cancer cases and their controls,United States,CLUE,972,324,648,Serum or Plasma,HPLC,beta-Carotene,"",Prostate cancer,Nested case-control study,Huang 2003
861,21845,All,Prostate cancer cases and their controls,United States,CLUE,972,324,648,Serum or Plasma,HPLC,Carotenes,alpha-Carotene + beta-Carotene,Prostate cancer,Nested case-control study,Huang 2003
862,21846,All,Prostate cancer cases and their controls,United States,CLUE,972,324,648,Serum or Plasma,HPLC,beta-Cryptoxanthin,"",Prostate cancer,Nested case-control study,Huang 2003
863,21847,All,Prostate cancer cases and their controls,United States,CLUE,972,324,648,Serum or Plasma,HPLC,Lutein,"",Prostate cancer,Nested case-control study,Huang 2003
864,21848,All,Prostate cancer cases and their controls,United States,CLUE,972,324,648,Serum or Plasma,HPLC,Lycopene,"",Prostate cancer,Nested case-control study,Huang 2003
865,21849,All,Prostate cancer cases and their controls,United States,CLUE,972,324,648,Serum or Plasma,HPLC,Retinol,"",Prostate cancer,Nested case-control study,Huang 2003
866,21850,All,Prostate cancer cases and their controls,United States,CLUE,972,324,648,Serum or Plasma,HPLC,Retinyl palmitate,"",Prostate cancer,Nested case-control study,Huang 2003
867,21851,All,Prostate cancer cases and their controls,United States,CLUE,972,324,648,Serum or Plasma,HPLC,alpha-Tocopherol,"",Prostate cancer,Nested case-control study,Huang 2003
868,21852,All,Prostate cancer cases and their controls,United States,CLUE,972,324,648,Serum or Plasma,HPLC,gamma-Tocopherol,"",Prostate cancer,Nested case-control study,Huang 2003
869,21853,All,Prostate cancer cases and their controls,United States,CLUE,972,324,648,Serum or Plasma,Colorimetry,Ascorbic acid,"",Prostate cancer,Nested case-control study,Huang 2003
870,21854,All,Gastric cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),836,235,601,"Plasma, fasting and non-fasting",LC-MS/MS,4-Pyridoxic acid,"",Gastric and oesophageal cancer,Nested case-control study,Eussen 2010
871,21855,All,Colorectal cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),3684,1365,2319,"Plasma, fasting and non-fasting",LC-MS/MS,Riboflavin,"",Colon and rectal cancer,Nested case-control study,Eussen 2010
872,21856,All,Colorectal cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),3684,1365,2319,"Plasma, fasting and non-fasting",LC-MS/MS,Vitamin B6,4-Pyridoxic acid + Pyridoxal 5'-phosphate + Pyridoxal,Colon and rectal cancer,Nested case-control study,Eussen 2010
873,21857,All,Colorectal cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),3684,1365,2319,"Plasma, fasting and non-fasting",LC-MS/MS,Pyridoxal 5'-phosphate,"",Colon and rectal cancer,Nested case-control study,Eussen 2010
874,21858,All,Colorectal cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),3684,1365,2319,"Plasma, fasting and non-fasting",LC-MS/MS,4-Pyridoxic acid,"",Colon and rectal cancer,Nested case-control study,Eussen 2010
875,21859,All,Colorectal cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),3684,1365,2319,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",Colon and rectal cancer,Nested case-control study,Eussen 2010
876,21860,All,Head and neck cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),700,350,350,"Plasma, fasting and non-fasting",LC-MS/MS,Riboflavin,"",Head and neck cancer,Nested case-control study,Fanidi 2015
877,21870,All,Oesophageal cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),332,166,166,"Plasma, fasting and non-fasting",LC-MS/MS,Riboflavin,"",Gastric and oesophageal cancer,Nested case-control study,Fanidi 2015
878,21861,All,Head and neck cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),700,350,350,"Plasma, fasting and non-fasting",LC-MS/MS,Pyridoxal 5'-phosphate,"",Head and neck cancer,Nested case-control study,Fanidi 2015
879,21871,All,Oesophageal cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),332,166,166,"Plasma, fasting and non-fasting",LC-MS/MS,Pyridoxal 5'-phosphate,"",Gastric and oesophageal cancer,Nested case-control study,Fanidi 2015
880,21862,All,Head and neck cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),700,350,350,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus casei),Folates,"",Head and neck cancer,Nested case-control study,Fanidi 2015
881,21872,All,Oesophageal cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),332,166,166,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus casei),Folates,"",Gastric and oesophageal cancer,Nested case-control study,Fanidi 2015
882,21863,All,Head and neck cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),700,350,350,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",Head and neck cancer,Nested case-control study,Fanidi 2015
883,21873,All,Oesophageal cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),332,166,166,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",Gastric and oesophageal cancer,Nested case-control study,Fanidi 2015
884,21864,All,Head and neck cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),700,350,350,"Plasma, fasting and non-fasting",GC-MS,Homocysteine,"",Head and neck cancer,Nested case-control study,Fanidi 2015
885,21874,All,Oesophageal cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),332,166,166,"Plasma, fasting and non-fasting",GC-MS,Homocysteine,"",Gastric and oesophageal cancer,Nested case-control study,Fanidi 2015
886,21866,All,Upper gastrointestinal tract cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",554,228,326,"Serum, fasting",Competitive protein-binding assay (CPBA),Vitamin B12,"",Gastric and oesophageal cancer,Nested case-control study,Miranti 2017
887,21865,All,Upper gastrointestinal tract cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",554,228,326,"Serum, fasting",Competitive protein-binding assay (CPBA),Folates,"",Gastric and oesophageal cancer,Nested case-control study,Miranti 2017
888,21867,All,Upper gastrointestinal tract cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",554,228,326,"Serum, fasting",Tyrosine decarboxylase apoenzyme assay,Pyridoxal 5'-phosphate,"",Gastric and oesophageal cancer,Nested case-control study,Miranti 2017
889,21868,All,Upper gastrointestinal tract cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",554,228,326,"Serum, fasting",HPLC,Riboflavin,"",Gastric and oesophageal cancer,Nested case-control study,Miranti 2017
890,21869,All,Upper gastrointestinal tract cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",554,228,326,"Serum, fasting",HPLC,Homocysteine,"",Gastric and oesophageal cancer,Nested case-control study,Miranti 2017
891,21875,All,Lung cancer cases,Denmark,Copenhagen City Heart Study,9791,507,,"Plasma, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Lung cancer,Prospective cohort study,Afzal 2013
892,21876,All,Head and neck cancer cases,Denmark,Copenhagen City Heart Study,9791,122,,"Plasma, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Head and neck cancer,Prospective cohort study,Afzal 2013
893,21881,All,Bladder cancer cases,Denmark,Copenhagen City Heart Study,9791,112,,"Plasma, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Bladder cancer,Prospective cohort study,Afzal 2013
894,21877,All,Kidney cancer cases,Denmark,Copenhagen City Heart Study,9791,55,,"Plasma, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Kidney cancer,Prospective cohort study,Afzal 2013
895,21880,All,Pancreatic cancer cases,Denmark,Copenhagen City Heart Study,9791,109,,"Plasma, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Pancreatic cancer,Prospective cohort study,Afzal 2013
896,21879,All,Stomach cancer cases,Denmark,Copenhagen City Heart Study,9791,64,,"Plasma, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Gastric and oesophageal cancer,Prospective cohort study,Afzal 2013
897,21878,All,Liver cancer cases,Denmark,Copenhagen City Heart Study,9791,55,,"Plasma, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Liver cancer,Prospective cohort study,Afzal 2013
898,21882,All,Prostate cancer cases,Australia,HIMS (Health in Men Study),4208,315,,"Plasma, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Prostate cancer,Prospective cohort study,Wong 2014
899,21883,All,Colorectal cancer cases,Australia,HIMS (Health in Men Study),4208,117,,"Plasma, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Prospective cohort study,Wong 2014
900,21884,All,Lung cancer cases,Australia,HIMS (Health in Men Study),4208,101,,"Plasma, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Lung cancer,Prospective cohort study,Wong 2014
909,21893,All,Pancreatic cancer cases and their controls,China,Combined cohorts,549,187,362,"Serum, non-fasting",LC-MS/MS,Pyridoxal 5'-phosphate,"",Pancreatic cancer,Nested case-control study,Huang 2016
910,21894,All,Pancreatic cancer cases and their controls,China,Combined cohorts,549,187,362,"Serum, non-fasting",LC-MS/MS,4-Pyridoxic acid,"",Pancreatic cancer,Nested case-control study,Huang 2016
911,21895,All,Renal cell carcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),1112,556,556,"Plasma, fasting and non-fasting",LC-MS/MS,Riboflavin,"",Kidney cancer,Nested case-control study,Johansson 2014
912,21896,All,Renal cell carcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),1112,556,556,"Plasma, fasting and non-fasting",LC-MS/MS,Pyridoxal 5'-phosphate,"",Kidney cancer,Nested case-control study,Johansson 2014
913,21897,All,Renal cell carcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),1112,556,556,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus casei),Folates,"",Kidney cancer,Nested case-control study,Johansson 2014
914,21898,All,Renal cell carcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),1112,556,556,"Plasma, fasting and non-fasting",Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",Kidney cancer,Nested case-control study,Johansson 2014
915,21899,All,Renal cell carcinoma cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),1112,556,556,"Plasma, fasting and non-fasting",GC-MS,Homocysteine,"",Kidney cancer,Nested case-control study,Johansson 2014
921,21905,All,Colorectal cancer cases and their controls,United States,Combined cohorts,1732,602,1130,"Plasma, fasting and non-fasting",Competitive protein-binding assay (CPBA),Folates,"",Colon and rectal cancer,Nested case-control study,Lee 2012
922,21906,All,Non-melanoma skin cancer cases and their controls,United States,NHS (Nurses' Health Study),4641,585,4056,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Skin cancer,Nested case-control study,Liang 2012
923,21907,All,Prostate cancer cases and their controls,United Kingdom,Combined cohorts,14979,6875,8104,Serum or Plasma,Microbioassay (Lactobacillus casei),Folates,"",Prostate cancer,Nested case-control study,Price 2016
924,21908,All,Prostate cancer cases and their controls,United Kingdom,Combined cohorts,14979,6875,8104,Serum or Plasma,Microbioassay (Lactobacillus leichmanii),Vitamin B12,"",Prostate cancer,Nested case-control study,Price 2016
925,21909,All,Breast cancer cases and their controls,United States,Combined cohorts,4525,1585,2940,Serum or Plasma,Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Scarmo 2013
926,21910,All,Pancreatic cancer cases and their controls,United States,Combined cohorts,831,208,623,"Plasma, fasting and non-fasting",Enzyme immunoassay (EIA),Folates,"",Pancreatic cancer,Nested case-control study,Schernhammer 2007
927,21912,All,Pancreatic cancer cases and their controls,United States,Combined cohorts,831,208,623,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),Pyridoxal 5'-phosphate,"",Pancreatic cancer,Nested case-control study,Schernhammer 2007
928,21911,All,Pancreatic cancer cases and their controls,United States,Combined cohorts,831,208,623,"Plasma, fasting and non-fasting",Enzyme immunoassay (EIA),Vitamin B12,"",Pancreatic cancer,Nested case-control study,Schernhammer 2007
929,21913,All,Pancreatic cancer cases and their controls,United States,Combined cohorts,831,208,623,"Plasma, fasting and non-fasting",Enzyme immunoassay (EIA),Homocysteine,"",Pancreatic cancer,Nested case-control study,Schernhammer 2007
930,21914,All,Head and neck cancer cases,Denmark,Combined cohorts,11130,38,,"Serum, unspecified",HPLC,25-Hydroxycholecalciferol,"",Head and neck cancer,Prospective cohort study,Skaaby 2014
931,21915,All,Colorectal cancer cases,Denmark,Combined cohorts,11119,141,,"Serum, unspecified",HPLC,25-Hydroxycholecalciferol,"",Colon and rectal cancer,Prospective cohort study,Skaaby 2014
932,21916,All,Bronchus and lung cancer cases,Denmark,Combined cohorts,11133,110,,"Serum, unspecified",HPLC,25-Hydroxycholecalciferol,"",Lung cancer,Prospective cohort study,Skaaby 2014
933,21917,All,Breast cancer cases,Denmark,Combined cohorts,5606,159,,"Serum, unspecified",HPLC,25-Hydroxycholecalciferol,"",Breast cancer,Prospective cohort study,Skaaby 2014
934,21918,All,Uterine (corpus uteri) cancer cases,Denmark,Combined cohorts,5670,25,,"Serum, unspecified",HPLC,25-Hydroxycholecalciferol,"",Endometrial cancer,Prospective cohort study,Skaaby 2014
935,21919,All,Prostate cancer cases,Denmark,Combined cohorts,5451,121,,"Serum, unspecified",HPLC,25-Hydroxycholecalciferol,"",Prostate cancer,Prospective cohort study,Skaaby 2014
936,21920,All,Urinary organs cancer cases,Denmark,Combined cohorts,11124,46,,"Serum, unspecified",HPLC,25-Hydroxycholecalciferol,"",Bladder cancer,Prospective cohort study,Skaaby 2014
937,21921,All,Non-melanoma skin cancer and malignant melanoma cases,Denmark,Combined cohorts,11036,424,,"Serum, unspecified",HPLC,25-Hydroxycholecalciferol,"",Skin cancer,Prospective cohort study,Skaaby 2014
938,21922,All,Colorectal cancer cases and their controls,United States,NHS (Nurses' Health Study) with HPFS (Health Professionals Follow-Up Study),1824,615,1209,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Song 2014
939,21923,All,Prostate cancer cases and their controls,Finland,Combined cohorts,2073,622,1451,"Serum, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Tuohimaa 2004
940,21924,All,Ovarian cancer cases and their controls,United States,Combined cohorts,827,224,603,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Ovarian cancer,Nested case-control study,Tworoger 2007
941,21925,All,Ovarian cancer cases and their controls,United States,Combined cohorts,827,224,603,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),"1,25-Dihydroxycholecalciferol","",Ovarian cancer,Nested case-control study,Tworoger 2007
942,21926,All,Pancreatic cancer cases and their controls,United States,Combined cohorts,1618,451,1167,"Plasma, fasting and non-fasting",Enzyme immunoassay (EIA),25-Hydroxycholecalciferol,"",Pancreatic cancer,Nested case-control study,Wolpin 2012
944,21928,All,Colorectal cancer cases and their controls,United States,NHS (Nurses' Health Study) with HPFS (Health Professionals Follow-Up Study),1111,372,739,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Wu 2007
948,21932,All,Gastric dysplasia and cancer cases,China,Linqu County Cohort,434,62,,"Serum, fasting",HPLC,Ascorbic acid,"",Gastric and oesophageal cancer,Prospective cohort study,You 2000
949,21933,All,Gastric dysplasia and cancer cases,China,Linqu County Cohort,434,62,,"Serum, fasting",HPLC,Retinol,"",Gastric and oesophageal cancer,Prospective cohort study,You 2000
950,21934,All,Gastric dysplasia and cancer cases,China,Linqu County Cohort,434,62,,"Serum, fasting",HPLC,beta-Carotene,"",Gastric and oesophageal cancer,Prospective cohort study,You 2000
951,21935,All,Gastric dysplasia and cancer cases,China,Linqu County Cohort,434,62,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Gastric and oesophageal cancer,Prospective cohort study,You 2000
952,21936,All,Gastric dysplasia and cancer cases,China,Linqu County Cohort,434,62,,"Serum, fasting",Neutron activation analysis,Selenium,"",Gastric and oesophageal cancer,Prospective cohort study,You 2000
953,21937,All,Breast cancer cases and their controls,United States,WHS (Women’s Health Study),1624,812,812,"Plasma, fasting and non-fasting",HPLC,Homocysteine,"",Breast cancer,Nested case-control study,Lin 2010
955,21940,All,Breast cancer cases and their controls,United States,Combined cohorts,7011,3055,3956,Serum or Plasma,HPLC,alpha-Carotene,"",Breast cancer,Nested case-control study,Eliassen 2012
956,21941,All,Breast cancer cases and their controls,United States,Combined cohorts,7011,3055,3956,Serum or Plasma,HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Eliassen 2012
957,21942,All,Breast cancer cases and their controls,United States,Combined cohorts,7011,3055,3956,Serum or Plasma,HPLC,beta-Cryptoxanthin,"",Breast cancer,Nested case-control study,Eliassen 2012
958,21943,All,Breast cancer cases and their controls,United States,Combined cohorts,7011,3055,3956,Serum or Plasma,HPLC,Lutein/Zeaxanthin,"",Breast cancer,Nested case-control study,Eliassen 2012
960,21944,All,Breast cancer cases and their controls,United States,Combined cohorts,7011,3055,3956,Serum or Plasma,HPLC,Lycopene,"",Breast cancer,Nested case-control study,Eliassen 2012
961,21939,All,Breast cancer cases and their controls,United States,Combined cohorts,7011,3055,3956,Serum or Plasma,HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Breast cancer,Nested case-control study,Eliassen 2012
962,21945,All,Lung cancer cases and their controls,United States,Kaiser Permanente Northern California (KPNC),453,151,302,"Serum, unspecified",HPLC,Retinol,"",Lung cancer,Nested case-control study,Friedman 1986
963,21946,All,Prostate cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,55,,"Serum, fasting",HPLC,Lycopene,"",Prostate cancer,Prospective cohort study,Karppi 2009
964,21947,All,Prostate cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,55,,"Serum, fasting",HPLC,Retinol,"",Prostate cancer,Prospective cohort study,Karppi 2009
965,21948,All,Prostate cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,55,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Prostate cancer,Prospective cohort study,Karppi 2009
966,21949,All,Prostate cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,55,,"Serum, fasting",HPLC,alpha-Carotene,"",Prostate cancer,Prospective cohort study,Karppi 2009
967,21950,All,Prostate cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,55,,"Serum, fasting",HPLC,beta-Carotene,"",Prostate cancer,Prospective cohort study,Karppi 2009
968,21951,All,Gastrointestinal cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,426,150,276,"Serum, unspecified",Atomic absorption spectrometry (AAS),Selenium,"",Gastric and oesophageal cancer,Nested case-control study,Knekt 1988
969,21952,All,Gastrointestinal cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,426,150,276,"Serum, unspecified",HPLC,alpha-Tocopherol,"",Gastric and oesophageal cancer,Nested case-control study,Knekt 1988
972,21953,All,Colorectal cancer cases and their controls,United States,NHS (Nurses' Health Study) with HPFS (Health Professionals Follow-Up Study),942,318,624,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Song 2016
974,21955,All,Breast cancer cases and their controls,Guernsey,ICRF prospective study in Guernsey,117,39,78,"Plasma, unspecified",HPLC,Retinol,"",Breast cancer,Nested case-control study,Wald 1984
975,21956,All,Breast cancer cases and their controls,Guernsey,ICRF prospective study in Guernsey,117,39,78,"Plasma, unspecified",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Wald 1984
976,21957,All,Breast cancer cases and their controls,Guernsey,ICRF prospective study in Guernsey,117,39,78,"Plasma, unspecified",HPLC,alpha-Tocopherol,"",Breast cancer,Nested case-control study,Wald 1984
977,21958,All,Lung cancer cases and their controls,China,SCS (Shanghai Cohort Study),831,209,622,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin,Lung cancer,Nested case-control study,Yuan 2001
978,21959,All,Lung cancer cases and their controls,China,SCS (Shanghai Cohort Study),831,209,622,"Serum, non-fasting",HPLC,alpha-Carotene,"",Lung cancer,Nested case-control study,Yuan 2001
979,21960,All,Lung cancer cases and their controls,China,SCS (Shanghai Cohort Study),831,209,622,"Serum, non-fasting",HPLC,beta-Carotene,"",Lung cancer,Nested case-control study,Yuan 2001
980,21961,All,Lung cancer cases and their controls,China,SCS (Shanghai Cohort Study),831,209,622,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",Lung cancer,Nested case-control study,Yuan 2001
981,21962,All,Lung cancer cases and their controls,China,SCS (Shanghai Cohort Study),831,209,622,"Serum, non-fasting",HPLC,Lycopene,"",Lung cancer,Nested case-control study,Yuan 2001
982,21963,All,Lung cancer cases and their controls,China,SCS (Shanghai Cohort Study),831,209,622,"Serum, non-fasting",HPLC,Lutein/Zeaxanthin,"",Lung cancer,Nested case-control study,Yuan 2001
983,21964,All,Lung cancer cases and their controls,China,SCS (Shanghai Cohort Study),831,209,622,"Serum, non-fasting",HPLC,Retinol,"",Lung cancer,Nested case-control study,Yuan 2001
984,21965,All,Lung cancer cases and their controls,China,SCS (Shanghai Cohort Study),831,209,622,"Serum, non-fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol,Lung cancer,Nested case-control study,Yuan 2001
985,21966,All,Lung cancer cases and their controls,China,SCS (Shanghai Cohort Study),831,209,622,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",Lung cancer,Nested case-control study,Yuan 2001
986,21967,All,Lung cancer cases and their controls,China,SCS (Shanghai Cohort Study),831,209,622,"Serum, non-fasting",HPLC,gamma-Tocopherol,"",Lung cancer,Nested case-control study,Yuan 2001
987,21968,All,Prostate cancer cases,United States,SELECT (Selenium and Vitamin E Cancer Prevention Trial),2198,834,1364,"Plasma, unspecified",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",Prostate cancer,Case-cohort study,Brasky 2013
988,21969,All,Prostate cancer cases,United States,SELECT (Selenium and Vitamin E Cancer Prevention Trial),2198,834,1364,"Plasma, unspecified",GC-FID,EPA (cis-20:5n-3),"",Prostate cancer,Case-cohort study,Brasky 2013
989,21970,All,Prostate cancer cases,United States,SELECT (Selenium and Vitamin E Cancer Prevention Trial),2198,834,1364,"Plasma, unspecified",GC-FID,DPA (cis-22:5n-3),"",Prostate cancer,Case-cohort study,Brasky 2013
990,21971,All,Prostate cancer cases,United States,SELECT (Selenium and Vitamin E Cancer Prevention Trial),2198,834,1364,"Plasma, unspecified",GC-FID,DHA (cis-22:6n-3),"",Prostate cancer,Case-cohort study,Brasky 2013
991,21972,All,Prostate cancer cases,United States,SELECT (Selenium and Vitamin E Cancer Prevention Trial),2198,834,1364,"Plasma, unspecified",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",Prostate cancer,Case-cohort study,Brasky 2013
992,21973,All,Prostate cancer cases,United States,SELECT (Selenium and Vitamin E Cancer Prevention Trial),2198,834,1364,"Plasma, unspecified",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",Prostate cancer,Case-cohort study,Brasky 2013
993,21974,All,Prostate cancer cases,United States,SELECT (Selenium and Vitamin E Cancer Prevention Trial),2198,834,1364,"Plasma, unspecified",GC-FID,trans-Octadecenoic acids (trans-18:1),"",Prostate cancer,Case-cohort study,Brasky 2013
994,21975,All,Prostate cancer cases,United States,SELECT (Selenium and Vitamin E Cancer Prevention Trial),2198,834,1364,"Plasma, unspecified",GC-FID,trans-Octadecadienoic acids (trans-18:2),"",Prostate cancer,Case-cohort study,Brasky 2013
995,21976,All,Prostate cancer cases,United States,SELECT (Selenium and Vitamin E Cancer Prevention Trial),2198,834,1364,"Plasma, unspecified",GC-FID,trans-Hexadecenoic acids (trans-16:1),"",Prostate cancer,Case-cohort study,Brasky 2013
996,21977,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),699,233,466,"Plasma, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Deschasaux 2016
998,21978,All,Prostate cancer cases and their controls,Sweden,MDCS (Malmö Diet and Cancer Study),1886,943,943,"Serum, non-fasting",HPLC,25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Brandstedt 2016
999,21979,All,Glioblastoma cases and their controls,Norway,Janus Serum Bank,220,110,110,"Serum, non-fasting",GC-MS,gamma-Tocopherol,"",Brain cancer,Nested case-control study,Bjorkblom 2016
1000,21980,All,Glioblastoma cases and their controls,Norway,Janus Serum Bank,220,110,110,"Serum, non-fasting",GC-MS,alpha-Tocopherol,"",Brain cancer,Nested case-control study,Bjorkblom 2016
1001,21981,All,Glioma cases and their controls,Norway,Janus Serum Bank,1704,592,1112,"Serum, non-fasting",LC-ID-MS/MS,25-Hydroxycholecalciferol,"",Brain cancer,Nested case-control study,Zigmont 2015
1003,21983,All,Urothelial cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),166,42,124,"Serum, fasting and non-fasting",HPLC,Retinol,"",Bladder cancer,Nested case-control study,Ozasa 2005
1004,21984,All,Urothelial cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),166,42,124,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Bladder cancer,Nested case-control study,Ozasa 2005
1005,21985,All,Urothelial cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),166,42,124,"Serum, fasting and non-fasting",HPLC,beta/gamma-Tocopherol,"",Bladder cancer,Nested case-control study,Ozasa 2005
1006,21993,All,Urothelial cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),166,42,124,"Serum, fasting and non-fasting",HPLC,Lutein/Zeaxanthin,"",Bladder cancer,Nested case-control study,Ozasa 2005
1007,21992,All,Urothelial cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),166,42,124,"Serum, fasting and non-fasting",HPLC,Canthaxanthin,"",Bladder cancer,Nested case-control study,Ozasa 2005
1008,21991,All,Urothelial cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),166,42,124,"Serum, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Bladder cancer,Nested case-control study,Ozasa 2005
1009,21988,All,Urothelial cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),166,42,124,"Serum, fasting and non-fasting",HPLC,alpha-Carotene,"",Bladder cancer,Nested case-control study,Ozasa 2005
1010,21989,All,Urothelial cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),166,42,124,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Bladder cancer,Nested case-control study,Ozasa 2005
1011,21990,All,Urothelial cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),166,42,124,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Bladder cancer,Nested case-control study,Ozasa 2005
1012,21986,All,Urothelial cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),166,42,124,"Serum, fasting and non-fasting",HPLC,Carotenes,alpha-Carotene + Lycopene + beta-Carotene,Bladder cancer,Nested case-control study,Ozasa 2005
1013,21987,All,Urothelial cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),166,42,124,"Serum, fasting and non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Canthaxanthin + Lutein/Zeaxanthin,Bladder cancer,Nested case-control study,Ozasa 2005
1014,21996,All,Bladder cancer cases and their controls,United States,HHP (Honolulu Heart Program),219,109,110,"Serum, non-fasting",HPLC,Lutein/Zeaxanthin,"",Bladder cancer,Nested case-control study,Nomura 2003
1015,21997,All,Bladder cancer cases and their controls,United States,HHP (Honolulu Heart Program),219,109,110,"Serum, non-fasting",HPLC,alpha-Cryptoxanthin,"",Bladder cancer,Nested case-control study,Nomura 2003
1016,21998,All,Bladder cancer cases and their controls,United States,HHP (Honolulu Heart Program),219,109,110,"Serum, non-fasting",HPLC,beta-Cryptoxanthin,"",Bladder cancer,Nested case-control study,Nomura 2003
1017,21999,All,Bladder cancer cases and their controls,United States,HHP (Honolulu Heart Program),219,109,110,"Serum, non-fasting",HPLC,Lycopene,"",Bladder cancer,Nested case-control study,Nomura 2003
1018,22000,All,Bladder cancer cases and their controls,United States,HHP (Honolulu Heart Program),219,109,110,"Serum, non-fasting",HPLC,alpha-Carotene,"",Bladder cancer,Nested case-control study,Nomura 2003
1019,22001,All,Bladder cancer cases and their controls,United States,HHP (Honolulu Heart Program),219,109,110,"Serum, non-fasting",HPLC,beta-Carotene,"",Bladder cancer,Nested case-control study,Nomura 2003
1020,21995,All,Bladder cancer cases and their controls,United States,HHP (Honolulu Heart Program),219,109,110,"Serum, non-fasting",HPLC,Carotenoids,alpha-Carotene + beta-Cryptoxanthin + Lycopene + beta-Carotene + Lutein/Zeaxanthin + delta-Tocopherol + alpha-Cryptoxanthin,Bladder cancer,Nested case-control study,Nomura 2003
1021,22002,All,Bladder cancer cases and their controls,United States,HHP (Honolulu Heart Program),219,109,110,"Serum, non-fasting",HPLC,Retinol,"",Bladder cancer,Nested case-control study,Nomura 2003
1022,22004,All,Bladder cancer cases and their controls,United States,HHP (Honolulu Heart Program),219,109,110,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",Bladder cancer,Nested case-control study,Nomura 2003
1023,22005,All,Bladder cancer cases and their controls,United States,HHP (Honolulu Heart Program),219,109,110,"Serum, non-fasting",HPLC,beta-Tocopherol,"",Bladder cancer,Nested case-control study,Nomura 2003
1024,22006,All,Bladder cancer cases and their controls,United States,HHP (Honolulu Heart Program),219,109,110,"Serum, non-fasting",HPLC,gamma-Tocopherol,"",Bladder cancer,Nested case-control study,Nomura 2003
1025,22007,All,Bladder cancer cases and their controls,United States,HHP (Honolulu Heart Program),219,109,110,"Serum, non-fasting",HPLC,delta-Tocopherol,"",Bladder cancer,Nested case-control study,Nomura 2003
1026,22003,All,Bladder cancer cases and their controls,United States,HHP (Honolulu Heart Program),219,109,110,"Serum, non-fasting",HPLC,Tocopherols,alpha-Tocopherol + gamma-Tocopherol + beta-Tocopherol,Bladder cancer,Nested case-control study,Nomura 2003
1027,22008,All,Colorectal cancer cases and their controls,United States,Combined cohorts,1556,289,1267,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Colon and rectal cancer,Nested case-control study,Longnecker 1992
1028,22009,All,Colorectal cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",1288,644,644,"Serum, fasting",LC-ID-MS/MS,Trimethylamine N-oxide,"",Colon and rectal cancer,Nested case-control study,Guertin 2017
1029,22010,All,Colorectal cancer cases and their controls,United States,WHI (Women's Health Initiative),1670,835,835,"Plasma, fasting",LC-MS/MS,Trimethylamine N-oxide,"",Colon and rectal cancer,Nested case-control study,Bae 2014
1030,22011,All,Liver cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",198,95,103,"Serum, fasting",HPLC,Homocysteine,"",Liver cancer,Nested case-control study,Schwartz 2013
1032,22013,All,Colorectal cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),635,224,411,"Plasma, fasting",LC-MS/MS,Methylmalonic acid (MMA),"",Colon and rectal cancer,Nested case-control study,Le Marchand 2009
1033,22014,All,Prostate cancer cases and their controls,Sweden,VIP (Vasterbotten Intervention Project),1595,561,1034,"Plasma, unspecified",GC-ID-MS,Methylmalonic acid (MMA),"",Prostate cancer,Nested case-control study,Johansson 2009
1034,22015,All,Gastric cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),878,247,631,"Plasma, fasting and non-fasting",GC-MS,Methylmalonic acid (MMA),"",Gastric and oesophageal cancer,Nested case-control study,Vollset 2007
1035,22016,All,Gastric cancer cases,United States,HHP (Honolulu Heart Program),7972,250,7722,"Serum, non-fasting",HPLC,beta-Carotene,"",Gastric and oesophageal cancer,Case-cohort study,Nomura 1995
1036,22017,All,Gastric cancer cases,United States,HHP (Honolulu Heart Program),7972,250,7722,"Serum, non-fasting",HPLC,Retinol,"",Gastric and oesophageal cancer,Case-cohort study,Nomura 1995
1037,22018,All,Gastric cancer cases,United States,HHP (Honolulu Heart Program),7972,250,7722,"Serum, non-fasting",HPLC,alpha-Tocopherol,"",Gastric and oesophageal cancer,Case-cohort study,Nomura 1995
1038,22020,All,Prostate cancer cases and their controls,United States,Combined cohorts,2840,370,2470,"Plasma, fasting and non-fasting",HPLC,alpha-Carotene,"",Prostate cancer,Nested case-control study,Graff 2017
1039,22025,All,Prostate cancer cases and their controls,United States,Combined cohorts,2840,370,2470,"Plasma, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Prostate cancer,Nested case-control study,Graff 2017
1040,22019,All,Prostate cancer cases and their controls,United States,Combined cohorts,2840,370,2470,"Plasma, fasting and non-fasting",HPLC,beta-Carotene,"",Prostate cancer,Nested case-control study,Graff 2017
1041,22021,All,Prostate cancer cases and their controls,United States,Combined cohorts,2840,370,2470,"Plasma, fasting and non-fasting",HPLC,beta-Cryptoxanthin,"",Prostate cancer,Nested case-control study,Graff 2017
1043,22026,All,Prostate cancer cases and their controls,United States,Combined cohorts,2840,370,2470,"Plasma, fasting and non-fasting",HPLC,gamma-Tocopherol,"",Prostate cancer,Nested case-control study,Graff 2017
1044,22023,All,Prostate cancer cases and their controls,United States,Combined cohorts,2840,370,2470,"Plasma, fasting and non-fasting",HPLC,Lutein,"",Prostate cancer,Nested case-control study,Graff 2017
1045,22022,All,Prostate cancer cases and their controls,United States,Combined cohorts,2840,370,2470,"Plasma, fasting and non-fasting",HPLC,Lycopene,"",Prostate cancer,Nested case-control study,Graff 2017
1046,22028,All,Breast cancer cases,Canada,Multicenter BRCA1 BRCA2 mutation cohort study,164,20,,"Plasma, non-fasting",Microbioassay (Lactobacillus casei),Folates,"",Breast cancer,Prospective cohort study,Kim 2016
1047,22029,All,Breast cancer cases,Canada,Multicenter BRCA1 BRCA2 mutation cohort study,164,20,,"Plasma, non-fasting",Colorimetry,Pyridoxal 5'-phosphate,"",Breast cancer,Prospective cohort study,Kim 2016
1048,22030,All,Breast cancer cases,Canada,Multicenter BRCA1 BRCA2 mutation cohort study,164,20,,"Plasma, non-fasting",Chemiluminescence immunoassay (CLIA),Vitamin B12,"",Breast cancer,Prospective cohort study,Kim 2016
1049,21820,All,Colorectal cancer cases and their controls,United States,NHS (Nurses' Health Study) with HPFS (Health Professionals Follow-Up Study),1491,499,992,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,Wu 2011
1050,22031,All,Colon and rectal cancer cases and their controls,United States,CLUE,317,106,211,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Colon and rectal cancer,Nested case-control study,Comstock 1991
1051,22032,All,Lung cancer cases and their controls,United States,CLUE,295,99,196,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Lung cancer,Nested case-control study,Comstock 1991
1052,22033,All,Prostate cancer cases and their controls,United States,CLUE,206,103,103,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Prostate cancer,Nested case-control study,Comstock 1991
1053,22034,All,Melanoma and basal cell skin cancer cases and their controls,United States,CLUE,123,41,82,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Skin cancer,Nested case-control study,Comstock 1991
1054,22035,All,Colon and rectal cancer cases and their controls,United States,CLUE,317,106,211,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Colon and rectal cancer,Nested case-control study,Comstock 1991
1055,22036,All,Lung cancer cases and their controls,United States,CLUE,295,99,196,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Lung cancer,Nested case-control study,Comstock 1991
1056,22037,All,Prostate cancer cases and their controls,United States,CLUE,206,103,103,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Prostate cancer,Nested case-control study,Comstock 1991
1057,22038,All,Melanoma and basal cell skin cancer cases and their controls,United States,CLUE,123,41,82,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Skin cancer,Nested case-control study,Comstock 1991
1058,22039,All,Prostate cancer cases and their controls,Sweden,MDCS (Malmö Diet and Cancer Study),2827,1010,1817,"Plasma, non-fasting",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Prostate cancer,Nested case-control study,Wallstrom 2018
1059,22040,All,Colorectal cancer cases and their controls,"Korea, Republic of",KMCC (Korean Multi-center Cancer Cohort),510,102,408,"Plasma, unspecified",LC-ID-MS/MS,Isoflavones,Genistein + Daidzein,Colon and rectal cancer,Nested case-control study,Ko 2018
1060,22041,All,Colorectal cancer cases and their controls,"Korea, Republic of",KMCC (Korean Multi-center Cancer Cohort),510,102,408,"Plasma, unspecified",LC-ID-MS/MS,Daidzein,"",Colon and rectal cancer,Nested case-control study,Ko 2018
1061,22042,All,Colorectal cancer cases and their controls,"Korea, Republic of",KMCC (Korean Multi-center Cancer Cohort),510,102,408,"Plasma, unspecified",LC-ID-MS/MS,Enterolactone,"",Colon and rectal cancer,Nested case-control study,Ko 2018
1062,22043,All,Colorectal cancer cases and their controls,"Korea, Republic of",KMCC (Korean Multi-center Cancer Cohort),510,102,408,"Plasma, unspecified",LC-ID-MS/MS,Genistein,"",Colon and rectal cancer,Nested case-control study,Ko 2018
1063,22044,All,Brain cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",128,64,64,"Serum, fasting",LC-MS/MS,Trigonelline,"",Brain cancer,Nested case-control study,Huang 2017
1064,22045,All,Brain cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",128,64,64,"Serum, fasting",LC-MS/MS,alpha-Tocopherol,"",Brain cancer,Nested case-control study,Huang 2017
1065,22046,All,Brain cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",128,64,64,"Serum, fasting",LC-MS/MS,1-Methyluric acid,"",Brain cancer,Nested case-control study,Huang 2017
1066,22047,All,Brain cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",128,64,64,"Serum, fasting",LC-MS/MS,1-Methylxanthine,"",Brain cancer,Nested case-control study,Huang 2017
1067,22048,All,Brain cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",128,64,64,"Serum, fasting",LC-MS/MS,Paraxanthine,"",Brain cancer,Nested case-control study,Huang 2017
1068,22049,All,Brain cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",128,64,64,"Serum, fasting",LC-MS/MS,Theobromine,"",Brain cancer,Nested case-control study,Huang 2017
1069,22050,All,Brain cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",128,64,64,"Serum, fasting",LC-MS/MS,Theophylline,"",Brain cancer,Nested case-control study,Huang 2017
1070,22051,All,Brain cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",128,64,64,"Serum, fasting",LC-MS/MS,7-Methylxanthine,"",Brain cancer,Nested case-control study,Huang 2017
1071,22052,All,Brain cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",128,64,64,"Serum, fasting",LC-MS/MS,AAMU,"",Brain cancer,Nested case-control study,Huang 2017
1072,22053,All,Prostate cancer cases and their controls,Finland,Combined cohorts,1538,483,1055,"Serum, non-fasting",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Prostate cancer,Nested case-control study,Lumme 2016
1073,22054,All,Prostate cancer cases and their controls,Finland,Combined cohorts,1538,483,1055,"Serum, non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Lumme 2016
1074,22055,All,Breast cancer cases and their controls,China,STIB (Shanghai Textile Industry Bureau),1296,269,1027,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA),Equol,"",Breast cancer,Nested case-control study,Atkinson 2016
1075,22056,All,Liver cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),265,90,175,"Plasma, fasting and non-fasting",LC-MS,Genistein,"",Liver cancer,Nested case-control study,Michikawa 2015
1076,22057,All,Liver cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),265,90,175,"Plasma, fasting and non-fasting",LC-MS,Daidzein,"",Liver cancer,Nested case-control study,Michikawa 2015
1077,22058,All,Liver cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),265,90,175,"Plasma, fasting and non-fasting",LC-MS,Glycitein,"",Liver cancer,Nested case-control study,Michikawa 2015
1078,22059,All,Liver cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),265,90,175,"Plasma, fasting and non-fasting",LC-MS,Equol,"",Liver cancer,Nested case-control study,Michikawa 2015
1079,22060,All,Colorectal cancer cases and their controls,Sweden,EPIC (European Prospective Investigation into Cancer and Nutrition),2744,1372,1372,"Plasma, fasting and non-fasting",GC-MS,Alkylresorcinols,"",Colon and rectal cancer,Nested case-control study,Kyro 2014
1080,22061,All,Colorectal cancer cases and their controls,Denmark,HELGA,900,450,450,"Plasma, fasting and non-fasting",GC-MS,Alkylresorcinols,"",Colon and rectal cancer,Nested case-control study,Knudsen 2014
1081,22062,All,Prostate cancer cases and their controls,Sweden,MDCS (Malmö Diet and Cancer Study),2833,1016,1817,"Plasma, non-fasting",HPLC,Alkylresorcinols,"",Prostate cancer,Nested case-control study,Drake 2014
1082,22063,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1604,802,802,"Plasma, fasting and non-fasting",LC-ID-MS/MS,Enterolactone,"",Breast cancer,Nested case-control study,Xie 2013
1083,22064,All,Gastric cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),966,483,483,"Plasma, fasting and non-fasting",HPLC,Daidzein,"",Gastric and oesophageal cancer,Nested case-control study,Hara 2013
1084,22065,All,Gastric cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),966,483,483,"Plasma, fasting and non-fasting",HPLC,Genistein,"",Gastric and oesophageal cancer,Nested case-control study,Hara 2013
1085,22066,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),3302,1605,1697,"Plasma, fasting and non-fasting",LC-MS/MS,Genistein,"",Prostate cancer,Nested case-control study,Travis 2012
1086,22067,All,Lung cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),378,126,252,"Plasma, fasting and non-fasting",LC-MS,Genistein,"",Lung cancer,Nested case-control study,Shimazu 2011
1087,22068,All,Lung cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),378,126,252,"Plasma, fasting and non-fasting",LC-MS,Daidzein,"",Lung cancer,Nested case-control study,Shimazu 2011
1088,22069,All,Lung cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),378,126,252,"Plasma, fasting and non-fasting",LC-MS,Glycitein,"",Lung cancer,Nested case-control study,Shimazu 2011
1089,22070,All,Lung cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),378,126,252,"Plasma, fasting and non-fasting",LC-MS,Equol,"",Lung cancer,Nested case-control study,Shimazu 2011
1090,22071,All,Lung cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),378,126,252,"Plasma, fasting and non-fasting",LC-MS,Isoflavones,Genistein + Daidzein + Equol + Glycitein,Lung cancer,Nested case-control study,Shimazu 2011
1091,22072,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1054,353,701,"Urine, spot",LC-MS/MS,Quercetin,"",Breast cancer,Nested case-control study,Luo 2010
1092,22073,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1054,353,701,"Urine, spot",LC-MS/MS,Kaempferol,"",Breast cancer,Nested case-control study,Luo 2010
1093,22074,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1054,353,701,"Urine, spot",LC-MS/MS,Flavonols,Quercetin + Kaempferol,Breast cancer,Nested case-control study,Luo 2010
1094,22075,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1054,353,701,"Urine, spot",LC-MS/MS,Polyphenols,"",Breast cancer,Nested case-control study,Luo 2010
1095,22080,All,Gastric cancer cases and their controls,"Korea, Republic of",KMCC (Korean Multi-center Cancer Cohort),524,131,393,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA),Genistein,"",Gastric and oesophageal cancer,Nested case-control study,Ko 2010
1096,22081,All,Gastric cancer cases and their controls,"Korea, Republic of",KMCC (Korean Multi-center Cancer Cohort),524,131,393,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA),Daidzein,"",Gastric and oesophageal cancer,Nested case-control study,Ko 2010
1097,22082,All,Gastric cancer cases and their controls,"Korea, Republic of",KMCC (Korean Multi-center Cancer Cohort),524,131,393,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA),Equol,"",Gastric and oesophageal cancer,Nested case-control study,Ko 2010
1098,22083,All,Gastric cancer cases and their controls,"Korea, Republic of",KMCC (Korean Multi-center Cancer Cohort),524,131,393,"Plasma, unspecified",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Gastric and oesophageal cancer,Nested case-control study,Ko 2010
1099,22084,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1992,950,1042,"Plasma, fasting and non-fasting",LC-MS/MS,Genistein,"",Prostate cancer,Nested case-control study,Travis 2009
1100,22085,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1992,950,1042,"Plasma, fasting and non-fasting",LC-MS/MS,Daidzein,"",Prostate cancer,Nested case-control study,Travis 2009
1101,22086,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1992,950,1042,"Plasma, fasting and non-fasting",LC-MS/MS,Equol,"",Prostate cancer,Nested case-control study,Travis 2009
1102,22087,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1992,950,1042,"Plasma, fasting and non-fasting",LC-MS/MS,Enterolactone,"",Prostate cancer,Nested case-control study,Travis 2009
1103,22088,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1992,950,1042,"Plasma, fasting and non-fasting",LC-MS/MS,Enterodiol,"",Prostate cancer,Nested case-control study,Travis 2009
1104,22090,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),653,249,404,"Urine, spot",LC-MS/MS,Daidzein,"",Prostate cancer,Nested case-control study,Park 2009
1105,22091,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),653,249,404,"Urine, spot",LC-MS/MS,Genistein,"",Prostate cancer,Nested case-control study,Park 2009
1106,22092,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),653,249,404,"Urine, spot",LC-MS/MS,Equol,"",Prostate cancer,Nested case-control study,Park 2009
1107,22093,All,Prostate cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),653,249,404,"Urine, spot",LC-MS/MS,Enterolactone,"",Prostate cancer,Nested case-control study,Park 2009
1108,22094,All,Postmenopausal breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),713,251,462,"Urine, overnight",LC-MS/MS,Daidzein,"",Breast cancer,Nested case-control study,Goodman 2009
1109,22095,All,Postmenopausal breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),713,251,462,"Urine, overnight",LC-MS/MS,Genistein,"",Breast cancer,Nested case-control study,Goodman 2009
1110,22096,All,Postmenopausal breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),713,251,462,"Urine, overnight",LC-MS/MS,Equol,"",Breast cancer,Nested case-control study,Goodman 2009
1111,22097,All,Postmenopausal breast cancer cases and their controls,United States,MEC (Multiethnic Cohort Study),713,251,462,"Urine, overnight",LC-MS/MS,Enterolactone,"",Breast cancer,Nested case-control study,Goodman 2009
1112,22098,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Serum, unspecified",LC-MS,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,Breast cancer,Nested case-control study,Ward 2008
1113,22099,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Serum, unspecified",LC-MS,Lignans,Enterodiol + Enterolactone,Breast cancer,Nested case-control study,Ward 2008
1114,22100,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Serum, unspecified",LC-MS,Daidzein,"",Breast cancer,Nested case-control study,Ward 2008
1115,22101,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Serum, unspecified",LC-MS,Equol,"",Breast cancer,Nested case-control study,Ward 2008
1116,22102,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Serum, unspecified",LC-MS,O-Desmethylangolensin,"",Breast cancer,Nested case-control study,Ward 2008
1117,22103,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Serum, unspecified",LC-MS,Genistein,"",Breast cancer,Nested case-control study,Ward 2008
1118,22104,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Serum, unspecified",LC-MS,Glycitein,"",Breast cancer,Nested case-control study,Ward 2008
1119,22105,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Serum, unspecified",LC-MS,Enterodiol,"",Breast cancer,Nested case-control study,Ward 2008
1120,22106,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Serum, unspecified",LC-MS,Enterolactone,"",Breast cancer,Nested case-control study,Ward 2008
1121,22107,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Urine, spot",LC-MS,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,Breast cancer,Nested case-control study,Ward 2008
1122,22108,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Urine, spot",LC-MS,Lignans,Enterodiol + Enterolactone,Breast cancer,Nested case-control study,Ward 2008
1123,22109,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Urine, spot",LC-MS,Daidzein,"",Breast cancer,Nested case-control study,Ward 2008
1124,22110,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Urine, spot",LC-MS,Equol,"",Breast cancer,Nested case-control study,Ward 2008
1125,22111,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Urine, spot",LC-MS,O-Desmethylangolensin,"",Breast cancer,Nested case-control study,Ward 2008
1126,22112,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Urine, spot",LC-MS,Genistein,"",Breast cancer,Nested case-control study,Ward 2008
1127,22113,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Urine, spot",LC-MS,Glycitein,"",Breast cancer,Nested case-control study,Ward 2008
1128,22114,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Urine, spot",LC-MS,Enterodiol,"",Breast cancer,Nested case-control study,Ward 2008
1129,22115,All,Breast cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1189,237,952,"Urine, spot",LC-MS,Enterolactone,"",Breast cancer,Nested case-control study,Ward 2008
1130,22116,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Plasma, unspecified",LC-MS,Lignans,Enterodiol + Enterolactone,Prostate cancer,Nested case-control study,Ward 2008
1131,22117,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Plasma, unspecified",LC-MS,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,Prostate cancer,Nested case-control study,Ward 2008
1132,22118,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Plasma, unspecified",LC-MS,Genistein,"",Prostate cancer,Nested case-control study,Ward 2008
1133,22119,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Plasma, unspecified",LC-MS,Daidzein,"",Prostate cancer,Nested case-control study,Ward 2008
1134,22120,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Plasma, unspecified",LC-MS,Equol,"",Prostate cancer,Nested case-control study,Ward 2008
1135,22121,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Plasma, unspecified",LC-MS,O-Desmethylangolensin,"",Prostate cancer,Nested case-control study,Ward 2008
1136,22122,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Plasma, unspecified",LC-MS,Glycitein,"",Prostate cancer,Nested case-control study,Ward 2008
1137,22123,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Plasma, unspecified",LC-MS,Enterodiol,"",Prostate cancer,Nested case-control study,Ward 2008
1138,22124,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Plasma, unspecified",LC-MS,Enterolactone,"",Prostate cancer,Nested case-control study,Ward 2008
1139,22151,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Urine, spot",LC-MS,Enterolactone,"",Colon and rectal cancer,Nested case-control study,Ward 2008
1140,22125,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Urine, spot",LC-MS,Lignans,Enterodiol + Enterolactone,Prostate cancer,Nested case-control study,Ward 2008
1141,22126,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Urine, spot",LC-MS,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,Prostate cancer,Nested case-control study,Ward 2008
1142,22127,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Urine, spot",LC-MS,Genistein,"",Prostate cancer,Nested case-control study,Ward 2008
1143,22128,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Urine, spot",LC-MS,Daidzein,"",Prostate cancer,Nested case-control study,Ward 2008
1144,22129,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Urine, spot",LC-MS,Equol,"",Prostate cancer,Nested case-control study,Ward 2008
1145,22130,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Urine, spot",LC-MS,O-Desmethylangolensin,"",Prostate cancer,Nested case-control study,Ward 2008
1146,22131,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Urine, spot",LC-MS,Glycitein,"",Prostate cancer,Nested case-control study,Ward 2008
1147,22132,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Urine, spot",LC-MS,Enterodiol,"",Prostate cancer,Nested case-control study,Ward 2008
1148,22133,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1021,193,828,"Urine, spot",LC-MS,Enterolactone,"",Prostate cancer,Nested case-control study,Ward 2008
1149,22134,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Plasma, unspecified",LC-MS,Lignans,Enterodiol + Enterolactone,Colon and rectal cancer,Nested case-control study,Ward 2008
1150,22135,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Plasma, unspecified",LC-MS,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,Colon and rectal cancer,Nested case-control study,Ward 2008
1151,22136,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Plasma, unspecified",LC-MS,Genistein,"",Colon and rectal cancer,Nested case-control study,Ward 2008
1152,22137,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Plasma, unspecified",LC-MS,Daidzein,"",Colon and rectal cancer,Nested case-control study,Ward 2008
1153,22138,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Plasma, unspecified",LC-MS,Equol,"",Colon and rectal cancer,Nested case-control study,Ward 2008
1154,22139,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Plasma, unspecified",LC-MS,O-Desmethylangolensin,"",Colon and rectal cancer,Nested case-control study,Ward 2008
1155,22140,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Plasma, unspecified",LC-MS,Glycitein,"",Colon and rectal cancer,Nested case-control study,Ward 2008
1156,22141,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Plasma, unspecified",LC-MS,Enterodiol,"",Colon and rectal cancer,Nested case-control study,Ward 2008
1157,22142,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Plasma, unspecified",LC-MS,Enterolactone,"",Colon and rectal cancer,Nested case-control study,Ward 2008
1158,22143,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Urine, spot",LC-MS,Lignans,Enterodiol + Enterolactone,Colon and rectal cancer,Nested case-control study,Ward 2008
1159,22144,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Urine, spot",LC-MS,Isoflavones,Genistein + Daidzein + Equol + Glycitein + O-Desmethylangolensin,Colon and rectal cancer,Nested case-control study,Ward 2008
1160,22145,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Urine, spot",LC-MS,Genistein,"",Colon and rectal cancer,Nested case-control study,Ward 2008
1161,22146,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Urine, spot",LC-MS,Daidzein,"",Colon and rectal cancer,Nested case-control study,Ward 2008
1162,22147,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Urine, spot",LC-MS,Equol,"",Colon and rectal cancer,Nested case-control study,Ward 2008
1163,22148,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Urine, spot",LC-MS,O-Desmethylangolensin,"",Colon and rectal cancer,Nested case-control study,Ward 2008
1164,22149,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Urine, spot",LC-MS,Glycitein,"",Colon and rectal cancer,Nested case-control study,Ward 2008
1165,22150,All,Colorectal cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1110,221,889,"Urine, spot",LC-MS,Enterodiol,"",Colon and rectal cancer,Nested case-control study,Ward 2008
1166,22152,All,Breast cancer cases and their controls,Sweden,MDCS (Malmö Diet and Cancer Study),1099,366,733,"Plasma, non-fasting",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Breast cancer,Nested case-control study,Sonestedt 2008
1167,22153,All,Prostate cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),603,201,402,"Plasma, fasting and non-fasting",LC-MS,Genistein,"",Prostate cancer,Nested case-control study,Kurahashi 2008
1168,22154,All,Prostate cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),603,201,402,"Plasma, fasting and non-fasting",LC-MS,Daidzein,"",Prostate cancer,Nested case-control study,Kurahashi 2008
1169,22155,All,Prostate cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),603,201,402,"Plasma, fasting and non-fasting",LC-MS,Glycitein,"",Prostate cancer,Nested case-control study,Kurahashi 2008
1170,22156,All,Prostate cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),603,201,402,"Plasma, fasting and non-fasting",LC-MS,Equol,"",Prostate cancer,Nested case-control study,Kurahashi 2008
1171,22157,All,Colorectal cancer cases and their controls,Netherlands,Monitoring Project on Cardiovascular Disease Risk Factors,547,160,387,"Plasma, unspecified",LC-ID-MS/MS,Enterodiol,"",Colon and rectal cancer,Nested case-control study,Kuijsten 2008
1172,22158,All,Colorectal cancer cases and their controls,Netherlands,Monitoring Project on Cardiovascular Disease Risk Factors,547,160,387,"Plasma, unspecified",LC-ID-MS/MS,Enterolactone,"",Colon and rectal cancer,Nested case-control study,Kuijsten 2008
1173,22159,All,Breast cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),432,144,288,"Plasma, fasting and non-fasting",HPLC,Genistein,"",Breast cancer,Nested case-control study,Iwasaki 2008
1174,22160,All,Breast cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),432,144,288,"Plasma, fasting and non-fasting",HPLC,Daidzein,"",Breast cancer,Nested case-control study,Iwasaki 2008
1175,22161,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),766,383,383,"Plasma, non-fasting",LC-ID-MS/MS,Daidzein,"",Breast cancer,Nested case-control study,Verheus 2007
1176,22162,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),766,383,383,"Plasma, non-fasting",LC-ID-MS/MS,Genistein,"",Breast cancer,Nested case-control study,Verheus 2007
1177,22163,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),766,383,383,"Plasma, non-fasting",LC-ID-MS/MS,Glycitein,"",Breast cancer,Nested case-control study,Verheus 2007
1178,22164,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),766,383,383,"Plasma, non-fasting",LC-ID-MS/MS,O-Desmethylangolensin,"",Breast cancer,Nested case-control study,Verheus 2007
1179,22165,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),766,383,383,"Plasma, non-fasting",LC-ID-MS/MS,Equol,"",Breast cancer,Nested case-control study,Verheus 2007
1180,22166,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),766,383,383,"Plasma, non-fasting",LC-ID-MS/MS,Enterodiol,"",Breast cancer,Nested case-control study,Verheus 2007
1181,22167,All,Breast cancer cases and their controls,Netherlands,EPIC (European Prospective Investigation into Cancer and Nutrition),766,383,383,"Plasma, non-fasting",LC-ID-MS/MS,Enterolactone,"",Breast cancer,Nested case-control study,Verheus 2007
1182,22168,All,Breast cancer cases and their controls,China,STIB (Shanghai Textile Industry Bureau),1198,196,1002,"Plasma, unspecified",LC-MS,Daidzein,"",Breast cancer,Nested case-control study,Lampe 2007
1183,22169,All,Breast cancer cases and their controls,China,STIB (Shanghai Textile Industry Bureau),1198,196,1002,"Plasma, unspecified",LC-MS,Genistein,"",Breast cancer,Nested case-control study,Lampe 2007
1184,22170,All,Endometrial cancer cases and their controls,United States,Combined cohorts,424,153,271,Serum or Plasma,Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Endometrial cancer,Nested case-control study,Zeleniuch-Jacquotte 2006
1185,22171,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),267,89,178,"Urine, spot",GC-ID-MS,Daidzein,"",Prostate cancer,Nested case-control study,Low 2006
1186,22172,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),267,89,178,"Urine, spot",GC-ID-MS,Genistein,"",Prostate cancer,Nested case-control study,Low 2006
1187,22173,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),267,89,178,"Urine, spot",GC-ID-MS,Glycitein,"",Prostate cancer,Nested case-control study,Low 2006
1188,22174,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),267,89,178,"Urine, spot",GC-ID-MS,O-Desmethylangolensin,"",Prostate cancer,Nested case-control study,Low 2006
1189,22175,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),267,89,178,"Urine, spot",GC-ID-MS,Equol,"",Prostate cancer,Nested case-control study,Low 2006
1190,22176,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),267,89,178,"Urine, spot",GC-ID-MS,Enterodiol,"",Prostate cancer,Nested case-control study,Low 2006
1191,22177,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),267,89,178,"Urine, spot",GC-ID-MS,Enterolactone,"",Prostate cancer,Nested case-control study,Low 2006
1192,22180,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),267,89,178,"Serum, unspecified",LC-ID-MS/MS,Genistein,"",Prostate cancer,Nested case-control study,Low 2006
1193,22181,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),267,89,178,"Serum, unspecified",LC-ID-MS/MS,Glycitein,"",Prostate cancer,Nested case-control study,Low 2006
1194,22182,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),267,89,178,"Serum, unspecified",LC-ID-MS/MS,O-Desmethylangolensin,"",Prostate cancer,Nested case-control study,Low 2006
1195,22183,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),267,89,178,"Serum, unspecified",LC-ID-MS/MS,Equol,"",Prostate cancer,Nested case-control study,Low 2006
1196,22179,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),267,89,178,"Serum, unspecified",LC-ID-MS/MS,Daidzein,"",Prostate cancer,Nested case-control study,Low 2006
1197,22184,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),267,89,178,"Serum, unspecified",LC-ID-MS/MS,Enterodiol,"",Prostate cancer,Nested case-control study,Low 2006
1198,22185,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),267,89,178,"Serum, unspecified",LC-ID-MS/MS,Enterolactone,"",Prostate cancer,Nested case-control study,Low 2006
1199,22186,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),834,417,417,"Serum, non-fasting",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Breast cancer,Nested case-control study,Zeleniuch-Jacquotte 2004
1200,22187,All,Prostate cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),790,265,525,"Plasma, fasting and non-fasting",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Prostate cancer,Nested case-control study,Stattin 2004
1201,22188,All,Prostate cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),203,52,151,"Serum, unspecified",LC-MS/MS,Daidzein,"",Prostate cancer,Nested case-control study,Ozasa 2004
1202,22189,All,Prostate cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),203,52,151,"Serum, unspecified",LC-MS/MS,Genistein,"",Prostate cancer,Nested case-control study,Ozasa 2004
1203,22190,All,Prostate cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),203,52,151,"Serum, unspecified",LC-MS/MS,Equol,"",Prostate cancer,Nested case-control study,Ozasa 2004
1204,22191,All,Breast cancer cases and their controls,Denmark,"DCH (Diet, Cancer and Health)",762,381,381,"Plasma, non-fasting",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Breast cancer,Nested case-control study,Olsen 2004
1205,22192,All,Breast cancer cases and their controls,Finland,National FINRISK Study,421,206,215,"Serum, fasting",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Breast cancer,Nested case-control study,Kilkkinen 2004
1206,22193,All,Prostate cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",428,214,214,"Serum, fasting",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Prostate cancer,Nested case-control study,Kilkkinen 2003
1207,22194,All,Prostate cancer cases and their controls,Sweden,Combined cohorts,3344,794,2550,Serum or Plasma,Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Prostate cancer,Nested case-control study,Stattin 2002
1208,22195,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),740,248,492,"Plasma, fasting and non-fasting",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Breast cancer,Nested case-control study,Hulten 2002
1209,22196,All,Breast cancer cases and their controls,Finland,Kuopio Breast Cancer Study,402,194,208,"Serum, unspecified",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Breast cancer,Nested case-control study,Pietinen 2001
1210,22197,All,Breast cancer cases and their controls,Netherlands,DOM (Diagnostisch Onderzoek Mammacarcinoom-project),356,88,268,"Urine, overnight",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Breast cancer,Nested case-control study,den Tonkelaar 2001
1211,22198,All,Breast cancer cases and their controls,Netherlands,DOM (Diagnostisch Onderzoek Mammacarcinoom-project),356,88,268,"Urine, overnight",Time-resolved fluoroimmunoassay (TR-FIA),Genistein,"",Breast cancer,Nested case-control study,den Tonkelaar 2001
1212,22199,All,Breast cancer cases,Italy,Women at risk for breast cancer in Genoa,383,18,,"Serum, unspecified",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Breast cancer,Prospective cohort study,Boccardo 2004
1214,22201,All,Endometrial cancer cases,Denmark,"DCH (Diet, Cancer and Health)",322,173,149,"Plasma, non-fasting",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Endometrial cancer,Case-cohort study,Aarestrup 2013
1215,22202,All,Endometrial cancer cases,Denmark,"DCH (Diet, Cancer and Health)",329,177,152,"Plasma, non-fasting",GC-MS,Alkylresorcinols,5-n-Heptadecylresorcinol (C17:0) + 5-n-Nonadecylresorcinol (C19:0) + 5-n-Heneicosylresorcinol (C21:0) + 5-n-Tricosylresorcinol (C23:0) + 5-n-Pentacosylresorcinol (C25:0),Endometrial cancer,Case-cohort study,Olsen 2010
1216,22203,All,Endometrial cancer cases,Denmark,"DCH (Diet, Cancer and Health)",329,177,152,"Plasma, non-fasting",GC-MS,5-n-Heptadecylresorcinol (C17:0),"",Endometrial cancer,Case-cohort study,Olsen 2010
1217,22204,All,Endometrial cancer cases,Denmark,"DCH (Diet, Cancer and Health)",329,177,152,"Plasma, non-fasting",GC-MS,5-n-Nonadecylresorcinol (C19:0),"",Endometrial cancer,Case-cohort study,Olsen 2010
1218,22205,All,Endometrial cancer cases,Denmark,"DCH (Diet, Cancer and Health)",329,177,152,"Plasma, non-fasting",GC-MS,5-n-Heneicosylresorcinol (C21:0),"",Endometrial cancer,Case-cohort study,Olsen 2010
1219,22206,All,Endometrial cancer cases,Denmark,"DCH (Diet, Cancer and Health)",329,177,152,"Plasma, non-fasting",GC-MS,5-n-Tricosylresorcinol (C23:0),"",Endometrial cancer,Case-cohort study,Olsen 2010
1220,22207,All,Endometrial cancer cases,Denmark,"DCH (Diet, Cancer and Health)",329,177,152,"Plasma, non-fasting",GC-MS,5-n-Pentacosylresorcinol (C25:0),"",Endometrial cancer,Case-cohort study,Olsen 2010
1221,22208,All,Colon and rectal cancer cases,Denmark,"DCH (Diet, Cancer and Health)",751,381,370,"Plasma, non-fasting",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Colon and rectal cancer,Case-cohort study,Johnsen 2010
1222,22209,All,Brain cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",128,64,64,"Serum, fasting",LC-MS/MS,N-Acetyltyrosine,"",Brain cancer,Nested case-control study,Huang 2017
1223,22210,All,Brain cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",128,64,64,"Serum, fasting",LC-MS/MS,Mannitol,"",Brain cancer,Nested case-control study,Huang 2017
1224,22211,All,Brain cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",128,64,64,"Serum, fasting",LC-MS/MS,gamma-Glutamyltyrosine,"",Brain cancer,Nested case-control study,Huang 2017
1225,22212,All,Brain cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",128,64,64,"Serum, fasting",LC-MS/MS,Quinic acid,"",Brain cancer,Nested case-control study,Huang 2017
1226,22213,All,Brain cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",128,64,64,"Serum, fasting",LC-MS/MS,Threonic acid,"",Brain cancer,Nested case-control study,Huang 2017
1232,22214,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),1278,211,1067,"Urine, spot",HPLC,Epicatechin,"",Liver cancer,Nested case-control study,Butler 2015
1233,22215,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),1278,211,1067,"Urine, spot",HPLC,Epigallocatechin,"",Liver cancer,Nested case-control study,Butler 2015
1234,22216,All,Hepatocellular carcinoma cases and their controls,China,SCS (Shanghai Cohort Study),1278,211,1067,"Urine, spot",HPLC,4'-O-Methylepigallocatechin,"",Liver cancer,Nested case-control study,Butler 2015
1235,22076,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1054,353,701,"Urine, spot",LC-MS/MS,Epicatechin,"",Breast cancer,Nested case-control study,Luo 2010
1236,22077,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1054,353,701,"Urine, spot",LC-MS/MS,Epigallocatechin,"",Breast cancer,Nested case-control study,Luo 2010
1237,22078,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1054,353,701,"Urine, spot",LC-MS/MS,4'-O-Methylepigallocatechin,"",Breast cancer,Nested case-control study,Luo 2010
1238,22079,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1054,353,701,"Urine, spot",LC-MS/MS,"5-(3',4'-Dihydroxyphenyl)-gamma-valerolactone","",Breast cancer,Nested case-control study,Luo 2010
1239,22217,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1054,353,701,"Urine, spot",LC-MS/MS,"5-(3',4',5'-Trihydroxyphenyl)-gamma-valerolactone","",Breast cancer,Nested case-control study,Luo 2010
1240,22218,All,Breast cancer cases and their controls,China,SWHS (Shanghai Women's Health Study),1054,353,701,"Urine, spot",LC-MS,Flavonols,"",Breast cancer,Nested case-control study,Luo 2010
1241,22219,All,Gastric and oesophageal cancer cases and their controls,China,SCS (Shanghai Cohort Study),1004,232,772,"Urine, spot",HPLC,Epigallocatechin,"",Gastric and oesophageal cancer,Nested case-control study,Sun 2002
1242,22220,All,Gastric and oesophageal cancer cases and their controls,China,SCS (Shanghai Cohort Study),1004,232,772,"Urine, spot",HPLC,Epicatechin,"",Gastric and oesophageal cancer,Nested case-control study,Sun 2002
1243,22221,All,Gastric and oesophageal cancer cases and their controls,China,SCS (Shanghai Cohort Study),1004,232,772,"Urine, spot",HPLC,"5-(3',4'-Dihydroxyphenyl)-gamma-valerolactone","",Gastric and oesophageal cancer,Nested case-control study,Sun 2002
1244,22222,All,Gastric and oesophageal cancer cases and their controls,China,SCS (Shanghai Cohort Study),1004,232,772,"Urine, spot",HPLC,"5-(3',4',5'-Trihydroxyphenyl)-gamma-valerolactone","",Gastric and oesophageal cancer,Nested case-control study,Sun 2002
1245,22223,All,Breast cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),432,144,288,"Plasma, fasting and non-fasting",HPLC,Epicatechin,"",Breast cancer,Nested case-control study,Iwasaki 2010
1246,22224,All,Breast cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),432,144,288,"Plasma, fasting and non-fasting",HPLC,Epicatechin 3-gallate,"",Breast cancer,Nested case-control study,Iwasaki 2010
1247,22225,All,Breast cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),432,144,288,"Plasma, fasting and non-fasting",HPLC,Epigallocatechin,"",Breast cancer,Nested case-control study,Iwasaki 2010
1248,22226,All,Breast cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),432,144,288,"Plasma, fasting and non-fasting",HPLC,Epigallocatechin 3-gallate,"",Breast cancer,Nested case-control study,Iwasaki 2010
1249,22231,All,Colorectal cancer cases and their controls,China,SCS (Shanghai Cohort Study),968,162,806,"Urine, spot",HPLC,Epigallocatechin,"",Colon and rectal cancer,Nested case-control study,Yuan 2007
1250,22232,All,Colorectal cancer cases and their controls,China,SCS (Shanghai Cohort Study),968,162,806,"Urine, spot",HPLC,4'-O-Methylepigallocatechin,"",Colon and rectal cancer,Nested case-control study,Yuan 2007
1251,22233,All,Colorectal cancer cases and their controls,China,SCS (Shanghai Cohort Study),968,162,806,"Urine, spot",HPLC,Epicatechin,"",Colon and rectal cancer,Nested case-control study,Yuan 2007
1252,22234,All,Colorectal cancer cases and their controls,China,SCS (Shanghai Cohort Study),968,162,806,"Urine, spot",HPLC,"5-(3',4'-Dihydroxyphenyl)-gamma-valerolactone","",Colon and rectal cancer,Nested case-control study,Yuan 2007
1253,22235,All,Colorectal cancer cases and their controls,China,SCS (Shanghai Cohort Study),968,162,806,"Urine, spot",HPLC,"5-(3',4',5'-Trihydroxyphenyl)-gamma-valerolactone","",Colon and rectal cancer,Nested case-control study,Yuan 2007
1254,22089,All,Breast cancer cases and their controls,Sweden,MDCS (Malmö Diet and Cancer Study),1093,365,728,"Plasma, non-fasting",Time-resolved fluoroimmunoassay (TR-FIA),Enterolactone,"",Breast cancer,Nested case-control study,Sonestedt 2009
1255,22236,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,Palmitic acid (16:0),"",Breast cancer,Nested case-control study,Chajes 2017
1256,22237,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,Stearic acid (18:0),"",Breast cancer,Nested case-control study,Chajes 2017
1257,22238,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",Breast cancer,Nested case-control study,Chajes 2017
1258,22239,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,Oleic acid (cis-18:1n-9),"",Breast cancer,Nested case-control study,Chajes 2017
1259,22240,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,trans-Hexadecenoic acids (trans-16:1n-7/9),"",Breast cancer,Nested case-control study,Chajes 2017
1260,22241,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",Breast cancer,Nested case-control study,Chajes 2017
1261,22242,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",Breast cancer,Nested case-control study,Chajes 2017
1262,22243,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",Breast cancer,Nested case-control study,Chajes 2017
1263,22244,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",Breast cancer,Nested case-control study,Chajes 2017
1264,22245,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",Breast cancer,Nested case-control study,Chajes 2017
1265,22246,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",Breast cancer,Nested case-control study,Chajes 2017
1266,22247,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0) + Capric acid (10:0),Breast cancer,Nested case-control study,Chajes 2017
1267,22248,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + cis-Tetradecenoic acids (cis-14:1) + cis-Heptadecenoic acids (cis-17:1) + Asclepic acid (cis-18:1n-7) + Nervonic acid (cis-24:1n-9) + cis-Eicosenoic acids (cis-20:1) + cis-Docosenoic acids (cis-22:1) + cis-Pentadecenoic acids (cis-15:1) + 13Z-Octadecenoic acid (cis-18:1n-5),Breast cancer,Nested case-control study,Chajes 2017
1268,22249,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),Breast cancer,Nested case-control study,Chajes 2017
1269,22250,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Stearidonic acid (cis-18:4n-3) + Omega-3 arachidonic acid (ETA; cis-20:4n-3) + Tetracosapentaenoic acid (cis-24:5n-3) + Nisinic acid (cis-24:6n-3),Breast cancer,Nested case-control study,Chajes 2017
1270,22251,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),Prostate cancer,Nested case-control study,Yang 2016
1271,22252,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,Myristic acid (14:0),"",Prostate cancer,Nested case-control study,Yang 2016
1272,22253,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,Palmitic acid (16:0),"",Prostate cancer,Nested case-control study,Yang 2016
1273,22254,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,Stearic acid (18:0),"",Prostate cancer,Nested case-control study,Yang 2016
1274,22255,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Myristoleic acid (cis-14:1n-5),Prostate cancer,Nested case-control study,Yang 2016
1275,22256,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,Myristoleic acid (cis-14:1n-5),"",Prostate cancer,Nested case-control study,Yang 2016
1276,22257,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,Palmitoleic acid (cis-16:1n-7),"",Prostate cancer,Nested case-control study,Yang 2016
1277,22258,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,Oleic acid (cis-18:1n-9),"",Prostate cancer,Nested case-control study,Yang 2016
1278,22259,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),Prostate cancer,Nested case-control study,Yang 2016
1279,22260,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),Prostate cancer,Nested case-control study,Yang 2016
1280,22261,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",Prostate cancer,Nested case-control study,Yang 2016
1281,22262,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),Prostate cancer,Nested case-control study,Yang 2016
1282,22263,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",Prostate cancer,Nested case-control study,Yang 2016
1283,22264,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",Prostate cancer,Nested case-control study,Yang 2016
1284,22265,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",Prostate cancer,Nested case-control study,Yang 2016
1285,22266,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",Prostate cancer,Nested case-control study,Yang 2016
1286,22267,All,Prostate cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",600,300,300,"Serum, fasting",GC-MS,Phytanic acid,"",Prostate cancer,Nested case-control study,Wright 2014
1287,22269,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Arachidic acid (20:0),Breast cancer,Nested case-control study,Pouchieu 2014
1288,22270,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,Myristic acid (14:0),"",Breast cancer,Nested case-control study,Pouchieu 2014
1289,22271,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,Palmitic acid (16:0),"",Breast cancer,Nested case-control study,Pouchieu 2014
1290,22272,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,Stearic acid (18:0),"",Breast cancer,Nested case-control study,Pouchieu 2014
1291,22273,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,Arachidic acid (20:0),"",Breast cancer,Nested case-control study,Pouchieu 2014
1292,22274,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7),Breast cancer,Nested case-control study,Pouchieu 2014
1293,22275,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",Breast cancer,Nested case-control study,Pouchieu 2014
1294,22276,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,Asclepic acid (cis-18:1n-7),"",Breast cancer,Nested case-control study,Pouchieu 2014
1295,22277,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,Oleic acid (cis-18:1n-9),"",Breast cancer,Nested case-control study,Pouchieu 2014
1296,22278,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),Breast cancer,Nested case-control study,Pouchieu 2014
1297,22279,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",Breast cancer,Nested case-control study,Pouchieu 2014
1298,22280,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",Breast cancer,Nested case-control study,Pouchieu 2014
1299,22281,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",Breast cancer,Nested case-control study,Pouchieu 2014
1300,22282,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",Breast cancer,Nested case-control study,Pouchieu 2014
1301,22283,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",Breast cancer,Nested case-control study,Pouchieu 2014
1302,22284,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",Breast cancer,Nested case-control study,Pouchieu 2014
1303,22285,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),Breast cancer,Nested case-control study,Pouchieu 2014
1304,22286,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",Breast cancer,Nested case-control study,Pouchieu 2014
1305,22287,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,EPA (cis-20:5n-3),"",Breast cancer,Nested case-control study,Pouchieu 2014
1306,22288,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,DPA (cis-22:5n-3),"",Breast cancer,Nested case-control study,Pouchieu 2014
1307,22289,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,DHA (cis-22:6n-3),"",Breast cancer,Nested case-control study,Pouchieu 2014
1308,22290,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,Mead acid (cis-20:3n-9),"",Breast cancer,Nested case-control study,Pouchieu 2014
1309,22291,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),Breast cancer,Nested case-control study,Pouchieu 2014
1310,22293,All,Prostate cancer cases and their controls,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),1132,566,566,"Plasma, fasting and non-fasting",GC-MS,Phytanic acid,"",Prostate cancer,Nested case-control study,Price 2010
1311,22294,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,Pentadecylic acid (15:0),"",Breast cancer,Nested case-control study,Chajes 2008
1312,22295,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,Margaric acid (17:0),"",Breast cancer,Nested case-control study,Chajes 2008
1313,22296,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,Palmitic acid (16:0),"",Breast cancer,Nested case-control study,Chajes 2008
1314,22297,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,Stearic acid (18:0),"",Breast cancer,Nested case-control study,Chajes 2008
1315,22298,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0) + Caprylic acid (8:0) + Capric acid (10:0) + Heneicosanoic acid (21:0) + Tricosanoic acid (23:0) + Undecylic acid (11:0) + Tridecylic acid (13:0),Breast cancer,Nested case-control study,Chajes 2008
1316,22513,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,Hexadecenoic acids (16:1),Palmitoleic acid (cis-16:1n-7) + Palmitelaidic acid (trans-16:1n-7),Breast cancer,Nested case-control study,Chajes 2008
1318,22301,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Palmitelaidic acid (trans-16:1n-7) + Oleic acid (cis-18:1n-9) + cis-Heptadecenoic acids (cis-17:1) + Asclepic acid (cis-18:1n-7) + Nervonic acid (cis-24:1n-9) + 11-Eicosenoic acid (cis-20:1n-9) + Elaidic acid (trans-18:1n-9) + 13-Docosenoic acid (cis-22:1n-9),Breast cancer,Nested case-control study,Chajes 2008
1320,22303,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",Breast cancer,Nested case-control study,Chajes 2008
1321,22304,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",Breast cancer,Nested case-control study,Chajes 2008
1322,22305,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)","Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + Linoelaidic acid (trans-18:2n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6) + 13,16-Docosadienoic acid (cis-22:2n-6)",Breast cancer,Nested case-control study,Chajes 2008
1323,22306,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",Breast cancer,Nested case-control study,Chajes 2008
1324,22307,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",Breast cancer,Nested case-control study,Chajes 2008
1325,22308,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",Breast cancer,Nested case-control study,Chajes 2008
1326,22309,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3),Breast cancer,Nested case-control study,Chajes 2008
1327,22310,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,Myristic acid (14:0),"",Breast cancer,Nested case-control study,Rissanen 2003
1328,22311,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,Pentadecylic acid (15:0),"",Breast cancer,Nested case-control study,Rissanen 2003
1329,22312,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,Palmitic acid (16:0),"",Breast cancer,Nested case-control study,Rissanen 2003
1330,22313,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,Margaric acid (17:0),"",Breast cancer,Nested case-control study,Rissanen 2003
1331,22314,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,Stearic acid (18:0),"",Breast cancer,Nested case-control study,Rissanen 2003
1332,22315,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0),Breast cancer,Nested case-control study,Rissanen 2003
1333,22316,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + cis-Heptadecenoic acids (cis-17:1) + Asclepic acid (cis-18:1n-7) + 7Z-Hexadecenoic acid (cis-16:1n-9),Breast cancer,Nested case-control study,Rissanen 2003
1334,22317,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,"Fatty acids, trans-monounsaturated (trans-MUFA)",10E-Octadecenoic acid (trans-18:1n-8) + Vaccenic acid (trans-18:1n-7) + Elaidic acid (trans-18:1n-9) + trans-Hexadecenoic acids (trans-16:1) + 6-8E-Octadecenoic acids (trans-18:1n-10-12),Breast cancer,Nested case-control study,Rissanen 2003
1335,22318,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,Vaccenic acid (trans-18:1n-7),"",Breast cancer,Nested case-control study,Rissanen 2003
1336,22319,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,Palmitoleic acid (cis-16:1n-7),"",Breast cancer,Nested case-control study,Rissanen 2003
1337,22320,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,Oleic acid (cis-18:1n-9),"",Breast cancer,Nested case-control study,Rissanen 2003
1338,22321,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6) + Conjugated linoleic acids (CLA; trans-18:2-CLA),Breast cancer,Nested case-control study,Rissanen 2003
1339,22322,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",Breast cancer,Nested case-control study,Rissanen 2003
1340,22323,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),Breast cancer,Nested case-control study,Rissanen 2003
1341,22324,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",Breast cancer,Nested case-control study,Rissanen 2003
1342,22325,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",Breast cancer,Nested case-control study,Rissanen 2003
1344,22327,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,Palmitic acid (16:0),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1345,22328,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,Stearic acid (18:0),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1346,22329,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Arachidic acid (20:0),Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1347,22330,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1348,22332,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,Oleic acid (cis-18:1n-9),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1349,22333,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,Asclepic acid (cis-18:1n-7),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1350,22331,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,Elaidic acid (trans-18:1n-9),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1351,22334,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + 11-Eicosenoic acid (cis-20:1n-9) + Elaidic acid (trans-18:1n-9),Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1352,22335,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1353,22336,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1354,22337,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1355,22338,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1356,22339,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1357,22340,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1358,22341,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,Osbond acid (cis-22:5n-6),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1359,22342,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1360,22343,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1361,22344,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,EPA (cis-20:5n-3),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1362,22345,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,DPA (cis-22:5n-3),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1363,22346,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,DHA (cis-22:6n-3),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1364,22347,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1365,22633,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1366,22349,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Arachidic acid (20:0),Breast cancer,Nested case-control study,Pala 2001
1367,22354,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Myristic acid (14:0),"",Breast cancer,Nested case-control study,Pala 2001
1368,22355,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Pentadecylic acid (15:0),"",Breast cancer,Nested case-control study,Pala 2001
1369,22356,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Palmitic acid (16:0),"",Breast cancer,Nested case-control study,Pala 2001
1370,22357,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Margaric acid (17:0),"",Breast cancer,Nested case-control study,Pala 2001
1371,22358,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Stearic acid (18:0),"",Breast cancer,Nested case-control study,Pala 2001
1372,22359,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Arachidic acid (20:0),"",Breast cancer,Nested case-control study,Pala 2001
1373,22350,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + 11-Eicosenoic acid (cis-20:1n-9) + Elaidic acid (trans-18:1n-9),Breast cancer,Nested case-control study,Pala 2001
1374,22360,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",Breast cancer,Nested case-control study,Pala 2001
1375,22361,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Asclepic acid (cis-18:1n-7),"",Breast cancer,Nested case-control study,Pala 2001
1376,22362,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Oleic acid (cis-18:1n-9),"",Breast cancer,Nested case-control study,Pala 2001
1377,22363,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Elaidic acid (trans-18:1n-9),"",Breast cancer,Nested case-control study,Pala 2001
1378,22364,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,11-Eicosenoic acid (cis-20:1n-9),"",Breast cancer,Nested case-control study,Pala 2001
1379,22352,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),Breast cancer,Nested case-control study,Pala 2001
1380,22365,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",Breast cancer,Nested case-control study,Pala 2001
1381,22366,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",Breast cancer,Nested case-control study,Pala 2001
1382,22367,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",Breast cancer,Nested case-control study,Pala 2001
1383,22368,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",Breast cancer,Nested case-control study,Pala 2001
1384,22369,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",Breast cancer,Nested case-control study,Pala 2001
1385,22370,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",Breast cancer,Nested case-control study,Pala 2001
1386,22371,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,Osbond acid (cis-22:5n-6),"",Breast cancer,Nested case-control study,Pala 2001
1387,22353,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),Breast cancer,Nested case-control study,Pala 2001
1388,22372,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",Breast cancer,Nested case-control study,Pala 2001
1389,22373,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,EPA (cis-20:5n-3),"",Breast cancer,Nested case-control study,Pala 2001
1390,22374,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,DPA (cis-22:5n-3),"",Breast cancer,Nested case-control study,Pala 2001
1391,22375,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,DHA (cis-22:6n-3),"",Breast cancer,Nested case-control study,Pala 2001
1392,22351,All,Breast cancer cases and their controls,Italy,ORDET,212,71,141,"Red blood cell membrane, fasting",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),Breast cancer,Nested case-control study,Pala 2001
1393,22376,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0) + Margaric acid (17:0) + Arachidic acid (20:0),Breast cancer,Nested case-control study,Chajes 1999
1394,22377,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,Myristic acid (14:0),"",Breast cancer,Nested case-control study,Chajes 1999
1395,22378,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,Palmitic acid (16:0),"",Breast cancer,Nested case-control study,Chajes 1999
1396,22379,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,Stearic acid (18:0),"",Breast cancer,Nested case-control study,Chajes 1999
1397,22380,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + 11-Eicosenoic acid (cis-20:1n-9) + Elaidic acid (trans-18:1n-9),Breast cancer,Nested case-control study,Chajes 1999
1398,22381,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,Palmitoleic acid (cis-16:1n-7),"",Breast cancer,Nested case-control study,Chajes 1999
1399,22382,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,Elaidic acid (trans-18:1n-9),"",Breast cancer,Nested case-control study,Chajes 1999
1400,22383,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,Asclepic acid (cis-18:1n-7),"",Breast cancer,Nested case-control study,Chajes 1999
1401,22384,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,Oleic acid (cis-18:1n-9),"",Breast cancer,Nested case-control study,Chajes 1999
1402,22385,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Osbond acid (cis-22:5n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),Breast cancer,Nested case-control study,Chajes 1999
1403,22386,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",Breast cancer,Nested case-control study,Chajes 1999
1404,22387,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",Breast cancer,Nested case-control study,Chajes 1999
1405,22388,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",Breast cancer,Nested case-control study,Chajes 1999
1406,22389,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),Breast cancer,Nested case-control study,Chajes 1999
1407,22390,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",Breast cancer,Nested case-control study,Chajes 1999
1408,22391,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,EPA (cis-20:5n-3),"",Breast cancer,Nested case-control study,Chajes 1999
1409,22392,All,Breast cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),584,196,388,"Serum, fasting and non-fasting",GC-FID,DHA (cis-22:6n-3),"",Breast cancer,Nested case-control study,Chajes 1999
1410,22393,All,Pancreatic cancer cases and their controls,China,Combined cohorts,549,187,362,"Serum, non-fasting",LC-MS/MS,Pyridoxal,"",Pancreatic cancer,Nested case-control study,Huang 2016
1411,22395,All,Colorectal cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),3684,1365,2319,"Plasma, fasting and non-fasting",LC-MS/MS,Vitamin B2,Riboflavin + Flavin mononucleotide (FMN),Colon and rectal cancer,Nested case-control study,Eussen 2010
1412,22394,All,Colorectal cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),3684,1365,2319,"Plasma, fasting and non-fasting",LC-MS/MS,Flavin mononucleotide (FMN),"",Colon and rectal cancer,Nested case-control study,Eussen 2010
1413,22396,All,Colorectal cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),3684,1365,2319,"Plasma, fasting and non-fasting",LC-MS/MS,Pyridoxal,"",Colon and rectal cancer,Nested case-control study,Eussen 2010
1414,22397,All,Gastric cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),836,235,601,"Plasma, fasting and non-fasting",LC-MS/MS,Pyridoxal,"",Gastric and oesophageal cancer,Nested case-control study,Eussen 2010
1415,22398,All,Gastric cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),836,235,601,"Plasma, fasting and non-fasting",LC-MS/MS,Vitamin B2,Riboflavin + Flavin mononucleotide (FMN),Gastric and oesophageal cancer,Nested case-control study,Eussen 2010
1416,22399,All,Gastric cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),836,235,601,"Plasma, fasting and non-fasting",LC-MS/MS,Flavin mononucleotide (FMN),"",Gastric and oesophageal cancer,Nested case-control study,Eussen 2010
1417,22400,All,Breast cancer cases and their controls,United States,Defense Medical Surveillance,1200,600,600,"Serum, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Mohr 2013
1418,22401,All,Lung cancer cases,Germany,Combined cohorts,13235,192,,Serum or Plasma,Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Lung cancer,Prospective cohort study,Ordonez-Mena 2016
1419,22402,All,Colorectal cancer cases,Germany,Combined cohorts,13809,616,,Serum or Plasma,Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Prospective cohort study,Ordonez-Mena 2016
1420,22403,All,Breast cancer cases,Germany,Combined cohorts,13487,378,,Serum or Plasma,Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Breast cancer,Prospective cohort study,Ordonez-Mena 2016
1421,22404,All,Prostate cancer cases,Germany,Combined cohorts,13351,392,,Serum or Plasma,Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Prostate cancer,Prospective cohort study,Ordonez-Mena 2016
1422,22405,All,Lymphoma cases,Germany,Combined cohorts,13600,279,,Serum or Plasma,Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Lymphoid cancer,Prospective cohort study,Ordonez-Mena 2016
1426,22406,All,Prostate cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",2000,1000,1000,"Serum, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Prostate cancer,Nested case-control study,Albanes 2011
1427,22407,All,Colorectal cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",550,275,275,"Serum, fasting",HPLC,Homocysteine,"",Colon and rectal cancer,Nested case-control study,Weinstein 2008
1428,22408,All,Colorectal cancer cases and their controls,United States,WHI-OS (Women's Health Initiative Observational Study),1976,988,988,"Plasma, fasting",HPLC,Homocysteine,"",Colon and rectal cancer,Nested case-control study,Miller 2013
1429,22409,All,Oesophageal adenocarcinoma cases,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),23697,73,,"Plasma, non-fasting",Colorimetry,Vitamin C,"",Gastric and oesophageal cancer,Prospective cohort study,Kang 2018
1430,22410,All,Liver cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",404,202,202,"Serum, fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Liver cancer,Nested case-control study,Lai 2018
1431,22411,All,Gastric and oesophageal cancer cases,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),4303,709,3594,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Gastric and oesophageal cancer,Case-cohort study,Budhathoki 2018
1432,22412,All,Colorectal cancer cases,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),4231,637,3594,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Case-cohort study,Budhathoki 2018
1433,22413,All,Liver cancer cases,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),3759,165,3594,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Liver cancer,Case-cohort study,Budhathoki 2018
1434,22414,All,Prostate cancer cases,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),3857,263,3594,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Prostate cancer,Case-cohort study,Budhathoki 2018
1435,22415,All,Breast cancer cases,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),3833,239,3594,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Breast cancer,Case-cohort study,Budhathoki 2018
1436,22416,All,Lung cancer cases,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),3990,396,3594,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Lung cancer,Case-cohort study,Budhathoki 2018
1437,22417,All,Colorectal cancer cases and their controls,United States,Combined cohorts,12813,5706,7107,Serum or Plasma,Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Colon and rectal cancer,Nested case-control study,McCullough 2018
1438,22418,All,Lung cancer cases and their controls,France,LC3 (Lung Cancer Cohort Consortium),10626,5313,5313,Serum or Plasma,LC-MS/MS,25-Hydroxycholecalciferol,"",Lung cancer,Nested case-control study,Muller 2018
1439,22419,All,Lung cancer cases,Norway,HUNT (Nord-Trøndelag Health Study),6421,696,5725,"Serum, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Lung cancer,Case-cohort study,Sun 2018
1440,22420,All,Pancreatic cancer cases and their controls,Netherlands,Combined cohorts,1476,738,738,Serum or Plasma,LC-ID-MS/MS,25-Hydroxycholecalciferol,"",Pancreatic cancer,Nested case-control study,van Duijnhoven 2018
1441,22421,All,Non-melanoma skin cancer cases,Denmark,Combined cohorts,33894,1569,,"Plasma, unspecified",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Skin cancer,Prospective cohort study,Winslow 2018
1442,22422,All,Lung cancer cases and their controls,Norway,EPIC (European Prospective Investigation into Cancer and Nutrition),2640,892,1748,"Serum, fasting and non-fasting",LC-MS/MS,PA-ratio (PAr),"",Lung cancer,Nested case-control study,Zuo 2018
1443,22423,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Lauric acid (12:0) + Arachidic acid (20:0) + Behenic acid (22:0) + Lignoceric acid (24:0),Colon and rectal cancer,Nested case-control study,Kojima 2005
1444,22424,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9) + Nervonic acid (cis-24:1n-9) + 11-Eicosenoic acid (cis-20:1n-9) + 13-Docosenoic acid (cis-22:1n-9),Colon and rectal cancer,Nested case-control study,Kojima 2005
1445,22425,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),Colon and rectal cancer,Nested case-control study,Kojima 2005
1446,22426,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + Eicosadienoic acid (cis-20:2n-6) + Docosatetraenoic acid (DTA; cis-22:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),Colon and rectal cancer,Nested case-control study,Kojima 2005
1447,22427,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,n6-PUFA / n3-PUFA,"",Colon and rectal cancer,Nested case-control study,Kojima 2005
1448,22428,All,Colorectal cancer cases and their controls,United States,PHS (Physicians' Health Study),460,178,282,"Whole blood, unspecified",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)","alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Eicosatrienoic acid (ETE; cis-20:3n-3) + 13Z,16Z,19Z-Docosatrienoic acid (cis-22:3n-3)",Colon and rectal cancer,Nested case-control study,Hall 2007
1449,22429,All,Colorectal cancer cases and their controls,United States,PHS (Physicians' Health Study),460,178,282,"Whole blood, unspecified",GC-FID,EPA (cis-20:5n-3),"",Colon and rectal cancer,Nested case-control study,Hall 2007
1450,22430,All,Colorectal cancer cases and their controls,United States,PHS (Physicians' Health Study),460,178,282,"Whole blood, unspecified",GC-FID,DHA (cis-22:6n-3),"",Colon and rectal cancer,Nested case-control study,Hall 2007
1451,22431,All,Colorectal cancer cases and their controls,United States,PHS (Physicians' Health Study),460,178,282,"Whole blood, unspecified",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Arachidonic acid (AA; cis-20:4n-6),Colon and rectal cancer,Nested case-control study,Hall 2007
1452,22434,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),Breast cancer,Case-cohort study,Bassett 2016
1453,22435,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,Myristic acid (14:0),"",Breast cancer,Case-cohort study,Bassett 2016
1454,22436,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,Palmitic acid (16:0),"",Breast cancer,Case-cohort study,Bassett 2016
1455,22437,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,Stearic acid (18:0),"",Breast cancer,Case-cohort study,Bassett 2016
1456,22438,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),Breast cancer,Case-cohort study,Bassett 2016
1457,22439,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,Palmitoleic acid (cis-16:1n-7),"",Breast cancer,Case-cohort study,Bassett 2016
1458,22440,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,Oleic acid (cis-18:1n-9),"",Breast cancer,Case-cohort study,Bassett 2016
1459,22441,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6),Breast cancer,Case-cohort study,Bassett 2016
1460,22442,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),Breast cancer,Case-cohort study,Bassett 2016
1461,22443,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",Breast cancer,Case-cohort study,Bassett 2016
1462,22444,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,EPA (cis-20:5n-3),"",Breast cancer,Case-cohort study,Bassett 2016
1463,22445,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,DHA (cis-22:6n-3),"",Breast cancer,Case-cohort study,Bassett 2016
1464,22446,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,DPA (cis-22:5n-3),"",Breast cancer,Case-cohort study,Bassett 2016
1465,22447,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6),Breast cancer,Case-cohort study,Bassett 2016
1466,22448,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",Breast cancer,Case-cohort study,Bassett 2016
1467,22449,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",Breast cancer,Case-cohort study,Bassett 2016
1468,22450,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",Breast cancer,Case-cohort study,Bassett 2016
1469,22451,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,n6-PUFA / n3-PUFA,"",Breast cancer,Case-cohort study,Bassett 2016
1470,22452,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,"Fatty acids, trans",trans-Octadecadienoic acids (trans-18:2) + Vaccenic acid (trans-18:1n-7) + Elaidic acid (trans-18:1n-9) + trans-Hexadecenoic acids (trans-16:1),Breast cancer,Case-cohort study,Bassett 2016
1471,22453,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,trans-Hexadecenoic acids (trans-16:1),"",Breast cancer,Case-cohort study,Bassett 2016
1472,22454,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,trans-Octadecadienoic acids (trans-18:2),"",Breast cancer,Case-cohort study,Bassett 2016
1473,22455,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,Vaccenic acid (trans-18:1n-7),"",Breast cancer,Case-cohort study,Bassett 2016
1474,22456,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0),Prostate cancer,Case-cohort study,Bassett 2013
1475,22457,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,Myristic acid (14:0),"",Prostate cancer,Case-cohort study,Bassett 2013
1476,22458,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,Palmitic acid (16:0),"",Prostate cancer,Case-cohort study,Bassett 2013
1477,22459,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,Stearic acid (18:0),"",Prostate cancer,Case-cohort study,Bassett 2013
1478,22460,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),Prostate cancer,Case-cohort study,Bassett 2013
1479,22461,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,Palmitoleic acid (cis-16:1n-7),"",Prostate cancer,Case-cohort study,Bassett 2013
1480,22462,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,Oleic acid (cis-18:1n-9),"",Prostate cancer,Case-cohort study,Bassett 2013
1481,22463,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6),Prostate cancer,Case-cohort study,Bassett 2013
1482,22464,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),Prostate cancer,Case-cohort study,Bassett 2013
1483,22465,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",Prostate cancer,Case-cohort study,Bassett 2013
1484,22466,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,EPA (cis-20:5n-3),"",Prostate cancer,Case-cohort study,Bassett 2013
1485,22467,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,DHA (cis-22:6n-3),"",Prostate cancer,Case-cohort study,Bassett 2013
1486,22468,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,DPA (cis-22:5n-3),"",Prostate cancer,Case-cohort study,Bassett 2013
1487,22469,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6),Prostate cancer,Case-cohort study,Bassett 2013
1488,22470,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",Prostate cancer,Case-cohort study,Bassett 2013
1489,22471,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",Prostate cancer,Case-cohort study,Bassett 2013
1490,22472,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",Prostate cancer,Case-cohort study,Bassett 2013
1491,22473,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,n6-PUFA / n3-PUFA,"",Prostate cancer,Case-cohort study,Bassett 2013
1492,22474,All,Prostate cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2125,464,1661,"Plasma, unspecified",GC-FID,"Fatty acids, trans",trans-Octadecenoic acids (trans-18:1) + trans-Octadecadienoic acids (trans-18:2) + trans-Hexadecenoic acids (trans-16:1),Prostate cancer,Case-cohort study,Bassett 2013
1493,22475,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,"Fatty acids, saturated (SFA)",Palmitic acid (16:0) + Stearic acid (18:0) + Myristic acid (14:0) + Pentadecylic acid (15:0),Colon and rectal cancer,Case-cohort study,Hodge 2015
1494,22476,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,Myristic acid (14:0),"",Colon and rectal cancer,Case-cohort study,Hodge 2015
1495,22477,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,Pentadecylic acid (15:0),"",Colon and rectal cancer,Case-cohort study,Hodge 2015
1496,22478,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,Palmitic acid (16:0),"",Colon and rectal cancer,Case-cohort study,Hodge 2015
1497,22479,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,Stearic acid (18:0),"",Colon and rectal cancer,Case-cohort study,Hodge 2015
1498,22480,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,"Fatty acids, monounsaturated (MUFA)",Palmitoleic acid (cis-16:1n-7) + Oleic acid (cis-18:1n-9),Colon and rectal cancer,Case-cohort study,Hodge 2015
1499,22481,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,Palmitoleic acid (cis-16:1n-7),"",Colon and rectal cancer,Case-cohort study,Hodge 2015
1500,22482,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,Oleic acid (cis-18:1n-9),"",Colon and rectal cancer,Case-cohort study,Hodge 2015
1501,22483,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,"Fatty acids, trans","",Colon and rectal cancer,Case-cohort study,Hodge 2015
1502,22484,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,"Fatty acids, n6-polyunsaturated (n6-PUFA)",Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),Colon and rectal cancer,Case-cohort study,Hodge 2015
1503,22485,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",Colon and rectal cancer,Case-cohort study,Hodge 2015
1504,22486,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",Colon and rectal cancer,Case-cohort study,Hodge 2015
1505,22487,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",Colon and rectal cancer,Case-cohort study,Hodge 2015
1506,22488,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",Colon and rectal cancer,Case-cohort study,Hodge 2015
1507,22489,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),Colon and rectal cancer,Case-cohort study,Hodge 2015
1508,22490,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",Colon and rectal cancer,Case-cohort study,Hodge 2015
1509,22491,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,EPA (cis-20:5n-3),"",Colon and rectal cancer,Case-cohort study,Hodge 2015
1510,22492,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,DPA (cis-22:5n-3),"",Colon and rectal cancer,Case-cohort study,Hodge 2015
1511,22493,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,DHA (cis-22:6n-3),"",Colon and rectal cancer,Case-cohort study,Hodge 2015
1512,22494,All,Colorectal cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),4205,395,3810,"Plasma, unspecified",GC-FID,"Fatty acids, polyunsaturated (PUFA)",alpha-Linolenic acid (ALA; cis-18:3n-3) + EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3) + Linoleic acid (LA; cis-18:2n-6) + Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6) + Arachidonic acid (AA; cis-20:4n-6) + gamma-Linolenic acid (GLA; cis-18:3n-6),Colon and rectal cancer,Case-cohort study,Hodge 2015
1513,22268,All,Prostate cancer cases and their controls,Finland,"ATBC (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study)",600,300,300,"Serum, fasting",GC-MS,Pristanic acid,"",Prostate cancer,Nested case-control study,Wright 2014
1514,22511,All,Prostate cancer cases and their controls,United States,PHS (Physicians' Health Study),952,476,476,"Whole blood, unspecified",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),Prostate cancer,Nested case-control study,Yang 2016
1515,22512,All,Breast cancer cases and their controls,France,SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants),158,79,79,"Plasma, fasting",GC-FID,n6-PUFA / n3-PUFA,"",Breast cancer,Nested case-control study,Pouchieu 2014
1516,4800,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),333,114,219,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,O-Desmethylangolensin,"",Breast cancer,Nested case-control study,Grace 2004
1517,4797,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),333,114,219,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Daidzein,"",Breast cancer,Nested case-control study,Grace 2004
1518,4798,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),333,114,219,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Genistein,"",Breast cancer,Nested case-control study,Grace 2004
1519,4799,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),333,114,219,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Glycitein,"",Breast cancer,Nested case-control study,Grace 2004
1520,4801,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),333,114,219,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Equol,"",Breast cancer,Nested case-control study,Grace 2004
1521,4802,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),333,114,219,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Enterodiol,"",Breast cancer,Nested case-control study,Grace 2004
1522,4803,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),333,114,219,"Urine, spot",GC-ID-MS after enzymatic hydrolysis,Enterolactone,"",Breast cancer,Nested case-control study,Grace 2004
1523,4807,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),333,114,219,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,O-Desmethylangolensin,"",Breast cancer,Nested case-control study,Grace 2004
1524,4804,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),333,114,219,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Daidzein,"",Breast cancer,Nested case-control study,Grace 2004
1525,4805,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),333,114,219,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Genistein,"",Breast cancer,Nested case-control study,Grace 2004
1526,4806,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),333,114,219,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Glycitein,"",Breast cancer,Nested case-control study,Grace 2004
1527,4808,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),333,114,219,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Equol,"",Breast cancer,Nested case-control study,Grace 2004
1528,4809,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),333,114,219,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Enterodiol,"",Breast cancer,Nested case-control study,Grace 2004
1529,4810,All,Cases and controls in a case-control study on breast cancer and diet,United Kingdom,EPIC (European Prospective Investigation into Cancer and Nutrition),333,114,219,"Serum, unspecified",LC-ID-MS/MS after enzymatic hydrolysis,Enterolactone,"",Breast cancer,Nested case-control study,Grace 2004
1531,22514,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,Octadecenoic acids (18:1),Oleic acid (cis-18:1n-9) + Asclepic acid (cis-18:1n-7) + Elaidic acid (trans-18:1n-9),Breast cancer,Nested case-control study,Chajes 2008
1532,22515,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,12-Octadecadienoic acids (18:2n-6),Linoleic acid (LA; cis-18:2n-6) + Linoelaidic acid (trans-18:2n-6),Breast cancer,Nested case-control study,Chajes 2008
1533,22518,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,6-9E-Octadecenoic acids (trans-18:1n-9-12),"",Breast cancer,Nested case-control study,Chajes 2017
1534,22519,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,Vaccenic acid (trans-18:1n-7),"",Breast cancer,Nested case-control study,Chajes 2017
1535,22520,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, ruminant, trans-",Vaccenic acid (trans-18:1n-7) + trans-Hexadecenoic acids (trans-16:1n-7/9) + Conjugated linoleic acids (CLA; trans-18:2-CLA),Breast cancer,Nested case-control study,Chajes 2017
1536,22521,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,"Fatty acids, industrial, trans-",Linoelaidic acid (trans-18:2n-6) + 6-9E-Octadecenoic acids (trans-18:1n-9-12) + trans-alpha-Linolenic acids (trans-18:3n-3),Breast cancer,Nested case-control study,Chajes 2017
1537,22522,All,Breast cancer cases and their controls,Finland,Finnish Mobile Clinic Surveys,369,127,242,"Serum, unspecified",GC-FID,Conjugated linoleic acids (CLA; trans-18:2-CLA),"",Breast cancer,Nested case-control study,Rissanen 2003
1538,22523,All,Breast cancer cases,Australia,MCCS (Melbourne Collaborative Cohort Study),2491,470,2021,"Plasma, unspecified",GC-FID,Elaidic acid (trans-18:1n-9),"",Breast cancer,Case-cohort study,Bassett 2016
1539,22554,All,Breast cancer cases and their controls,France,EPIC (European Prospective Investigation into Cancer and Nutrition),5964,2982,2982,"Plasma, fasting and non-fasting",GC-FID,n6-PUFA / n3-PUFA,"",Breast cancer,Nested case-control study,Chajes 2017
1540,22588,All,Breast cancer cases and their controls,France,E3N (Etude Epidemiologique aupres des femmes de la Mutuelle Generale de l’Education Nationale),1065,363,702,"Serum, fasting and non-fasting",GC-FID,n6-PUFA / n3-PUFA,"",Breast cancer,Nested case-control study,Chajes 2008
1541,22595,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,alpha-Linolenic acid (ALA; cis-18:3n-3),"",Colon and rectal cancer,Nested case-control study,Kojima 2005
1542,22596,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,EPA (cis-20:5n-3),"",Colon and rectal cancer,Nested case-control study,Kojima 2005
1543,22597,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,DPA (cis-22:5n-3),"",Colon and rectal cancer,Nested case-control study,Kojima 2005
1544,22598,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,DHA (cis-22:6n-3),"",Colon and rectal cancer,Nested case-control study,Kojima 2005
1545,22599,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,Linoleic acid (LA; cis-18:2n-6),"",Colon and rectal cancer,Nested case-control study,Kojima 2005
1546,22600,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,gamma-Linolenic acid (GLA; cis-18:3n-6),"",Colon and rectal cancer,Nested case-control study,Kojima 2005
1547,22601,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,Eicosadienoic acid (cis-20:2n-6),"",Colon and rectal cancer,Nested case-control study,Kojima 2005
1548,22602,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",Colon and rectal cancer,Nested case-control study,Kojima 2005
1549,22603,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,Arachidonic acid (AA; cis-20:4n-6),"",Colon and rectal cancer,Nested case-control study,Kojima 2005
1550,22604,All,Colorectal cancer cases and their controls,Japan,JACC Study (Japan Collaborative Cohort Study),650,169,481,"Serum, unspecified",GC-FID,Docosatetraenoic acid (DTA; cis-22:4n-6),"",Colon and rectal cancer,Nested case-control study,Kojima 2005
1551,22634,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,Myristic acid (14:0),"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1552,22348,All,Breast cancer cases and their controls,United States,NYUWHS (New York University Women's Health Study),394,197,197,"Serum, non-fasting",GC-FID,PUFA / SFA,"",Breast cancer,Nested case-control study,Saadatian-Elahi 2002
1553,22643,All,Prostate cancer cases,United States,SELECT (Selenium and Vitamin E Cancer Prevention Trial),2198,834,1364,"Plasma, unspecified",GC-FID,"Fatty acids, n3-polyunsaturated (n3-PUFA)",EPA (cis-20:5n-3) + DHA (cis-22:6n-3) + DPA (cis-22:5n-3),Prostate cancer,Case-cohort study,Brasky 2013
1554,22644,All,Epithelial ovarian cancer cases and their controls,United States,Combined cohorts,482,168,314,Serum or Plasma,Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Ovarian cancer,Nested case-control study,Arslan 2009
1556,22652,All,Colon and rectal cancer cases and their controls,United States,CLUE,317,106,211,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Colon and rectal cancer,Nested case-control study,Comstock 1991
1558,22654,All,Prostate cancer cases and their controls,United States,CLUE,206,103,103,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Prostate cancer,Nested case-control study,Comstock 1991
1559,22655,All,Melanoma and basal cell skin cancer cases and their controls,United States,CLUE,123,41,82,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Skin cancer,Nested case-control study,Comstock 1991
1560,22646,All,Pancreatic cancer cases and their controls,United States,CLUE,66,22,44,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Pancreatic cancer,Nested case-control study,Comstock 1991
1561,22650,All,Postmenopausal breast cancer cases and their controls,United States,CLUE,89,30,59,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Breast cancer,Nested case-control study,Comstock 1991
1562,22656,All,Pancreatic cancer cases and their controls,United States,CLUE,66,22,44,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Pancreatic cancer,Nested case-control study,Comstock 1991
1563,22658,All,Postmenopausal breast cancer cases and their controls,United States,CLUE,89,30,59,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Breast cancer,Nested case-control study,Comstock 1991
1564,22649,All,Pancreatic cancer cases and their controls,United States,CLUE,66,22,44,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Pancreatic cancer,Nested case-control study,Comstock 1991
1565,22647,All,Postmenopausal breast cancer cases and their controls,United States,CLUE,89,30,59,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Breast cancer,Nested case-control study,Comstock 1991
1566,22651,All,Bladder cancer cases and their controls,United States,CLUE,105,35,70,"Serum, fasting and non-fasting",HPLC,alpha-Tocopherol,"",Bladder cancer,Nested case-control study,Comstock 1991
1567,22648,All,Bladder cancer cases and their controls,United States,CLUE,105,35,70,"Serum, fasting and non-fasting",HPLC,beta-Carotene,"",Bladder cancer,Nested case-control study,Comstock 1991
1568,22659,All,Bladder cancer cases and their controls,United States,CLUE,105,35,70,"Serum, fasting and non-fasting",HPLC,Lycopene,"",Bladder cancer,Nested case-control study,Comstock 1991
1569,22660,All,Colorectal cancer cases and their controls,Sweden,NSHDC (Northern Sweden Health and Disease Study Cohort),1803,613,1190,"Plasma, fasting and non-fasting",GC-MS,PA-ratio (PAr),"",Colon and rectal cancer,Nested case-control study,Gylling 2017
1570,22662,All,Lung cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,17,,"Serum, fasting",HPLC,Lycopene,"",Lung cancer,Prospective cohort study,Karppi 2009
1571,22663,All,Lung cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,17,,"Serum, fasting",HPLC,Retinol,"",Lung cancer,Prospective cohort study,Karppi 2009
1572,22664,All,Lung cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,17,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Lung cancer,Prospective cohort study,Karppi 2009
1573,22665,All,Lung cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,17,,"Serum, fasting",HPLC,alpha-Carotene,"",Lung cancer,Prospective cohort study,Karppi 2009
1574,22666,All,Lung cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,17,,"Serum, fasting",HPLC,beta-Carotene,"",Lung cancer,Prospective cohort study,Karppi 2009
1575,22667,All,Urinary bladder cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,10,,"Serum, fasting",HPLC,Lycopene,"",Bladder cancer,Prospective cohort study,Karppi 2009
1576,22668,All,Urinary bladder cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,10,,"Serum, fasting",HPLC,Retinol,"",Bladder cancer,Prospective cohort study,Karppi 2009
1577,22669,All,Urinary bladder cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,10,,"Serum, fasting",HPLC,alpha-Tocopherol,"",Bladder cancer,Prospective cohort study,Karppi 2009
1578,22670,All,Urinary bladder cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,10,,"Serum, fasting",HPLC,alpha-Carotene,"",Bladder cancer,Prospective cohort study,Karppi 2009
1579,22671,All,Urinary bladder cancer cases,Finland,KIHD (Kuopio Ischaemic Heart Disease Risk Factor),997,10,,"Serum, fasting",HPLC,beta-Carotene,"",Bladder cancer,Prospective cohort study,Karppi 2009
1580,22677,All,Bladder cancer cases,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),3654,60,3594,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Bladder cancer,Case-cohort study,Budhathoki 2018
1581,22680,All,Ovarian cancer cases,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),3634,40,3594,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Ovarian cancer,Case-cohort study,Budhathoki 2018
1582,22676,All,Kidney cancer cases,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),3659,65,3594,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Kidney cancer,Case-cohort study,Budhathoki 2018
1583,22678,All,Thyroid cancer cases,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),3662,68,3594,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Thyroid cancer,Case-cohort study,Budhathoki 2018
1584,22673,All,Biliary tract cancer cases,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),3709,115,3594,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Liver cancer,Case-cohort study,Budhathoki 2018
1585,22679,All,Uterine corpus cancer cases,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),3647,53,3594,"Plasma, fasting and non-fasting",Chemiluminescence immunoassay (CLIA),25-Hydroxycholecalciferol,"",Endometrial cancer,Case-cohort study,Budhathoki 2018
1586,22495,All,Colorectal cancer cases and their controls,Singapore,Singapore Chinese Health Study,700,350,350,"Plasma, non-fasting",GC-MS/MS,Palmitic acid (16:0),"",Colon and rectal cancer,Nested case-control study,Butler 2017
1587,22496,All,Colorectal cancer cases and their controls,Singapore,Singapore Chinese Health Study,700,350,350,"Plasma, non-fasting",GC-MS/MS,Stearic acid (18:0),"",Colon and rectal cancer,Nested case-control study,Butler 2017
1588,22497,All,Colorectal cancer cases and their controls,Singapore,Singapore Chinese Health Study,700,350,350,"Plasma, non-fasting",GC-MS/MS,Palmitoleic acid (cis-16:1n-7),"",Colon and rectal cancer,Nested case-control study,Butler 2017
1589,22498,All,Colorectal cancer cases and their controls,Singapore,Singapore Chinese Health Study,700,350,350,"Plasma, non-fasting",GC-MS/MS,Oleic acid (cis-18:1n-9),"",Colon and rectal cancer,Nested case-control study,Butler 2017
1590,22499,All,Colorectal cancer cases and their controls,Singapore,Singapore Chinese Health Study,700,350,350,"Plasma, non-fasting",GC-MS/MS,alpha-Linolenic acid (ALA; cis-18:3n-3),"",Colon and rectal cancer,Nested case-control study,Butler 2017
1591,22500,All,Colorectal cancer cases and their controls,Singapore,Singapore Chinese Health Study,700,350,350,"Plasma, non-fasting",GC-MS/MS,EPA (cis-20:5n-3),"",Colon and rectal cancer,Nested case-control study,Butler 2017
1592,22501,All,Colorectal cancer cases and their controls,Singapore,Singapore Chinese Health Study,700,350,350,"Plasma, non-fasting",GC-MS/MS,DHA (cis-22:6n-3),"",Colon and rectal cancer,Nested case-control study,Butler 2017
1593,22502,All,Colorectal cancer cases and their controls,Singapore,Singapore Chinese Health Study,700,350,350,"Plasma, non-fasting",GC-MS/MS,Linoleic acid (LA; cis-18:2n-6),"",Colon and rectal cancer,Nested case-control study,Butler 2017
1594,22503,All,Colorectal cancer cases and their controls,Singapore,Singapore Chinese Health Study,700,350,350,"Plasma, non-fasting",GC-MS/MS,gamma-Linolenic acid (GLA; cis-18:3n-6),"",Colon and rectal cancer,Nested case-control study,Butler 2017
1595,22504,All,Colorectal cancer cases and their controls,Singapore,Singapore Chinese Health Study,700,350,350,"Plasma, non-fasting",GC-MS/MS,Dihomo-gamma-linolenic acid (DGLA; cis-20:3n-6),"",Colon and rectal cancer,Nested case-control study,Butler 2017
1596,22505,All,Colorectal cancer cases and their controls,Singapore,Singapore Chinese Health Study,700,350,350,"Plasma, non-fasting",GC-MS/MS,Arachidonic acid (AA; cis-20:4n-6),"",Colon and rectal cancer,Nested case-control study,Butler 2017
1597,22227,All,Gastric cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),988,494,494,"Plasma, fasting and non-fasting",HPLC,Epicatechin,"",Gastric and oesophageal cancer,Nested case-control study,Sasazuki 2008
1598,22228,All,Gastric cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),988,494,494,"Plasma, fasting and non-fasting",HPLC,Epicatechin 3-gallate,"",Gastric and oesophageal cancer,Nested case-control study,Sasazuki 2008
1599,22229,All,Gastric cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),988,494,494,"Plasma, fasting and non-fasting",HPLC,Epigallocatechin,"",Gastric and oesophageal cancer,Nested case-control study,Sasazuki 2008
1600,22230,All,Gastric cancer cases and their controls,Japan,JPHC (Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases),988,494,494,"Plasma, fasting and non-fasting",HPLC,Epigallocatechin 3-gallate,"",Gastric and oesophageal cancer,Nested case-control study,Sasazuki 2008
1601,22681,All,Breast cancer cases and their controls,United States,NHS (Nurses' Health Study),1168,584,584,"Plasma, fasting and non-fasting",Radioimmunoassay (RIA),25-Hydroxycholecalciferol,"",Breast cancer,Nested case-control study,Wang 2014
1602,22024,All,Prostate cancer cases and their controls,United States,Combined cohorts,2840,370,2470,"Plasma, fasting and non-fasting",HPLC,Retinol,"",Prostate cancer,Nested case-control study,Graff 2017
1603,22027,All,Prostate cancer cases and their controls,United States,Combined cohorts,2840,370,2470,"Plasma, fasting and non-fasting",Neutron activation analysis,Selenium,"",Prostate cancer,Nested case-control study,Graff 2017
